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SYNOPSIS 
 
Portland cement (PC) is generally known for its various applications in the construction 
industry. However, since mineral trioxide aggregate (MTA), a PC based root filling material, 
obtained food and drug administration (FDA) approval in the late 1990’s there has been an 
increased interest in the use of the cement for other in vivo applications. PCs are durable, 
possess high compressive strengths, set in aqueous environments such as those found in vivo 
and have demonstrated desirable tissue responses as an endodontic sealant. 
The injectability of PC with various additives was investigated for use in clinical applications 
such as vertebroplasty (the stabilisation of a fractured vertebra with bone cement) using a 
syringe with a 2 mm aperture. Additives significantly improved cement injectability, 
decreased setting times from over 2 h to below 20 minutes while maintaining the compressive 
strength of the material. Cement characterisation methods including X-ray diffraction (XRD), 
helium pycnometry and zeta potential measurements were employed to elucidate the effect of 
the additives on the cement setting reaction. The biocompatibility of PC was investigated 
with fibroblast and bone marrow cells. The freshly mixed cement appeared cytotoxic while 
set cement upregulated genes associated with the osteogenic phenotype. 
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1 INTRODUCTION 
1.1 Project background 
Portland cement (PC) is generally known for its various applications in the construction 
industry (1). However, since mineral trioxide aggregate (MTA), a PC based root filling 
material, obtained food and drug administration (FDA) approval in the late 1990’s there has 
been an increased interest in the use of the cement for other in vivo applications (2-4). PCs 
are durable, possess high compressive strengths, set in aqueous environments such as those 
found in vivo and have demonstrated desirable tissue responses as an endodontic sealant (5-
8).  
Vertebral compression fractures (VCFs) are caused by the collapse of a vertebra due to 
diseases such as osteoporosis or vertebral myelomas (5, 9-12). Vertebroplasty is the 
minimally invasive surgical procedure which stabilises a fractured vertebral body by the 
injection of bone cement into the fracture (13). At present the cement used in the majority of 
these procedures is polymethylmethacrylate (PMMA) (14). PMMA has a compressive 
strength in the region of 80 MPa and a setting time of approximately 6.5 to 15 minutes, which 
permits complete immobilisation of vertebrae while the patient is in the operating theatre and 
allows the patient to be discharged on the same day (15, 16). However, the use of PMMA is 
associated with several procedural complications including the highly exothermic 
polymerisation of the methyl methacrylate monomer which may lead to localised tissue 
necrosis (17). In contrast, PCs setting reaction is only weakly exothermic and has been shown 
not to increase localised tissue temperature during setting (18). The toxic PMMA monomer 
has also been shown to diffuse from the site of application and has been linked to increased 
morbidity for patients through pulmonary embolism (19).  
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There are two key challenges which need to be addressed before PC can be considered as 
suitable bone cement for applications such as vertebroplasty. Firstly, it would be desirable if 
the cement was injectable through the aperture of a needle using a force applicable for 
manual injection. Secondly, the extended setting times of PC of 3-4 hour at the manufacturers 
standard powder-to-liquid ratio (PLR) of 3 g ml
-1
 needs to be reduced (20).
 
There are several 
commercially available liquefying and accelerating additives available for PC from the 
building industry (21-24). However, these additives were not developed for in vivo use and 
can contain biologically harmful chemicals such as formaldehyde (25). Hence a range of non-
biologically harmful chemicals will be selected from the cement chemistry literature.  
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1.2 Vertebral column anatomy and mechanics 
The vertebral column, (spine), normally consists of twenty four separate vertebrae, together 
with five fused vertebrae that form the sacrum and four fused vertebrae that form the coccyx 
(figure 1.2.1). The separate vertebrae can be further subdivided according to their location on 
the spine, into (starting from the skull), 7 cervical, 12 thoracic and 5 lumbar 
vertebra regions (26). Vertebral sizes increase down the spinal column, with the cervical 
vertebrae being the smallest and the lumbar vertebrae being the largest. The lumbar region 
supports the majority of the bodies load during movement (27).  
 
Figure 1.2.1 MRI of the vertebral column highlighting the different regions of the spine [27]. 
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The vertebral column has many functions these include: 
1. Protecting the spinal cord and spinal nerves. 
2. Supporting the majority of the body weight. 
3. Providing a partly rigid and flexible axis for the body and a pivot for the head.  
4. Playing an essential role in locomotion (28) (26).  
 A typical vertebra consists of, a vertebral body, a vertebral (neural) arch and seven processes 
(figure 1.2.2). The vertebral body is the anterior part of the vertebra that gives strength to the 
vertebral column and provides support for body weight (26). The inner cores of the vertebral 
bodies are composed of spongy trabecular or cancellous bone and are surrounded by dense, 
hard cortical bone (27). This design is lighter than purely solid bone and is better suited for 
coping with dynamic loads as it is more flexible (29). Between the vertebral bodies are inter-
vertebral discs that are largely responsible for transferring load between vertebral bodies (26).  
 
Figure 1.2.2 A typical vertebrae of the spine illustrating the vertebral body, consisting of cancellous bone the neural 
arch, where the spinal cord threads and the spinal processes.  Adapted from (30). 
    
The spine possesses two degrees of movement with flexion extension (forward and back) and 
lateral bending (side to side). Experimental compressive strength for lumbar vertebrae ranges 
from approximately 1.4-9 MPa (31-33). The flexural strength of vertebrae is only 1.58 ± 
Neural arch 
Vertebral body 
Spinal processes 
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0.61 MPa the strength being limited by the brittle nature of the major mineral phase 
hydroxyapatite (31).  
1.3 Predominant causes of vertebral compression fractures 
Osteoporosis is defined as ‘A systemic skeletal disease characterised by low bone mass and 
micro-architectural deterioration of bone tissue causing (trabecular thinning), with a 
consequent increase in bone fragility and susceptibility to fracture risk’ (34).  
In developed countries, osteoporosis is the leading cause of vertebral compression fractures 
(VCFs) (35) (36), with more than 1.4 million spinal fractures occurring worldwide each 
year (37). Medical annual costs in Europe and the USA alone total in excess of $1.1 billion 
dollars (38).  Osteoporosis is predominantly an age related disease (figure 1.3.1), it 
particularly affects post-menopausal women. This population bias has been attributed to 
increased remodelling and resorption of bone, by osteoclasts, in women after the menopause 
(27) (39).  (26% of women over 50 years old and 40 % of women over 80 years old are 
reported to have sustained a VCF (40) (41).) 
 
Figure 1.3.1  Graph illustrating the age related incidence of osteoporosis with increasing prevalence particularly in  
post-menopausal women (42).  
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With the rapidly aging population in developed countries, the number of osteoporosis cases 
are expected to increase greatly, escalating the financial burden of treatment for developed 
economies (43).  Vertebral fractures can also be caused by vertebral myelomas and spinal 
sporting injuries therefore, research into an effective, safe and efficacious treatment for VCF 
is essential (44). The most widely used treatment for VCFs is percutaneous vertebroplasty 
(PVP); the procedure has changed little in over 20 years and still uses 
polymethylmethacrylate (PMMA) cement as the main vertebral body filler. This cement 
satisfactorily performs its PVP function; however, it also has many inadequacies and for 
improved treatments should ideally be revised or replaced.  
 
1.4 Overview of vertebroplasty, kyphoplasty and skyphoplasty 
Percutaneous vertebroplasty (PVP) and kyphoplasty (KP) are the main procedures for 
treatment of VCFs including those caused by osteoporotic vertebral compression fractures, 
spinal metastases and vertebral myelomas (45) (46). Both PVP and KP are minimally 
invasive surgical procedures which stabilise the fractured vertebral body by injection of a 
bone cement material into the vertebral fracture (47). KP varies from normal PVP at the 
injection stage, prior to injection of the cement a balloon is inflated in the vertebra in order to 
restore the vertebral body height and kyphotic angle of 8.5° (48) (49). Evidence suggests that 
this modified technique also reduces cement leakage which can lead to reduced cases of 
pulmonary embolism (50).  
Lordoplasty (51) (49) and Skyphoplasty (13) are subcategories of KP in the former technique 
the vertebra adjacent to the fracture are also cemented and the needles are left in the vertebral 
body during the cement curing process. The needles can then be subsequently used as levers 
to try and restore the vertebral body height. Skyphoplasty uses an expanding polymer in place 
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of a balloon. The disadvantage with this technique is that the introduced polymer could also 
have toxic side effects (52).  
1.4.1 Description of the vertebroplasty procedure  
The patient is placed in the prone position, before being locally anaesthetised in the 
paraspinal muscles and periosteum (51). Under fluoroscopic guidance
1
 K-wires
2
 are then 
inserted through the paraspinal muscle and pedicles into the vertebral body holding the 
vertebra in place (53-55). Bore needles are subsequently inserted over the K-wires into the 
vertebral body, at which point the supporting wires can be removed (figure 1.4.1). The bone 
cement is then mixed  before being injected into the fracture cavity (56).  
                                                 
1
 Fluoroscopy is a 4-D imaging technique which allows surgeons to view the spine and surrounding tissue in 
real time during the operation. It requires an x-ray source and a fluorescent screen behind the patient. 
2
 A Kirschner wire (also called a K-wire) is a thin, rigid wire that can be used to stabilize bone fragments. These 
wires can be drilled through the bone to hold the fragments in place. 
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Figure 1.4.1 Adapted from [50] Diagrammatic representation of the  vertebroplasty procedure depicting: (a) lateral 
view of the lumbar spinal segment with a compression fracture; (b) two large bore needles that are introduced in the 
vertebral body; (K-wires have been omitted). (c) Vertical view of the correct transpedicular needle placement (d) 
stabilization of the compressed vertebral body with bone cement into the fracture.  
 
 After the procedure is complete the surgeon usually prescribes bed rest for patients in a 
supine position for another 6 h prior to discharge.  
  
Vertebra fracture 
Bore needles 
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1.5 Review of model systems used to assess efficacy of the vertebroplasty procedure 
Computational, human cadaver and animal studies are presently being researched in order to 
discover new methods for improving the vertebroplasty procedure.   
1.5.1 Vertebroplasty computational models  
Kozic et al (57) modelled patients vertebrae based on computerised tomography (CT) scans 
and subsequently during the vertebroplasty procedure utilised a developed algorithm to 
predict real-time cement volumes in various parts of the vertebrae based on the flow rate of 
the surgeons syringe. The aim of the study was to devise a warning system for cement 
leakage which could prevent instances of localised tissue necrosis and pulmonary embolism. 
Widmer et al (58) developed a similar computational model that described the flow of acrylic 
bone cements in porous bone structures by considering the materials porosity and the cements 
rheology. The predicted final filling volume of the computational model was compared with 
actual volumes used during the vertebroplasty procedure and demonstrated a 17 % relative 
error. In the future a refined model may be used to predict 3D filling shape of the bone 
cement prior to surgery assisting the surgeon in assessing if any complications may arise such 
as cement leakage.    
Rohlmann et al  (59) composed a numerical finite element (FE) model of augmented lumbar 
vertebrae from CT scans in order to investigate the synergistic effect of the multiple stresses 
produced by bone cements. The study measured cement filling shape, cement volume and 
effect of elastic moduli of the bone cement on the mechanical properties of the augmented 
bone. The study concluded that maximum stresses in the augmented vertebral body mainly 
depended on the original fracture shape. Kinzl et al (60) also composed an FE model based 
on CT images of lumbar vertebrae before and after the PVP augmentation procedure. 
Subsequently, cylindrical PMMA/bone specimens were extracted from the augmented 
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vertebrae and tested in compression and axial strain measured with an extensometer. The 
elastic modulus was defined as the maximum slope of the stress-strain curve and yield stress 
calculated using the offset-method. The elastic modulus and yield stresses were then 
correlated with the bone volume fraction and porosities calculated from the model. There was 
an R
2
 correlation of 0.98 between the elastic modulus of the experimental biopsies and the 
materials porosity leading the author to conclude that porosity was a determining factor in 
mechanical properties of augmented vertebrae.   
Unikrishnan et al (61) developed a new mapping procedure to build a more accurate and 
precise quantitative computer tomography model (QCT). In addition to producing a mesh of 
the vertebrae based on CT scans the mechanical properties (e.g. material stiffness) of the 
vertebrae were also predicted based on bone mineral density. Since the model differentiates 
between materials densities it may find particular use the refinement between vertebral 
myelomas and hard bone tissue.  
1.5.2 Vertebroplasty models based on the human cadaver 
Vertebroplasty models based on the human cadaver have provided useful insights into the 
dissipation of heat through vertebrae and cement leakage.   
Cadaver models were used to assess the temperature in various parts of lumbar vertebrae 
during the exothermic setting reaction of PMMA. Rodrigues et al (62) inserted 
thermocouples in the midbody of the vertebrae and after equilibration at 37 °C, 5 ml of  
commercial PMMA (KyphX, Medtronic, USA) was injected into the vertebrae reaching 
temperature’s of over 75 °C. At temperatures above 70°C it was determined tissue necrosis 
could have occurred. Golz et al (63) used a cadaver model to assess localised tissue 
temperatures during a simulated cranioplasty procedure. As the heat dissipated from the 
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PMMA after injection localised tissues experienced a temperature of 50 °C, 25 °C lower than 
the injection site but still high enough to cause tissue necrosis.       
Another cadaver model simulated cement leakage into the local arterial blood supply of 
vertebrae. The arterial blood supply was simulated by means of saline irrigation via 2 needles 
into the ventral section of the vertebral body. The authors found that PMMA injection 
actually resulted in trabecular fractures and the subsequent movement of the bone fragments 
into the spinal canal (64).  
 
1.5.3 Vertebroplasty models based on animal studies  
There are a limited number of human vertebrae for evaluating PVP augmentation procedures. 
Animal testing provides critical insights into PVP and forms an essential part of the clinical 
trials process (65).  
A major problem with animal studies is that the test species are often quadrupeds with 
different forces being exerted on the spine than human subjects. As a consequence animal 
vertebrae possess altered mechanical properties to humans and may not represent an accurate 
PVP model. However, animals can be bred and selected for a particular disease phenotype of 
interest. Galovich et al  (66) bred osteoporotic sheep and performed PVP on several vertebrae 
of each sheep with novel calcium phosphate cement. In over 20 % of the vertebrae the 
fracture site was found to be devoid of cement after sacrificing the animals which may have 
been caused in part by excessive cement leakage as cement escaped from the wide cancellous 
pores.    
Animal studies also provide the possibility to obtain histological information at precise time 
points which in many cases cannot occur for ethical reasons in human studies. Krebs et al 
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(67) investigated the reported effect of inter-vertebral disc degeneration following the PVP 
augmentation procedure. The vertebroplasty procedure was performed on mature sheep 
which were sacrificed 6 or 12 months after the augmentation procedure. The 
histomorphological data indicated that there was no significant difference anatomically 
between the disks in contact with vertebrae containing PMMA and those which were not.  
Patients are monitored for improvements in mobility after the PVP operation. However, 
performing the procedure on an animal with initial excellent mobility allows researchers to 
closely assess degradation in movements.  Lu et al  (68) monitored the effect of bone cement 
in a dog model. The status of the tissues adjacent to the injection site was monitored with 
MRI and demonstrated little inflammation. The range of movement of the dogs following the 
procedure was observed and found to be largely unaffected. 
Animal studies also provide insights into rare human diseases such as vertebral cancers. 
Axelsen et al (69) designed an animal study to investigate tissue migration from the vertebrae 
to the lungs with patients suffering from spinal metastases. A labelled albumin marker was 
injected into the centre of each pigs L5 and L6 lumbar vertebrae prior to vertebroplasty to 
assess tissue migration. The study concluded that there was a significant risk of tissue 
migration to the lungs for vertebroplasty patients who suffer from vertebral myelomas and 
the procedure was not suitable for these patients.  
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1.6 The use of Polymethylmethacrylate (PMMA) as an orthopaedic bone cement  
Polymethylmethacrylate (PMMA) is an acrylic polymer based on the methylmethacrylate 
monomer. It was first used clinically for cranioplasty in the Second World War and was 
developed into orthopaedic cement by the surgeon Sir John Charnley in the late 1950’s (70).  
1.6.1 Advantages and disadvantages of Polymethylmethacrylate (PMMA)  
PMMA has many benefits as a vertebroplasty bone cement; it is injectable through a wide 
bore needle, allows the addition of radiopacifiers for fluoroscopic monitoring, has 
demonstrated a long-term stabilising effect on vertebrae and sets after mixing in 5-15 minutes 
which is considered a working time for the vertebroplasty operation (15, 71, 72).  
However, there are many procedural complications associated with PVP and its related 
techniques. Some of these complications, such as haemorrhage, infection and increased risk 
of vertebral collapse (VC), are due to the surgical procedure and are independent of the type 
of bone cement used (19).  The other main reason for complication is the use of the bone 
cement PMMA.      
The polymerisation of methyl methacrylate is an exothermic process leading to possible 
necrosis of contacting tissues (44).  Exothermic setting also lowers the activity of biologically 
active ingredients such as growth factors through their denaturation at high temperatures. The 
same monomer has also shown to lead to hypersensitivity, allergic dermatitis and mucosal 
irritation (73). The material also suffers from poor osseointegration (bonding between bone 
and biomaterial) (74).  
The PMMA cement monomer, through radiopacity monitoring, has been shown to leak from 
its site of injection in the vertebra (75). The methyl methacrylate monomer is toxic and has 
been shown to damage osteocytes (76) and has also been linked to pulmonary embolism (19).  
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PMMA cement once set is a relatively inert material that does not resorb and thus will reside 
in the body for many years. This may pose little problem for elderly patients where the 
cement will probably have a clinical life span of approximately 20 years, but for younger 
sufferers of VCFs the high modulus cement could increase the possibility of fractures in 
adjacent vertebrae in later life (51).  
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1.7 Current developments in vertebroplasty bone cements  
1.7.1 Current developments in acrylic bone cements   
Given the extensive clinical history of PMMA and the probability of obtaining clinical 
equivalency for any future products based on the material, many researchers have used it as a 
starting material.    
1.7.1.1 Reducing polymerisation temperature of PMMA 
Reducing polymerisation temperatures to permit incorporation of biologically active drugs 
has been widely researched. Bone cements containing a mixture of linear PMMA with either 
cross-linked PMMA nanospheres (η-spheres) or microspheres (µ-spheres) were investigated 
as a solution for reducing polymerisation temperatures (62). The cements were injected into 
cadaveric lumbar vertebrae and temperatures measured by thermocouples in the midbody of 
each vertebrae (located halfway between the superior and inferior end plates along the 
intersection of the middsagittal axis). Mean curing temperatures for the η-sphere containing 
cement were 30 °C lower than the commercial control cement KyphX (HV-R; Medtronic, 
Sunnyvale, CA, USA). The 45 °C setting temperatures of the η-sphere containing cements 
were low enough for antibiotic encapsulation.  
 Xyloglucan is a highly substituted starch like polysaccharide which has been grafted onto the 
methylmethacrylate monomer (MMA). The grafted material has demonstrated a decreased 
exotherm during polymerisation compared with standard PMMA (77).  
Chitosan, another polysaccharide, significantly lowered curing temperatures when used as 
PMMA filler. Tan et al (78) suggested that the large polysaccharide particles lowered the 
MMA concentration per ml of bone cement which may explain the lower curing temperature 
when the filler was present.  
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Carbon nanotube filling materials also lowered cure temperatures. It was proposed that the 
nanotubes decreased the propagation reaction speed of the PMMA free radical reaction (79, 
80).  
1.7.1.2  Induction of bone formation:  
Osseointegration does not occur readily with PMMA. Following a vertebroplasty operation 
this can result in a fibrous layer of tissue surrounding the implant impairing effective load 
transfer with the bone (74).  
 
Calcium phosphate cements bond well with bone and have been researched extensively as 
filler materials for PMMA to improve osseointegration (bone bonding). G2B1 is one of the 
composite cements containing β-tricalcium phosphate particles (81).  Its osseointegration was 
evaluated by implanting the cement into the proximal tibia of a randomised group of rabbits 
and comparing fibrous layer around the implant build-up with a control group with ordinary 
PMMA implants. The histological findings indicated that the calcium phosphate containing 
cement contacted the bone directly with no fibrous layer of soft tissue unlike the commercial 
PMMA. Bone bonding strength was also significantly higher than the control after 4-8 weeks 
of implantation.  
Arabmotlagh et al (82) recently investigated a similar composite material consisting of 
PMMA and nanocrystalline HA (70:30 v/v). The composite material and control PMMA 
were each implanted into opposing distal femurs of a group of 18 adult female sheep. After 3 
and 6 months the femurs were histologically investigated and the composite implants 
exhibited “a tight junction to the surrounding bone tissue” in contrast, the control PMMA 
implants exhibited “fibrous connective tissue encapsulating the implant”. The group 
concluded that nanocrystalline HA enabled osseointegration of PMMA in bone tissue.  
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The structure of PMMA has also been modified to try and improve osseointegration. Surface 
phosphorylated poly (2-hydroxyethyl methacrylate-co-methyl meth-acrylate [poly HEMA-
co-MMA]) a phosphorylated form of PMMA was investigated for biocompatibility (74). The 
bone cement was implanted into rabbits according to ISO 10993-6 (83) and demonstrated 
biomineralisation based on the mineral staining Von Kossa assay.  
 
1.7.1.3 The addition of antibiotics to Polymethylmethacrylate (PMMA) 
Biomaterial associated infections such as osteomyelitis are rare in orthopaedic procedures. 
However, infections do routinely occur at a rate of 1 % worldwide which creates an argument 
for the direct incorporation of antibiotics into bone cements in addition to the drugs being 
systematically administered (78, 84, 85).  
Antibiotics are routinely mixed into PMMA prior to PVP in order to provide localised drug 
release. However, the simple incorporation of antibiotics during mixing often results in a 
sharp initial burst of the drug with over 90% of the antibiotic remaining trapped in the 
materials matrix (86). Specialised cement fillers are presently being investigated to extend the 
antibiotic release profile.  
Lactose and hydroxypropylmethylcellulose (HPMC) are PMMA fillers that have been 
investigated as “antibiotic release modulators” and were found to increase quantities of 
gentamicin release up to four-fold compared to the commercial antibiotic containing cement 
(CMW1) (87).  
Giavaresi et al (88) considered the filler material (β-tricalcium phosphate) to prolong the 
effect of gentamicin release and indicated the drug release profile was sufficient to prevent 
MRSA infection in animal studies 7 weeks after initial infection.  
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Wei et al  (89) loaded clay nanotubes with antibiotic prior to the PMMA cement being doped 
with between 5-8 wt% of the nanotubes. The nanotubes isolated the drug from the cement 
monomers and served as nano-containers sustaining drug release for several weeks. The 
tensile strength of the composite material was also not significantly different compared with 
the standard cement and adhesion of the material to bone also noticeably improved. The only 
commercial cement with antibiotic preloaded is CMW1 (Depuy, Leeds, UK). The material 
contains 1 g of the antibiotic gentamicin per 40 g pack of cement. The cement has 
demonstrated significant reductions in localised infections in knee operations over a 2 week 
post-operative period to less than 2 % (90).  
 
1.7.2 Calcium Phosphate Cements (CPCs) 
Calcium phosphate cements (CPCs) have been developed to closely match the composition of 
bone. Examples of CPCs include; hydroxyapatite which is a naturally occurring form of 
calcium apatite (Ca5(PO4)3(OH)) (91) the natural mineral component of bone and brushite 
(CaHPO4·2H2O) an acidic calcium phosphate cement (92). The cements demonstrate 
excellent osseointegration with bone, release encapsulated drugs over weeks not hours like 
unmodified PMMA, do not cure exothermically and are all too some degree resorbable (51). 
The bone cements have been used in a variety of non-loading clinical applications such as 
cranioplasty, alveolar ridge augmentation and as a coating for metal prostheses.       
However, in the cements native form, the mechanical properties are not suited to the transfer 
of physiological loads. They are inferior, in terms of both flexural and shear stress 
capabilities to PMMA,  possess setting times in the region of 90 minutes (93) which is in 
excess of the 6-15 minutes permitted for acrylic bone cements and are friable (15, 94, 95).   
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β-tricalciumphosphate cements are also known for possessing high viscosities which lead to 
low cement injectabilities (96, 97).  
Recent research into chemical additives has attempted to address the materials shortcomings 
as a PVP material. Di-sodium hydrogen phosphate accelerated cement setting times to13 ± 
3 minutes and increased compressive strength strengths to 26 ± 2.4 MPa (98). Citric acid at a 
concentration of 800 mM increased the compressive strength of brushite cements to 51.6 ± 
6.9 MPa and reduced setting times to 4.5 ± 0.5 minutes (99). Addition of the silicate mineral 
mullite to calcium phosphate cements created a composite which increased both the 
compressive and flexural strengths of CPCs to similar values to PMMA (100).  
Phosphate and/or calcium ions have been added to CPCs to accelerate the setting reaction 
according to the common ion effect (101).  Sulphates, with concentrations of 0.3M have been 
shown to increase the diametral tensile strength of CPCs (102). Sodium hyaluronate has 
shown to decrease cohesion, increasing injectability improving CPCs for PVP (103).  
One very interesting new development is light cured calcium phosphate cement (LCCPCs). 
The cements were developed by mixing powdered tetracalcium phosphate and di-calcium 
phosphate with a photo-curable resin. At a powder-to-liquid (PLR) ratio of 2.8 g ml
-1
 the 
initial compressive strengths of the material was 80 MPa similar with PMMA. However, 
unlike PMMA initial cell studies indicated that the material could support proliferation of 
osteoblasts cultured on the surface of the material (104).  
 
Commercial orthopaedic calcium phosphate bone cements are already available and were 
recently tested for both compressive and flexural strengths according to ISO 5833: 2002. 
Calcibon Biomet (Berlin, Germany) and Graftys HBS (Aix En Provence, France) had 
compressive strengths of 9.9 ± 2.5 MPa and 4.0 ± 0.4 MPa respectively and flexural strengths 
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of 4.3 ± 0.5 MPa and 2.1 ± 0.6 MPa respectively. These values were significantly lower than 
the control PMMA (Gentafix 3, Bettlach, Switzerland) with compressive strengths of 88.5 ± 
0.8 MPa and flexural strengths of 54.8 ±7.4 MPa. However, the CPCs values are close to 
both the mean compressive strength of lumbar vertebrae 5 ± 2.3 MPa (32) and flexural 
strength  of 1.58 ± 0.61 MPa. As discussed earlier, there is an argument that high modulus 
maybe negative for the long-term stability of adjacent vertebrae. However, it would appear 
that through the use of additives, calcium phosphate cements will play an important role in 
the PVP procedure.   
One of the reasons for the popularity of PMMA is that it is viewed as “long-term” stabilising 
bone cement.  To assess whether calcium phosphate produced similar long-term clinical 
outcomes to PMMA during vertebroplasty, 86 patients were followed up to 44 months after 
the initial operation (105). All patients reported decreased pain according to the visual 
analogue scale (VAS). Radiographs indicated complete bone union had occurred and no 
follow up surgery was required. In a supporting study, calcium phosphate cements were used 
in kyphoplasty operations, the material demonstrated the ability to significantly reduce the 
pain of the patient in addition to a decrease in the Oswestry Disability Index (ODI) (106). 
However, the study also discovered that nearly 50 % of patients suffered cement leakage into 
the spinal canal.  
1.7.3 Filamentary composite cements 
Presently the only medically approved resin based PVP materials are Cortoss and Comp06. 
Cortoss is composed of the matrix polymers; Bisphenol-a-glycidyl dimethacrylate (Bis-
GMA) and Bisphenol-a-ethoxy dimethacrylate (Bis-EMA). Both are high molecular weight 
and cross-linked which provides the implants with strength and reduces leaching, Triethylene 
glycol dimethacrylate acid (TEGDMA) is added for improved viscosity, the accelerator 
Dihydroxyethyl-p-toluidine and the initiator Benzoyl peroxide (107-109).  
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There are also a number of reinforcing materials in Cortoss bone cement; Boro-alumino 
silicate glass acts as the radiopacifier, silica particles act as reinforcing particles improves 
mechanical strength coupled to the matrix by silica coupling agents, Combeite glass is 
included to improve biological compatibility (109).  
 
There are many advantages of Cortoss as a bone cement; it has a high degree of monomer 
conversion decreasing the amount of leachable monomer (107), the curing process generates 
less heat than PMMA (108), more radiopaque than PMMA so easier to detect and minimise 
leaks (108), possesses higher initial compressive strengths than PMMA and tensile fatigue 
(109),  sets in 5-8 minutes a time appropriate for PVP and is injectable (107).  
 
However, there are several disadvantages with the bone cement. The compressive strength of 
the material decreases with maturation (179 MPa to 91 MPa) in 30 days. The hydroxyl 
groups of Bis-GMA cements contribute to water sorption leading to plasticisation of the 
cement matrix in time resulting in filler failure and filler matrix debonding and decreased 
strength (107). In comparison Portland cements strength matures over time. The exothermic 
reaction of Cortoss is lower than PMMA (63 °C compared with up to 90 °C respectively). 
Nevertheless, it is still higher than the threshold required to cause necrosis in healthy tissue 
(56 °C) (107).   
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1.8 Introduction to Portland cement (PC) and the materials use in mineral trioxide 
aggregate (MTA) 
 Portland cement, (PC), is manufactured from 60-70 wt% lime (CaO), 20-25 wt% silicon 
dioxide (SiO2), 5-7 wt% aluminium oxide (Al2O3) and 3-5 wt% iron oxide (Fe2O3) (21). The 
components are crushed, finely ground then proportioned into the desired composition prior 
to heating at 1400-1600 °C to form the clinker phase (110). The hydraulic cement contains 
four major anhydrous phases after heating (111) including the calcium silicates, alite 
(3CaO.SiO2) and belite (2CaO.SiO2) constituting ~75 wt% of the cement clinker phase (21),   
tricalcium aluminate (3CaO.Al2O3) and ferrite (calcium aluminoferrite, (4CaO.Al2O3.Fe2O3)) 
contributing 5-10 wt% and 5-15 wt% respectively. The final phase gypsum (calcium sulphate 
di-hydrate (CaSO4.2H2O) is added at ~5 wt% to the cement after heating. PC is typically grey 
in colour; however, white PC is also available and is produced by increasing the cements 
Al2O3 and Fe2O3 content (110).  
 
1.8.1 The hydration of Portland cement    
1.8.1.1 Hydration of calcium silicates 
The hydration of alite and belite forms calcium-silicate-hydrate (C-S-H) which possesses 
more than 30 polymeric forms, all of which have the general formula CaOx. SiO2.H2Oy (112-
114). Formation of alite hydrated C-S-H occurs within a few hours after the start of cement 
hydration and is essential for the initial strengthening of the cement paste (Equation 1.8.1) 
(113).  In contrast belite reacts slower and begins to form C-S-H after several days 
contributing to long-term cement strength (Equation 1.8.2) (110).  
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2(3CaO.SiO2) + 11 H2O           3CaO.2SiO2.8H2O + 3Ca(OH)2 
(Tricalcium silicate + water           calcium silicate hydrate (C-S-H) + calcium hydroxide) 
(Equation 1.8.1) 
2(2CaO.SiO2) + 9 H2O             3CaO.2SiO2.8H2O + Ca(OH)2 
(Dicalcium silicate + water         calcium silicate hydrate (C-S-H) + calcium hydroxide) 
(Equation 1.8.2) 
 
1.8.1.2 Hydration of aluminate phases: tricalcium aluminate 
Tricalcium aluminate is a highly reactive cement phase and in the absence of calcium 
sulphate dihydrate (gypsum) hydrates leading to the formation of calcium aluminate hydrate 
(equation 1.8.3), causing premature stiffening of the cement paste without adding to the 
structural integrity (110).  
3CaO.Al2O3 + Ca(OH)2 + 12 H2O          4CaO.Al2O3.13H2O 
(Tricalcium aluminate + calcium hydroxide + water = calcium aluminate hydrate) 
(Equation 1.8.3) 
 
However, in the presence of gypsum the tricalcium aluminate  reacts to form ettringite, which 
has shown to be a set cement phase crucial in providing early cement strength (equation 
1.8.4) (110, 111, 113, 115).  
 
 
3CaO.Al2O3 + 3CaSO4.2H2O + 26 H2O           6CaO.Al2O3.3SO3.32H2O 
(Tricalcium aluminate  + gypsum + water          ettringite) 
(Equation 1.8.4) 
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The ettringite forms a coating across the cement matrix resulting in a reduction in the rate of 
cement hydration and increasing cement working time (116). Typically, in PC when all the 
gypsum has been consumed by the formation of ettringite, occurring after 1-2 days, the 
remaining aluminate will begin to react with the formed ettringite to create calcium 
monosulphate which possesses a lower sulphate content (equation 1.8.5) (117).  
2(3CaO.Al2O3) + 6CaO.Al2O3.3SO3.32H2O + 4H2O           3(4CaO.Al2O3.SO3.12H2O) 
(calcium aluminate + ettringite + water          calcium monosulphate) 
(Equation 1.8.5) 
 
1.8.2 Mineral trioxide aggregate 
Mineral trioxide aggregate (MTA) is a type of “hydraulic silicate cement” (118) initially 
developed by Torabinejad et al (119) as a root end filing material in the 1990’s. It was the 
first PC based cement to obtain approval for medical use by the U.S food and drug 
administration agency (FDA). The materials in vivo effects have been extensively 
investigated the cement has demonstrated hard tissue induction (calcification) of connective 
tissue adjacent to the material (120), antimicrobial abilities (121) and the ability to stimulate 
genes associated with both the odontogenic (122) and osteogenic phenotypes (123).   There 
are presently three commercially available varieties of MTA ProRoot MTA (grey and white), 
MTA Angelus (grey) and MTA Bio (tooth coloured). Commercial MTA differs chemically 
from PC with the incorporation of ~20 wt% bismuth oxide (124).  
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1.8.3 Properties of Portland cement in relation to its use as a PVP material 
PC has many physical, chemical and biological properties that would be advantageous as a 
PVP cement.  
 Compressive strengths comparable with PMMA: With a powder weight to liquid 
ratio (PLR) of 3 g/l for an ordinary PC, a compressive strength of 82 MPa ± 11 MPa 
can be achieved after 10-days of setting (125).  
 Hydraulic setting: PC sets in an aqueous environment (hydraulic), this is crucial as 
blood will be present when the cement sets near the spinal tissues.  
 Durability: PC has demonstrated long-term durability and stability which is 
important for non-resorbable bone cements clinical application (9).  
 Less exothermic setting: PC has a less exothermic setting reaction, therefore 
avoiding problems associated with tissue necrosis. It also means inclusion of 
thermally labile biologically active compounds such as antibodies, hormones and 
growth factors are not denatured and rendered inactive (126).  
 Simple incorporation of radiopacifiers: As outlined earlier radiopacity is important 
for PVP cement in order to monitor cement leakage using radiography. Barium 
sulphate (BaSO4), lanthanum oxide (La2O3) and tantalum pentoxide (Ta2O5) can all 
be used as radiopacifiers for PC (124).  
 Clinical history:  PCs have been investigated for dental applications, so translation of 
existing knowledge is possible and is likely to improve feasibility of producing a 
product approved by regulatory bodies (127).  
 High alkalinity: of PCs provides intrinsic antibacterial action but also increases cell 
death (128).  
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1.9 Overview of the cytocompatibility of Portland cement (PC) and mineral trioxide 
aggregate (MTA). 
1.9.1 The effect of Portland cement (PC) and mineral trioxide aggregate on the 
proliferation and viability of cells in vitro  
Scanning electron micrographs (SEM) of human marrow stromal cells (HMSC) seeded onto 
PC demonstrated adherence and an even spread of the cells on the material (129). Using light 
microscopy Human osteosarcoma cells (MG-63) were also found to adhere closely to MTA 
when incubated with the cement (130). Growth rates of fibroblasts and human dental pulp 
cells (hDPCs) in the presence of MTA have been reported to be significantly higher than 
indicated with controls (122, 131). However, flow cytometry indicated that the proportion of 
hDPCs in the DNA replication “S” phase was not significantly different between cells 
incubated with MTA and wells containing no cement (132). If the proportion of cells in 
replication phase was similar between the control and cement exposed to MTA then the 
growth rates should theoretically have also been similar.  Primary osteoblast cells incubated 
with set MTA for a week have also demonstrated viability using the Trypan blue staining 
method (133).  Calcium phosphate has also been observed on the surface of MTA confirmed 
independently by energy X-ray analysis (EDX) for both hDPCs and human osteoblast like 
cells (Saos-2) (129) (134).  Mineralisation of calcium phosphate on the cements surface may 
indicate that the presence of the material was causing the cells to undergo osteogenesis. 
Osteoblastic differentiation has also been indicated by calcium deposits in wells that had 
contained MTA using the Von Kossa staining method (133).  
The biocompatibility of PC containing cements has been attributed to several biochemical 
mechanisms. The cements pore solution contains a higher concentration of calcium and 
phosphorus ions than the culture medium and will diffuse down the gradient (3, 135). As 
these ions are the principal components of vertebral and dental hard tissues they have been 
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linked with the activation of intracellular pathways for osteogenesis and dentinogenesis (136, 
137). The hydroxyapatite reported by EDX may also act as an interface between PC and cells 
adjacent to the material (137).  
 
1.9.2 Osteogenic and dentinogenic properties of PC and mineral trioxide aggregate   
PC demonstrated upregulation of the osteogenic gene markers vascular cell adhesion 
molecule-1, alkaline phosphatase (ALPase) and bone sialoprotein (BSP) when the cements 
were incubated for 10 days with orofacial bone mesenchymal stem cells (OFMSCs) (123). 
The interleukin cytokines (Il-1 and Il-6) associated with the osteoblast phenotype have also 
been shown to be upregulated by real-time polymerase chain reaction (RT-PCR) (130) which 
was confirmed using an ELISA assay (138). MTA has also demonstrated odontoblastic gene 
marker upregulation when hDPCs were seeded onto tricalcium-silicates in culture medium 
(122). There was increased expression of the odontoblastic marker genes dentine 
sialophosphoprotein (DSPP), dentine matrix protein 1 (DMP 1), osteocalcin (OC), alkaline 
phosphatase (ALP), and collagen type 1 (Col 1) (122). The expression of Mitogen-activated 
protein kinases (MAPK) important for odontoblastic differentiation in hDPCs has also been 
investigated  using Western blotting which indicated the phosphorylated forms of MAPK 
proteins p42 and p44 were present after incubation of the DPSCs with MTA (139).  
Microarray analysis indicated that there was over a two-fold up-regulation of over 100 genes 
when hDPCs cells were incubated with MTA (140). Some of the upregulated genes 
corresponded with cell adhesion such as the extracellular matrix proteins COL10A1 and FN1 
which indicated that the cells may be producing proteins to bind to MTA.  
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1.9.3 In vivo studies 
MTA was reported to induce little or no inflammation when implanted into guinea pig 
mandibles (8).  MTA also generated only a moderate inflammatory response in subcutaneous 
connective tissues after 7 days in rats, by evaluating Von Kossa stained section and a scoring 
system to determine the level of inflammation (120). However, another study observed acute 
inflammation around the implant site after 2 weeks and white blood cell macrophages were 
present in the radicular pulp (141). After 4 weeks of an in vivo study in rats, MTA caused the 
formation of dentine bridges surrounding pulps that were capped with the material (142) and 
did not alter the pulp histology in rat molars containing MTA (141). A fibrous layer was 
detected surrounding MTA after 8 weeks of an in vivo study in rats with no evidence of 
inflammation, collagen or mineralised tissue deposition (143).  
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1.10 Challenges of using Portland cement as a percutaneous vertebroplasty material  
There are several challenges that need to be addressed before PCs full potential can be 
realised as a PVP material. Firstly, aqueous cement systems, like PCs are prone to phase 
separation, leading to in-homogeneity and weakening of the cement structure (101). The 
possibility of phase separation is increased during the high 100 N pressure applied to the 
cement paste during injection.  
Secondly, the setting time of the cement is 3-12 hours which is significantly longer than the 
20 minutes typical for acrylic based cements used in vertebroplasty (126).   
 
1.10.1 Improve injectability with a liquefier to prevent phase separation 
Liquefiers reduce the amount of water required to mix a cement paste by 12-30% (144). 
Thus, aiding liquefaction of Portland cements at high PLRs. Table1.10.1 below outlines a list 
of PC liquefiers:   
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Table 1.10.1 Liquefiers and Viscosity Modifying Agents (VMA) of PC. 
Admixture name/ formula Proprietary name/ 
company purchase 
Powder to 
liquid ratio 
(PLR) 
Range 
(g ml
-1
) 
Admixture 
Quantity 
(w/w) Range 
Setting 
Temperature 
°C  
Mechanism of action/ further comments  
Sulfonated melamine-formaldehyde 
condensates (SMF) 
Melement (21) (145) 
(increase the 
compressive strength).  
 
Ruredil Fluiment 33M 
(22) 
 
W.R Grace chem (23) 
 
Cementa 92 M (24) 
 
F,FS,G20 (146) 
2.5:1 (147) 
 
2.5:1 (23) 
 
3:1 (24) 
 
3:1 (146) 
 
3:1 (145) 
3% (148) 
 
1.8-2% (149) 
 
0.5% (21) 
 
0.1-0.6% 
(147) 
 
0-2% (23) 
 
0.5% (24) 
 
1-2% (146) 
 
1% (145) 
20 (148) 
 
20 (21) 
 
25 (24) 
‘Adsorption of the admixture molecules 
on the cement surface causes steric 
hindrances’ (148)  
 
‘Admixture adsorbed by the cement 
particles act as a thin layer bringing 
about repulsion forces between cement 
particles due to negative electrical 
charge so that flocculation is prevented, 
cement particles are dispersed 
homogeneously in the fresh concrete.’ 
(148) 
Sulfonated naphthalene-formaldehyde 
condensates (SNF) 
Lomar-D (21) 
 
Mighty 100 (146) 
 
NFS (145) 
3.8:1 (150) 
 
2.5:1 (147) 
 
3:1  (146) 
 
3:1 (145) 
3% (148)  
 
1.8-2% (149) 
 
0.5% (21) 
 
1-2% (146) 
(145) 
20 (150) 
 
20 (148) 
‘Retardation with naphthalene-based 
liquefiers at 2%’ (149) 
Modified lignosulfonates  (MLS) Concretan (22) 
 
Cementa P40 (24) 
2.5:1 (147) 
 
3:1 (24) 
3% (148) 
 
3% (22) 
20 (148) 
 
25 (22) 
‘most effective retarder 10-40 h’ (147) 
 
‘Liquefiers strong polyelectrolytes 
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Ligtek (146) 
 
3:1 (146) 
 
0.5% (24) 
 
1-2% (146) 
 
25 (24) 
(anionic)’ (23) 
Polycarboxylate derivatives  (151) (150)  2.5:1 (151) 
 
2.5:1 (147) 
3% (148) 20 (151) 
 
20 (150) 
 
 
‘Induces cement grains dispersions as a 
result of both the electrostatic and 
especially steric repulsion generated by 
the long side chains.’ (151) 
 
‘PC disperses cement particles with the 
help of steric hindrance effects that 
results from the extension of their graft 
chains away from the surface of cement 
particles.’ (150)  
 
‘Polycarboxylate liquefier was much 
more intense in calcium aluminate 
cements.’ (151)  
 
Methylcellulose (126) Sigma Aldrich (126) 3:1 (126) 1% (126) 20 (126) ‘Used in conjunction with CaCl2 ‘ (126) 
High molecular wt hydroxylated 
polymer (152) 
Viscosity Modifying 
Admixture (152) 
 0.05-0.15% 
(152) 
  
Citrate (102) Haneseler, Switzerland 
(102) 
  23 (102) A calcium phosphate cement liquefier.  
sodium hexaphosphate (153)  2.5:1 (153) 1-2% (153) 23 (153) A calcium phosphate cement liquefier  
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Many of these additives in table 1.10.1 are used in the building industry in, ‘self-levelling 
cements’, where the biological effects of the chemical constituents are not considered. 
However, the formaldehyde monomer in both SMF and SNF could prove to be acutely toxic 
if extravasation occurs during PVP (154). Therefore, these two liquefying agents will be 
discounted from the study.  
A second problem with the liquefiers is the use of ‘black box’ formulations. It is difficult to 
deduce the exact chemical formulation of, ‘Polycarboxylate derivatives’ and many authors 
have had to utilise advanced analytical techniques in order to decipher complex proprietary 
formulations (150). Thus, one of the aims of the project will be to use only liquefiers where 
the full chemical formula of the compound is known. 
Unfortunately, the liquefier additives often have a dual functionality, they can act as both 
liquefiers and ‘retarders’ increasing the setting times of the PC by as much as 40 h (e.g. 
MLS) (147). Liquefiers are highly charged anionic species which bind and adsorb onto the 
surface of the PC constituents. Binding results in both electrostatic, and due to the large size 
of the polymeric liquefiers, a steric repulsion. This disperses cement aggregates leading to the 
liquefying effect, although it also leads to a reduction in the reaction rate of the cement with 
water leading to slower reaction kinetics, thus causing cement setting retardation (148).      
1.10.2 Decreasing setting times of Portland cement  
There are many chemically simple, setting accelerators, available from the building industry, 
see table 1.10.2. Many of setting accelerators increase the formation of C-S-H bonds 
contributing to long term strength of the PC. This combination of accelerated setting and 
hardening is essential for supporting the vertebral column shortly after the PVP operation is 
completed. 
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Table 1.10.2 Various Portland cement accelerators and their properties 
Accelerant name/ 
formula 
Proprietary name/ 
company 
purchase 
Powder to 
liquid ratio 
(PLR) 
Accelerant 
Quantity (w/w) 
Setting 
Temperature (°C) 
Portland cement + 
accelerant 
 Setting times 
(minutes) 
Compression 
Strengths (MPa) 
Accelerant 
Mechanism of 
action  
Al2O3(s)=17%  
SO3(s)=40% (155) 
 
Al2O3(l) Refer table 
1 (156) 
 
NaAlO2 (157) 
Mapequick AFK 
777 by Mapei  
(155) 
 
Not Stated (156) 
 
 
Strem Chemicals 
(157) 
3:1 (155) 
 
 
3.5:1 (156) 
 
 
1:1 (157) 
7% (155) 
 
 
3.8% (156) 
32 (155) 
 
 
Not Stated (156) 
 
 
20 (157) 
10-150 (155)  
 
120 (156) 
Not Stated (155) 
 
 
0.31 (20 minutes) 
(156) 
Al
3+
 and SO4
2-
 
ions interact with 
C3A and Ca
2+
 to 
form ettringite 
(158) 
 
 
NaAlO2 
accelerates the 
hydration of alite 
and belite which 
results in long  
C-S-H phases. 
(157) 
Calcium Chloride 
(CaCl2(s)) (126) 
 
 
Sigma Aldrich 
(159)  
3:1 (126) 2% (126) 
 
 
2% (160) 
 
 
5% (159) 
37 (126) 83 (126) final  
 
100 (160) final 
  
32 (159) initial  
35.6 (24h) (126)  
 
62 (7 days) (160) 
CaCl2 increases 
heat evolution 
during early 
hydration (126) 
Calcium Nitrite/ 
Nitrate CaNO3 (25-
50%) (159) 
 
 
DCI corrosion 
inhibitor (159)  
3:1 (159) 
 
 
3:1 (161) 
Not stated 
(159) 
 
 
1% (161)  
 
1% (162)  
 
 
 
20 (161) 
 
 
20 (162) 
7 (159)  
 
125 (161)  
 
125(162) Initial 
and 195 final  
Not stated (159) 
 
 
27 (After 1 day) 
(161) 
 
 
 
Calcium nitrate 
effects have been 
linked to the belite 
content of the 
Portland Cement 
(162).  
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Calcium Formate 
(CHOO
-
) (159) 
Target Set 
Accelerator (159)  
 
 
3:1 (159) 
 
 
 
20% (159) 
 
 
 
20 (159) 10 (159)  Not Stated (159)  
Triethanolamine 
(TEA) 
N(CH2CH2OH)3 
(162) 
Not stated (162) Not stated 
(162) 
0.05% (162) 20 (162) 150 (162) 
Initial and final 
235  
28 (162) (After 1 
day) 
 
Trisopropanolamine 
(TIPA) 
(CH2CH2 CH2 OH)3 
[C9H21O3N] (162) 
Not Stated (162) Not Stated 
(162) 
0.05% (162) 20 (162) 140 (162) 
Initial and final 
210  
32 (162) (After 1 
day) 
 
Oxalic Acid  
(H2C2O4) (163) 
Not Stated (163) 3:1 (163) 4% (163) 20 (163) 65 (163) Initial 
and final 100  
37.13 (163) (After 
1 day)  
Anionic binding  
Calcium Carbonate 
(CaCO3
2-
) (156) 
Proprietary 
Powder (156) 
Not Stated 
(156) 
10% (156)  Not Stated  13.1 (156) 
Initial and final 
72.5  
0.38 (156) (After 
20 minutes) 
 
Sodium phosphate 
monobasic 
(Na2HPO4) (164) 
 
Sodium phosphate 
dibasic (Na2H2PO4) 
JT baker (164) 3:1 (164) 10% and 15% 
(164) 
37 (164) 26 (164)  
 
33 (164) dibasic 
-  
Calcium Acetate 
(165) 
  2% (165)    Acts as both an 
accelerator and 
liquefier  
 INTRODUCTION 
35 
 
In the literature many of these hardening accelerators have been used in conjunction with 
each other and have shown a synergistic relationship (162). In addition, various accelerators 
e.g. CaCl2 have been used in conjunction with liquefiers and the setting times recorded (160).  
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1.11 Project Aims: 
The initial aim of the project will be to develop an injectable PC that can pass through a 2-
4 mm needle without the occurrence of blockages at a force that is applicable for manual 
injection. A customised holder for the syringe and needle will be designed and produced. 
Injectability of PC without any liquefying agents will then be tested at a range of powder-to-
liquid ratios (PLRs) to investigate whether by adding more water to the cement, it is possible 
to significantly increase cement extrusion from the syringe. Previous research has indicated 
that powder based cements such as calcium phosphates suffer from phase separation of the 
powder from the liquid phase during injection and a liquefiers may limit this separation 
(166). Injectability of PC at different rates of plunger depression will be assessed during the 
current study and compared with the manual speed of injection of spinal surgeons performing 
the vertebroplasty operation. If liquefiers are required for injection, the optimum method of 
delivery in either the liquid (water) or solid (cement) phase will also be determined. During 
the initial stages of the project, X-ray diffraction will be used to assess the effect of filtering 
cement (aggregate removal) and cement batch aging.  
A range of liquefying additives and setting accelerants will then be studied for their effect on 
cement injectability and influence on cement setting time. The material properties of the 
additives on the compressive strength, porosity and density of the cement will be tested 
concurrently with the injectability and setting time experiments. The cements will be 
characterised with scanning electron microscopy (SEM) (surface morphology), energy 
dispersive X-ray spectroscopy (EDS) (elemental analysis), X-ray diffraction (XRD) (phase 
analysis), Zeta potential measurements (charge analysis) and differential scanning 
calorimetry (DSC) (heat evolution of the cement). 
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A bespoke porous vertebral model to test percolation of the cement within the vertebrae will 
be created in collaboration with Bath University. A universal testing machine will provide 
force on a piston connected to a chamber containing PC which will be injected into a 
synthetic bone substitute (sawbone). The pressure drop during injection will be recorded with 
a monitor and assessed against commercial acrylic cement. Subsequently, the synthetic bone 
model will be replaced by a section of sheep vertebral cancellous bone and the pressure drop 
during injectability retested. The rheology of the final cement will be investigated using a 
parallel plate rheometer and Micro-CT (µ-CT) will be investigated as a technique for 
assessing phase separation of PCs during injection.   
Following the development of appropriate injectable cement, the biological responses of 
primary osteoblast and bone marrow cells will be assessed according to the cells ability to 
colonise the cements, along with the subsequent growth, proliferation and differentiation on 
these materials. Mineralisation of calcium species by osteoblasts exposed to PC will be 
assessed by incubating cells exposed to the cement for 14-days with Alizarin red stain. The 
expression levels of genes associated with the osteoblast phenotype including osteoadherin 
(OSAD), alkaline phosphatase (ALPase), bone morphogenic protein (BMP) and bone 
sialoprotein will be studied by reverse transcriptase PCR (RT-PCR).  
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CHAPTER 2: MATERIALS AND METHODS 
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2 MATERIALS AND METHODS 
2.1 Materials and methods for chapters 3.1-3.5 
2.1.1 Materials 
Portland cement (Mastercrete, Lafarge, UK) was initially passed through a 500 µm steel 
mesh sieve (Endecotts Ltd, UK) to remove agglomerates present in the powder phase. In 
chapter 3.2 the additives sodium chloride, sodium aluminate, sodium hexaphosphate, calcium 
acetate, methyl cellulose, calcium sulphate dihydrate, calcium carbonate and  oxalic acid 
(Sigma, UK) were added at between 2-10 wt% into the powder phase and mixed by vortexing 
(Miximatic, Jensons, UK). In chapter 3.3 the additives calcium chloride and calcium nitrate 
(Sigma, UK) were added at between 5 and 10 wt%. In chapter 3.4 sodium citrate, potassium 
citrate, calcium citrate and citric acid (Sigma, UK) were added at between 0.5 to 5 wt%. 
Finally in chapter 3.5 Bismuth oxide was added at 10 wt% to the cement (as indicated) 
(Sigma, UK). Filtered reverse osmosis water (5 µm filter, Aquarium Solutions, UK) was 
added at a powder-to-liquid (PLR) of 5.0 g ml
-1
 (unless otherwise stated) and samples were 
hand mixed for 1 minute to produce cement slurries.  
In the chapter 3.1 the sieve mesh size was varied between 45-500 µm, the additives were 
mixed in the liquid phase (Vortexer, Jensons, UK) prior to adding to the powder phase and 
the powder to liquid ratios were varied between 3 and 5 g ml
-1
. 
 
2.1.2 Injectability testing 
Five grams of PC slurry were transferred into a 5 ml disposable syringe (Starstedt, UK) and 
extruded through an outlet diameter of 2 mm (for each additive addition n=4). A mechanical 
testing machine (Instron 1185, High Wycombe Bucks, UK) was used to apply a cross-head 
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speed of 30 mm min
-1
 (3-30 mm min
-1
 in chapter 3.1) and the maximum force to the syringe 
plunger was restricted to 100 N. The force and crosshead speed were selected to mimic the 
maximum force and typical rate of extrusion used during manual injection (based on 
communications with surgeons) (167). The amount of cement remaining within the syringe 
was weighed and the injectability (I) was calculated according to Equation 2.1.1:     
 
 
 
 
  (   )  
                                              
                                 
      
 
 
   (Equation 2.1.1) 
 
2.1.3 Setting time 
The initial setting times of the cements were measured in a temperature controlled laboratory 
environment (20–23 °C and 50–60 % humidity) using the Gilmore needles test. After mixing 
(section 2.1.1) each individual cement slurry (n=3) was poured into a cell culture well (BD 
Falcon, UK) with a surface area of  3 cm
2
 which provided an adequate surface area (and 
thickness of the cement paste) to observe needle indentation on the setting cement surface. At 
3 minute intervals the Gilmore needle (0.21 mm, mass 113.4 g) was indented into the cement 
paste and assessed for setting in accordance with ASTM standard C266-99 (168).  
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2.1.4 Compressive strengths  
After sample preparation, the cement pastes were cast into cylindrical Polytetrafluoroethylene 
(PTFE) moulds (6mm diameter, 12mm height) and left to set for 6h at 37°C in a drying oven 
(Laboratory thermal equipment, UK) before removal from the moulds and storage in distilled 
water at 37°C for a further 1 or 30-days. After storage the wet samples were weighed and the 
dimensions measured with a digital Vernier (Linear Tools, UK).  The wet compressive 
strengths (CS) of the cement samples (n =30 per sample set) were then measured using a 
Universal testing machine (Instron 5544, Instron, UK) at a cross-head speed of 1mm min
-1
. 
CS values were calculated using the following equation: 
   
 
 
  
 
  (
 
 )
  
(Equation 2.1.2) 
 CS= Compressive strength (MPa)  A= Cross-sectional area (mm
2
) of cylindrical sample, 
 L= Load (N),     d= Diameter (mm) 
 
2.1.5 Calculating the dry densities of the cement samples 
Fragments obtained following the compressive strength testing were collected, weighed and 
then dried in a desiccator containing calcium chloride (Nalgene, UK) until the weight of the 
samples remained constant. Wet densities (ρdry) were determined by dividing the individual 
wet weight (Ww) by the respective sample volumes.     
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The dry densities of the cement samples were then calculated using the following equation: 
     
  
  
       
Equation 2.1.3 
ρdry= Apparent dry density (g cm
-3
)       WD= Dry weight of fragments (g) 
ρwet= Apparent wet density (g cm
-3
)      WW= Wet weight of fragments 
(g)  
 
2.1.6 Calculating cement relative porosities 
After drying of the compressive strength fragments the materials’ strut densities were 
measured in a helium pycnometer (Accupyc 1330, Micromeritics, USA). The relative 
porosities of the cement samples were then calculated using the following equation:  
     
    
      
 
(Equation 2.1.4) 
ρdry= Apparent dry density (g cm
-3
) 
ρstrut= Strut density (g cm
-3
) 
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2.1.7 Biaxial-flexural strengths 
The hand mixed slurries were poured into PTFE split moulds producing 30 nominally 
identical disc-shaped specimens (12 mm diameter by 2 mm thickness). The samples were set 
for 24 h at 37 °C, removed from the split moulds and subsequently immersed in water at 
37 °C for 29 days. 
The bi-axial flexure strength of the disc-shaped specimens was determined by generating a 
central load (using a 4 mm ball indenter) on a 10 mm knife-edge support at a cross-head 
speed of 1 mm min
-1
. The samples were loaded using a universal testing machine (Instron 
5544, Instron, England) and the fracture load for each disc recorded. The biaxial flexure 
strength was calculated according to Eq. 2.1.5 (169) 
      
 
  
{(   ) [        (
 
 
)      ]      } 
(Equation 2.1.5) 
 
 σmax was the maximum tensile stress (MPa), P the measured load at fracture (N), a the radius 
of the knife-edge support (mm), h was the sample thickness (mm) and v, the Poisson’s ratio 
for the material. The Poisson’s ratio of a material is defined as the lateral contraction per unit 
breadth divided by the longitudinal extension per unit length (169) and a value of 0.160 was 
substituted for Portland cement (170). The sample thickness was measured at the point of 
fracture for each disc-shaped specimen using a micrometre screw gauge (Moore and Wright, 
Sheffield, England) accurate to 10 µm. 
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2.1.8 Scanning electron microscopy (SEM)  
Dried cement fragments were attached onto an aluminium stub with a conducting electrodag 
1415 paste (Agar Scientific, Stanstead UK) before being gold sputter coated (Emitech 
K550X, UK). A scanning electron microscope (SEM) (JEOL 7000F, Japan) was then used to 
image the samples at an accelerating voltage of 20kV capturing images at 2000-8000x 
magnification. 
 
2.1.9 Energy dispersive X-ray spectrophotometer (EDX)  
Backscattered X-rays emitted by the elements on the surface of the cement, after irradiation 
with a beam of electrons were collected and recorded by a detector (Inca, Oxford instruments, 
UK) before analysis of the elemental composition using Software CMax (Wycombe, Bucks). 
The software assigned both a weight % (wt%) and an atomic % for each element present. The 
wt% ratio of each element pair (e.g. Ca/O or Ca/Fe) was then calculated and compared with 
theoretical compounds known to be present during cement hydration using the following 
equation (see appendices): 
                                                          
   (
              
                
)      
(Equation 2.1.6) 
 
2.1.10 X-ray diffraction (XRD) 
X-ray diffraction patterns of the set cements were recorded using a D8 Advance 
diffractometer (Bruker, Germany). Data sets were collected from 2θ = 5-20 ° with a step size 
of 0.02 and the count time was normalised to 1 s step
-1
. The phase compositions of the 
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cements were determined according to the inorganic crystal structure database, calcium 
hydroxide (PDF Ref. 04-010-3117), calcium silicate (PDF Ref. 04-011-1393) and ettringite 
(PDF 00-041-1451). The calcium silicate hydrate (CSH) standard was supplied by Supleco 
analytical (UK).  
 
2.1.11 Zeta-potential measurements 
The effective surface charge of PC with various additives was measured using a Zeta-Sizer 
Delsa-Nano Z (Beckman-Coulter, UK). Suspensions of 0.1 g l
-1
 Portland cement were 
produced just prior to the zeta-potential measurements. Sodium and potassium citrate were 
added at 0.2 g l
-1
 to the PC solutions resulting in an excess of anions to bind with the PC 
particles. The Zeta-Sizer calculated the zeta-potential by determining electrophoretic mobility 
using Henry’s equation (171). For each suspension, the average zeta-potential value was 
obtained from 5 measurements. 
 
2.1.12 Fourier transform Infrared (FTIR) 
One gram of newly mixed PC was placed on the diamond window of an attenuated total 
reflectance (ATR) FTIR (Nicolet 6700, Thermo scientific) set to either 23 °C or 37 °C and 
covered with a glass slide with spectra recorded at 0 and 60 minutes. At each time point the 
samples were scanned 32 times with a resolution of 2.0 cm
-1
.  
 
2.1.13 Differential Scanning Calorimetry (DSC) 
Eighty to one 120 milligrams of cement paste was transferred to an aluminium crucible 
before being inserted into the sample compartment of a differential scanning calorimeter 
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(DSC 7, Perkin-Elmer, UK). The enthalpy change of the cement was then recorded for the 
proceeding 2 h and calculated by integrating the DSC-curves from the heat capacity base line 
using the Pyris
TM
 DSC software (n=3 for each variation).   
2.1.14 Statistical analysis 
Data sets derived from the injectability, setting time, compressive strength, cement specific 
densities, zeta potential measurements, calorimetry, biaxial flexure testing and biological 
growth curves were tested for normality prior to further analysis (Kologorov-Smirnov). For 
normally distributed data sets, comparisons of group means were achieved utilising statistical 
tests appropriate to the experimental design and included, one-way analysis of variance (1-
way ANOVA) two-way analyses of variance (2-way ANOVA) and three-way analyses of 
variance (3-way ANOVA) tested at a 95 % significance level. A statistical software package 
SPSS for Windows 19.0 supplied by IBM, UK was utilised in the current investigation. 
 In addition, as ceramic materials contain flaws which can vary significantly in size, 
orientation and severity, strength is often expressed in terms of failure probability. Weibull 
(172) developed a statistical theory to analyse failure probabilities that enabled the prediction 
of survival rates at different stress levels, allowing comparison of the relative performance of 
different materials. The Weibull approach assumes a weakest link principle whereby the 
strength of a body is determined by the products of the survival probabilities of the individual 
elements and the most critical flaw in a specimen is responsible for its failure. The Weibull 
distribution for a body failing under tensile stress and can be expressed as:  
        [   (
      
  
)
 
] 
(Equation 2.1.7) 
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Where σ is the applied stress failure (MPa) and σ min, σ0 and m are the Weibull m are the 
Weibull parameters. The Weibull modulus (m) characterises the brittleness of a material 
(173) and reflects the shape parameter of the Weibull probability density function describing 
flaw size and distribution and therefore the resultant scatter and associated reliability of the 
flexure strength data. σmin is the threshold stress occurring when the failure probability 
approaches zero and σ0 is the characteristic stress and is the scale parameter of the Weibull 
distribution.  
In the current investigation bi-axial flexure strength data was ranked in ascending order and a 
Weibull analysis performed on the resultant data by plotting ln ln (1/Ps) against lnσ. The 
gradient m was calculated by superimposing a regression line along the data points to provide 
the Weibull modulus for each group of specimens tested. To determine statistical differences 
between the Weibull moduli of the flexure strength data the 95 % confidence intervals for the 
specimen groups under investigation were calculated by least squares regression analysis 
(using excel). The differences in Weibull modulus of the flexure strength data was considered 
to be significantly different when the 95 % confidence interval failed to overlap. Confidence 
in the linearisation of Weibull data was reflected by R
2
 values and the range of the 95 % 
confidence intervals. The Weibull distribution is employed to provide improved validation of 
the fracture strength data rather than depending on the average fracture strength.  
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2.2 Materials and methods for chapter 3.6 (Investigating the rheology and 
injectability of Portland cement) 
2.2.1 Materials 
Portland cement (Mastercrete, Lafarge, UK) was prepared according to section 2.1.1. Sodium 
citrate (Sigma, UK) was added at 2 or 5 wt% into the powder phase of the cement and mixed 
by vortexing (Miximatic, Jensons, UK).  The liquid phase was added to the cement at a 
powder-to-liquid (PLR) of 5.0 g ml
-1
 and samples were hand mixed for 1 minute to produce 
cement slurries. Bismuth oxide 10 wt% was added to the samples for µ-CT scanning.  
2.2.2 Dynamic viscosity measurements using a plate rheometer 
Viscosity measurements were performed at room temperature (23°C +/- 1°C) using a 
rotational parallel plate rheometer (Malvern Instruments Ltd, UK) using 30 mm plates 
separated by a 2 mm gap. Gap size was chosen based on previous investigations of large-
particle size suspensions which indicated that the “gap-to-particle size ratio” should be at 
least 10:1 (174). The largest particle size of PC was approximately 200 µm (175). The 
complex viscosity (Pa.s) was measured at constant strain amplitude of 0.06 with a rotational 
frequency of 0.3 Hz.  
Cements were initially mixed at 0 minutes and then tested for viscosity at 0, 10, 20 and 30 
minutes (n=3). The PC standard was stored in the mixing vessel. In contrast, the 0 and 10 
minute replicates of citrate were added to 5 ml syringes and tested using the rheometer at the 
appropriate time points. The 20 and 30 minute samples were added directly to the rheometer 
at time 0 as it was not possible to extrude the cement containing 2 wt% citrate from the 
syringe after 20 minutes. 
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2.2.3 Injectability of Portland cement through a 5cm needle 
The injectability experiments were performed in accordance with section 2.1.2. For 
injectability testing requiring a needle the Luer 
TM
 lock fitting system on each of the 
disposable syringes was used to attach a 5 cm long 11 G needle. 
 
2.2.4 Micro-CT 
2.2.4.1 Standard preparation  
The slurries were cast into PTFE moulds producing cylindrical samples with 3mm height and 
6mm diameter. The samples were stacked vertically starting with PLR 5.0 g ml
-1
 and 
decreasing to PLR 2.5 g ml
-1
 in 0.5 g ml
-1
 intervals (n=3 stacks) 
2.2.4.2 Testing pressure drop during injection 
Sawbone (Pacific research laboratories, USA) was drilled into 3 cm by 6 cm shapes using a 
pillar drill (Sealey SDM 30, UK).  
PC slurry (100 ml) was loaded into a 120 ml piston chamber connected to a universal testing 
machine (Instron 5544, Bucks, UK) used to control flow rate. The cement was injected from 
the chamber into a sealed injection compartment containing the sawbone model. A pressure 
monitor (FPM 100, Maretron, USA) was used to assess the pressure drop during injection  
2.2.4.3 Creation of artificial fractures in sheep and porcine vertebrae 
A universal testing machine (Instron 5544, UK) was used to artificially create a fracture in 
the posterior lumbar vertebra of both a sheep and pig. Five grams of cement paste was 
manually injected into the fracture using an 11 G needle. 
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2.2.4.4 Micro-CT imaging 
A high resolution micro-CT (Skyscan 1172, Belgium) was used to image the standard 
cements and vertebral models. The samples were secured on the rotating central stage and 
imaged by the scanners 11 MP camera. The fine detail resolution of the images was 13.59 µm 
the source voltage was set at 80 kV and the source current at 100 uA. The images were 
recorded on the Skyscan control software (Skyscan, Belgium) in TIFF format at 8 bit depth. 
Reconstruction of the 3D image was performed with N-Reconn (Skyscan, Belgium) and Fiji 
(Open source, international free license). Each individual pixel in the standard cement images 
was assigned a grey scale value from 1 to 250. These values were then plotted as a percentage 
of total pixel number. 
 
2.3 Materials and methods for chapter 3.7: Investigating the cytocompatibility of 
Portland cement 
2.3.1 Cement sterilisation 
Portland cement (Mastercrete, Lafarge, UK) was prepared according to section 2.1.1 before 
being heat sterilised in an oven (BRF 16/5, Elite, UK) at 180 °C for 2 h. Sodium citrate, 
calcium chloride and calcium nitrate (Sigma, UK) were added at 2 or 5 wt% into double 
distilled water which was then autoclaved.  The liquid phase was added to the cement at a 
powder-to-liquid ratio (PLR) of 5.0 g ml
-1
 and samples were hand mixed for 1 minute to 
produce cement slurries. The slurries were cast into PTFE moulds, under aseptic conditions 
in a laminar flow hood, producing cylindrical samples with 3mm height and 6mm diameter. 
The samples were incubated at 37 °C in a universal test tube then removed at the following 
time points 0.3, 1, 3, 6, 12 and 24 hours. The cements set for 6 h after removal were 
incubated in water for a further 18 h.  
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2.3.2 Media preparation 
Minimum essential medium (alpha modification) (all reagents in this section were from 
Sigma, UK) was used as the basis of both the growth and transport medium. Growth medium 
was supplemented with 1% penicillin/ streptomycin (100 unit’s ml-1 of penicillin with 100 µg 
ml
-1
 streptomycin), 2.5% HEPES buffer and 10% (v/v) foetal calf serum (FCS). Transport 
medium contained 10 % penicillin/ streptomycin with 1 % amphotericin.  
2.3.3 3T3 fibroblast cell line 
The 3T3 cells were defrosted from liquid nitrogen (BOC chemicals, UK). Based on the 
fibroblast cell line initially established in 1962 (176) and seeded in 25 ml of media (alpha 
modification). The cell line was selected due to its comparatively short doubling time (1.5 
days per cell cycle) compared with stromal cells. The cell lines are also more resistant to 
changes in extracellular conditions (176) making them ideal as an initial cell line to 
investigate pH change.  
2.3.4 Bone marrow stromal cell extraction 
The femora of young adult albino Wistar (250 g) male rats were extracted for bone marrow 
stromal cells (BMSC) using an established method (177). A surgical scalpel (Swann Morton, 
Sheffield, UK) was used to cut through the rats epidermis to gain access to the underlying 
connective tissues from which the femora were removed. Femora were stored in a petri dish 
containing transport medium and the remaining soft tissues cleaned away using a scalpel and 
forceps. Sterile wire cutters were used to remove the epiphyses of the femora. An 18 gauge 
needle (Tyco healthcare, Northern Ireland) was used to flush the marrow cavity using growth 
medium. The BMSCs cells were then pelleted using a centrifuge (Thermo, Durafuge 100) at 
1200 rpm for 3 minutes and transferred to a T-75 tissue culture flask and incubated at 37°C, 
in an atmosphere of 5% CO2 (IG150, Jouan, UK) until the flask was approximately 80-90% 
confluent.  
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2.3.5 Incubation of cells with the setting cement 
0.1 M phosphate buffered saline, PBS (Sigma Aldrich, UK) was used to remove any non-
adherent or dead cells from the surface of the T-75 before 5 ml of Trypsin/EDTA 0.25% 
(w/v) (Sigma, UK) was used to detach the confluent cell monolayer.  Once detached, an equal 
volume of supplemented α-MEM containing 10% FCS was added to neutralise the enzyme. 
After centrifugation the supernatant was removed from the pellet, discarded and replaced 
with growth medium. At the time points outlined in section 2.3.1 the cements were removed 
from the moulds and aligned in the centre of a 35 mm petri dish. Three millilitres of growth 
medium was then added to each well before 3 x 10
4
 cells (bone marrow cells) or 5 x 10
3
 cells 
(3T3 fibroblasts) were seeded directly on top of the cements. At 2-day intervals the culture 
dishes were viewed using a phase contrast microscope (Flovert, UK) and imaged using a 
digital camera (Coolpix, Nikon, Tokyo, Japan). For each type of cement in the experiment 
three petri dishes (n=3) were harvested at 0, 1, 3, 5, 7, 9 and 11 days or at 0, 2, 6, 8 and 10 
days using 2 ml of trypsin (including the cement in the well). After centrifugation the 
trypsinised cells were resuspended in 1 ml of growth medium. Cell suspensions were mixed 
with an equal volume of 0.2 % trypan blue before counting using an improved Neubauer 
haemocytometer (Agar Scientific, UK) viewed with a phase contrast microscope (Zeiss, 
Germany) to determine cell numbers and viabilities.    
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2.3.6 Investigating gene expression with RT-PCR 
2.3.6.1 Experimental set-up 
Two sets of disc cement samples (n=24) of 3 mm height and 6 mm diameter containing 
2 wt% of the accelerant sodium citrate were set for 1 and 12 hours respectively. The samples 
were aligned in the centre of a 35 mm petri dish (Sarstedt, USA) to which 3 ml of growth 
medium was added before seeding with 1 x 10
5
 mesenchymal bone marrow stem cells 
(passage 1) on top of the cement and incubated at 37 °C for 5 days, whilst controls contained 
no cement.  
 
2.3.6.2 Isolation of RNA 
After the incubation period each 35 mm petri dish (Sarstedt, USA) was washed with 1 ml of 
PBS before being treated with 350 µl of lysate solution (Buffer RLT, Qiagen, Rneasy Kit, 
UK), containing 10 µl of beta-mercaptoethanol (Promega, UK). Each lysate was 
homogenised for 30 s using a 21 gauge needle (Terumo, UK). An equal volume of 70 % 
ethanol (Sigma-Aldrich, UK) was then added to each homogenised lysate and mixed on a 
vortexer (Vortex genie 2, Scientific Industries, USA) for 10 s. Each sample was transferred to 
an RNA binding spin column (Rneasy, Qiagen, UK) with a 2 ml collection tube and 
centrifuged for 30 s at 10,000 rpm (eppendorf centrifuge 5415D, UK). The flow-through was 
discarded before 350 µl of wash buffer (RW1, Qiagen, UK) was added to the column before 
a second round of centrifugation at 10,000 rpm for 30 s. A Dnase I digest mix produced by 
adding 10 µl of Dnase I (Qiagen, UK) to 70 µl of Buffer RDD (Qiagen, UK) was added 
directly to the columns membrane followed by a 15 minute incubation period. A 350 µl 
aliquot of another wash buffer (RW1, Qiagen, UK) was then spun through the column at 
10,000 rpm for 30 s followed by two times 500 µl of a third wash buffer (RPE, Qiagen, UK) 
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at 10,000 rpm for 1 minute. The column was then placed in a new collection tube and spun at 
14,000 rpm for 1 minute to extract the remaining buffer. The column was finally placed in a 
1.5 ml collection tube to which 30 µl of RNase free water was added and spun for 10,000 
rpm for 1 minute to elute the RNA.  
 
2.3.6.3 RNA quantification 
The RNA was diluted 1:35 before single stranded RNA concentration was measured using a 
UV/ visible spectrophotometer (Eppendorf Biophotometer, Germany) at 260/280 nm.  
 
2.3.6.4 RNA visualisation 
TAE buffer (Fermentas, Lithuania) was diluted 1:50 with RNase free water (Qiagen, UK). A 
1 % agarose gel was made by adding 0.7 g of agarose (Web Scientific, UK) to 70 ml of TAE 
buffer stock. The gel was then heated for 2 minutes in a microwave (Samsung 850W, 
Germany) to melt the agarose, 3 µl of SYBR gold stain (Invitrogen, UK) was added before 
the agarose was set in a Perspex mould. The set gel was then transferred to an electrophoresis 
tank (Consort 132) filled with TAE buffer stock. Five microlitres of RNA was loaded into 
each well and a DNA ladder (PCR Ranger, Norgen) added adjacent to the samples. The gels 
were then run for 20 minutes at 120 V before being viewed using a lightbox (Gbox, 
geneflow, UK)  and imaged with Genesnap software (Version 7, Syngene, UK).  
 
 
 MATERIALS AND METHODS 
55 
 
2.3.6.5 Reverse transcription of RNA 
A reverse transcription kit was used to convert the RNA samples into cDNA (Omniscript, 
Qiagen, UK). Twelve microlitres of each RNA sample was added to individual eppendorf 
tubes (Eppendorf, UK) with two microlitres of 10 µM stock oligo-dT (Qiagen, UK) and 
heated to 80 °C for 10 minutes in a water bath (Echotherm, UK) before being quenched in ice 
for 5 minutes. A reverse transcription mastermix comprising of 2 µl of both Buffer RT 
(Qiagen, UK) and dNTP (Qiagen, UK) with 1 µl of both RNase Inhibitor (Qiagen, UK) and 
Omniscript Reverse Transcriptase (Qiagen, UK) was prepared. To each RNA/oligodT sample 
6 µl of the mastermix was added and the mixture vortexed and centrifuged before incubation 
for 60 minutes at 37 °C followed by 5 minutes at 95 °C before storage at -80 °C (Nuaire, UK) 
 
2.3.6.6 Concentrating cDNA with micron filters 
The samples were thawed and a micron filter (Amicon Ultra, UK) labelled for each sample. 
To each filter 18 µl of RNA/oligodT/Mastermix was added to 482 µl of RNA free water to 
achieve a total volume of 500 µl. The column was then repeatedly centrifuged for 1 minute at 
8,000 rpm until the column had an approximate volume of 60- 70 µl. The column was then 
inverted in a new collection tube before again centrifuging at 8000 rpm for 1 minute. The 
cDNA samples were then stored at -20 °C (Zanussi, UK). 
 
2.3.6.7 Normalising cDNA using GAPDH 
Forward and reverse primers were prepared by diluting the primer master mixes (Invitrogen, 
UK) in a 1: 4 dilution with RNase free water. RED Taq master mix was then made in a PCR 
tube consisting of 12.5 µl REDTaq (Sigma-aldrich, UK), 2 µl of the reverse primer 
mastermix dilutions, 2 µl of cDNA and RNase free water to achieve a total volume of 25 µl. 
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A PCR thermal cycler (Eppendorf Mastercycler, Germany) was then used to run 18, 21 and 
24 cycles of the GAPDH gene which were collected in a 96 well plates (Sarstedt, UK). A 
1.5 % agarose gel made by adding 0.9 g of Agarose to 60 ml of TAE buffer with 5 µl of 
GelRed stain (Biotium, USA). The gel was then loaded with the cDNA samples and a DNA 
ladder and ran at 120 V for 30 minutes. 
 
2.3.6.8 Semi-quantification of PCR using gel imaging and quantification software 
The gels were placed in a light box (G-box, Geneflow, UK) and imaged using Genesnap 
software (Version 7, SynGene, UK) at an exposure time of 80 ms. Genetools software 
(version 4, SynGene, UK) was used to semi-quantitatively assess the intensity of the cDNA 
bands and the results exported to a spread sheet (Excel, Microsoft, U.S) Based on the 
GAPDH band intensities the cDNA content of each sample was increased or decreased until 
the intensity of each band was within a 10 % error margin.   
 
2.3.7 Alizarin red assay to determine the presence of mineralisation in cell cultures 
Cells were grown according to section 2.3.5.  Media was aspirated from each 35 mm 
dish/well and cells washed gently with 1 ml of PBS (Sigma, UK). The cells were then fixed 
with 1 ml of 10 % formalin (Sigma, UK) for 15 minutes at room temperature. After the 
incubation period the formalin was removed before the cells were washed three times with 1 
ml PBS for 5 minutes ensuring that any excess solution was removed after each washing. 
Alizarin red solution (BDH laboratory supplies, UK) (13.69 g l
-1
) adjusted to pH 4.1-4.2 
using 1.0 % ammonium hydroxide (Sigma, UK) was added to each well. The cells were then 
gently agitated for 20 minutes. Any unincorporated dye was aspirated off and each plate 
washed three times with 1 ml PBS. Each well was then filled with 1 ml of ddH2O to prevent 
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the cells from drying. Cells were viewed using a microscope (Flovert, UK) and imaged with a 
digital camera (Coolpix, Nikon, Japan). 
 
2.3.8 Buffer addition to Portland cement (PC) 
Sodium dihydrogen orthophosphate, potassium dihydrogen dibasic and TRIS EDTA (Sigma, 
UK) were added individually at either 2 or 10 wt% into the powder phase of PC. The cement 
slurries were then cast into moulds of 3 mm by 6 mm and left to set for 25 minutes. The 
cements were then removed and exposed to 3 ml of cell culture medium for 20 minutes. In 
the event the cements had not set in the allotted time frame they were removed from the split 
mould based on the initial setting times indicated by the Gilmores needles test. A pH meter 
(Mettler Toledo, UK) was used to assess the change in alkalinity after 20 minutes of 
incubation
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3 RESULTS 
3.1 CHAPTER: Investigating the parameters of an injectability model 
3.1.1 Effect of varying the powder-to-liquid ratio 
3.1.1.1 Injectability  
A gradual increase in cement extrusion was observed as the powder-to-liquid ratio (PLR) was 
decreased from 4.2 to 2.4 g ml
-1 
(figure 3.1.1). Lafarge, the manufacturers of Mastercrete® 
(Lafarge, UK) recommend a PLR of 3 g ml
-1
 (178) which without a liquefying agent 
produced an extrusion of 77%.  
 
 
Figure 3.1.1 Graph illustrating the effect of the cements powder: liquid ratio (PLR) on cement extrusion 
(injectability) of standard Portland cement. Reducing the PLR from 4.8 to 2.4 g ml-1 significantly (p<0.05) increased 
cement extrusion to 85 wt% (sample number n=4).   
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Below a PLR of 2.6 g ml
-1
 a low initial force under 10 N was required to extrude the majority 
of the cement from the 2 mm syringe aperture. An increase in force was required only when 
the syringe was nearly empty (figure 3.1.2). In contrast, cements with a PLR above 2.8 g ml
-1
 
demonstrated an initial increase in force followed by a shallow force plateau before a marked 
increase in force as the cement failed to extrude from the syringe. 
 
 
Figure 3.1.2 Force/displacement graph showing traces for different PLRs recorded during the injectability 
experiments. Reducing the PLR from 4 to 2.4 g ml-1 decreased the force required to displace the syringe plunger 
during cement injection. At 2.4 g ml-1 less than 5 N was required to extrude 85 wt% of the cement. 
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3.1.1.2 Setting times  
Decreasing the PLR of the cement from 4.2-2.4 g ml
-1
 significantly (p<0.05) increased the 
setting time (figure 3.1.3). However, without a setting accelerant the setting times were in 
excess of the 6.5-15 minutes required for the vertebroplasty operation (15).  
 
 
Figure 3.1.3 Graph demonstrating the effect of Powder-to-liquid ratio on the setting time of Portland cement. 
Decreasing the PLR of the Portland cement standard from 4.2 to 2.4 g ml-1 significantly (p<0.05) increased cement 
setting time from 2 to over 4 hours (sample number n=3).  
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3.1.2 Initial injectability set-up investigating the effect of different cross-head speeds 
Increasing the cross-head speed of the universal testing machine from 3 to 10 mm minute
-1
 
significantly (p<0.05) increased cement extrusion for both the standard cements and those 
containing a liquefying agent (figure 3.1.4). There was less of an effect on extrusion when 
increasing the cross-head speed from 10 to 30 mm minute
-1
.  
 
 
Figure 3.1.4 Graph demonstrating the increase in cement extrusion (injectability) when the cross-head speed of the 
universal testing machine supplying the injection force was increased from 3 to 30 mm minute-1 (sample number 
n=4).  
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3.1.3 Investigating additive addition to PC in the powder vs. liquid phase 
3.1.3.1 Injectability 
Both calcium acetate and sodium hexaphosphate acted as liquefying agents for PC. A 5 or 
10 wt% addition of either additive significantly (p<0.05) increased cement extrusion 
compared with the PC standard (fig. 3.1.5). There was a further significant (p<0.05) increase 
in extrusion when the liquefiers were vortex mixed into the powder phase (striped lines) as 
opposed to being dissolved in the liquid phase (white bars) prior to hydration of the cement 
powder.  
 
 
       = powder phase  = liquid phase 
 
Figure 3.1.5 Graph demonstrating the effect of calcium acetate and sodium hexaphosphate liquefiers on cement 
extrusion (injectability). The liquefiers were either dissolved in the liquid phase (white bars) prior to adding to the 
powder phase or mixed directly with the powder phase (striped bars) prior to hydration.  There was a significant 
(p<0.05) increase in cement extrusion values when the additives were mixed in the powder phase as opposed to being 
dissolved in the liquid phase (sample number n=4).  
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3.1.3.2 Setting times 
Calcium acetate and sodium hexaphosphate both acted as setting accelerants, significantly 
(p<0.05) decreasing setting times from over 2 hours to below 30 minutes (figure 3.1.6). There 
was also a significant (p<0.05) decrease in setting times when the additives were mixed with 
the powder phase as opposed to being dissolved with the liquid phase prior to the setting 
reaction occurring. 
 
 
= powder phase        = liquid phase 
 
 
Figure 3.1.6 Graph showing the influence of adding setting accelerants into the powder vs. liquid phase of the cement. 
There was a significant (p<0.05) decrease in setting times when the additives were dissolved in the liquid phase prior 
to adding to the hydraulic cement powder (sample number n=3). 
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3.1.4 Phase analysis of a new versus aged batch of cement 
The overall peak intensities for the 2005 batch of PC were less intense than for the 2010 
batch (figure 3.1.7). The ‘Full-width half peak maximum’ values for the peak at 32.5° Theta 
were 0.140 and 0.114 for the old batch and new batch respectively. Both of these features 
indicate a general degradation of the old batch of cement (179). However, lack of formation 
of any of the hydration product calcium-silicate-hydrate at 29° theta indicated that neither of 
the cement powders was degraded by reaction with water.   
 
 
Figure 3.1.7 XRD patterns of a 2005 (red line) and 2010 (black line) batch of Portland cement. Peak intensities were 
greater in the new batch compared with the old batch. 
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3.1.5 Elemental analysis of a new versus aged batch of cement 
The elemental composition of the cement powder was analysed using energy dispersive X-
ray spectroscopy (EDX) there was approximately an 11% difference between the observed 
and theoretical optimum Ca/Si ratio for tricalcium silicate in the aged batch of cement. In 
comparison, there was a 22% difference in the Ca/Si ratio with the new batch (refer to 
appendices for full calculations).    
 
Table 3.1.1 Elemental composition of Mastercrete® (Lafarge, UK) cement from both a 2005 and 2011 batch. There 
were no major differences in the cements composition between the batches which were produced 6 years apart.  
 
 2005 batch of Mastercrete® PC 2011 batch of Mastercrete® PC 
Element Weight % Atomic % Weight % Atomic % 
O 52.35 71.4 53.16 72.20 
Na 0.50 0.47 0.47 0.44 
Mg 0.73 0.65 0.69 0.62 
Al 2.10 1.70 1.76 1.41 
Si 6.83 5.31 6.31 4.88 
S 2.07 1.41 2.05 1.39 
K 1.15 0.64 0.87 0.49 
Ca 32.66 17.78 33.14 17.97 
Fe 1.61 0.63 1.55 0.60 
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3.1.6 Investigating the effect of sieving cement powder 
3.1.6.1 XRD characterisation 
The overall peak intensities for the cement sieved through a 63 µm mesh size were greater 
than the cement passed through a 500 µm mesh (figure 3.1.8). The ‘Full-width half peak 
maximum’ values for the peak at 32.5° Theta were 0.182 and 0.122 for the 500 µm and 
63 µm sieved batches respectively. This may indicate the cement passed through the 63 µm 
filter possessed less cement aggregates which does not absorb strongly on the XRD trace.  
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Figure 3.1.8 XRD patterns of a 63 µm mesh (red line) and 500 µm mesh (black line) sieved batches of Portland 
cement powder. Peak intensities were greater when a smaller sieve size had been used. Phase composition appeared 
identical. 
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3.1.6.2 Setting times 
Preparing the PC with a 63 µm sieve significantly (p<0.05) reduced the setting time of the PC 
from over 3.5 hours to just over 1 hour (figure 3.1.9). 
 
 
Figure 3.1.9 Graph demonstrating the effect of sieving Portland cement powder using different mesh sizes on the 
materials setting time. Decreasing the sieve diameter from 500 to 62 µm significantly decreased cement setting time 
(sample number n=3). 
  
62 
146 
162 
180 
190 
211 
0
50
100
150
200
250
63 75 90 125 250 500
Se
tt
in
g 
ti
m
e
 (
m
in
u
te
s)
 
Sieve size (uM) 
RESULTS  
69 
 
3.2 CHAPTER: Development of Portland cement for orthopaedic applications, 
establishing injectability and decreasing setting times using researched additives 
Liquefiers and setting accelerants were identified from tables 1.10.1 and 1.10.2 which met 
two criteria. 
1. The PC additives have previously not demonstrated to be hazardous according to 
HAZDAT data sheets.  
2. The chemical structures of the additives were available and not patented.  
3.2.1 Injectability studies (powder-to-liquid ratio 4 g ml-1) 
Sodium chloride, sodium aluminate, sodium hexaphosphate and calcium acetate all acted as 
liquefiers significantly (p<0.05) increasing the injectability of PC with 2- 10wt% additions to 
the cement (figure 3.2.1a). The liquefiers exerted greatest influence at 10 wt% with sodium 
chloride, sodium aluminate and calcium acetate producing extrusion values of over 95 wt% 
with a plunger force of less than 100 N. In contrast, methyl cellulose, calcium sulphate 
dihydrate, calcium carbonate and oxalic acid significantly (p<0.05) reduced cement extrusion 
values compared with the standard PC (figure 3.2.1b).  
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Figure 3.2.1(A) PC injectability significantly (p<0.05) increased with the additions of sodium chloride, sodium 
aluminate, sodium hexaphosphate and calcium acetate. Maximum injectability was achieved with 10 wt% additions 
of sodium aluminate, sodium hexaphosphate and calcium acetate all extruded over 95 wt% of cement from the 
syringe.  (B) In contrast, Additions of methyl cellulose, calcium sulphate dihydrate, calcium carbonate and oxalic acid 
significantly (p<0.05) decreased cement injectability. (Error bars represent standard deviations) (sample number 
n=4). 
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The force required to extrude cement during injection decreased as the wt% of sodium 
chloride, sodium aluminate, sodium hexaphosphate and calcium acetate were increased from 
2 to 10 wt% (figure 3.2.2). For cements with 5-10 wt% of these liquefiers a relatively low 
initial force i.e. 5 to 30 N was required to extrude the majority of the cement and an increase 
in force was observed only when the syringe was nearly empty.  In contrast, PC without a 
liquefier and cements with the additives methyl cellulose, calcium sulphate dihydrate, 
calcium carbonate, and oxalic acid did not demonstrate a characteristic force plateau but 
exhibited a sharp increase in displacement as the cements failed to extrude from the syringe.  
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Figure 3.2.2 Graph depicting the force required to displace the cement plunger during the injectability experiments. 
A gradual decrease in extrusion force was observed when cement liquefiers were increased from 2-10 wt% (calcium 
acetate given as an example). In contrast, the PC standard and additives which reduced PC injectability did not 
noticeably displace the syringe plunger as the cement failed to extrude from the syringe (methyl cellulose given as an 
example. 
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3.2.2 Setting time measurements (powder-to-liquid ratio 4 g ml-1) 
A 5 or 10 wt% addition of sodium chloride, sodium aluminate, sodium hexaphosphate, 
calcium acetate or calcium sulphate dihydrate significantly (p<0.05) reduced the setting times 
of PC from over 2 hours to below 55 minutes (figure 3.2.3). The shortest setting times were 
observed with a 10 wt% addition of the accelerants. Sodium hexaphosphate at 10 wt% was 
the most powerful accelerant used generating setting of under 10 minutes. Cements 
containing methyl cellulose, calcium carbonate and oxalic acid were too dry to assess setting 
using the Gilmore’s needles test.  
 
Figure 3.2.3 Sodium chloride, sodium aluminate, sodium hexaphosphate, calcium acetate and calcium sulphate 
dihydrate significantly (p<0.05) reduced cement setting times compared with PC standard (error bars equal 
minimum error of method) (sample number n=3).  
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3.2.3 Compressive strengths, porosity and density measurements  
The highest compressive strengths were obtained by 5 wt% additions of sodium chloride 
(table 3.2.1). The three remaining liquefiers at 5 wt% sodium aluminate, sodium 
hexaphosphate and calcium acetate all had significantly (p<0.05) lower compressive strength 
values compared with the unmodified control but were still higher than the 1.4- 9 MPa 
compressive strength for lumbar vertebrae (31). An addition of 5 wt% sodium chloride and 
calcium acetate had lower relative porosities and specific densities than the standard. In 
contrast, sodium aluminate and sodium hexaphosphate generally possessed higher porosities 
and specific densities than the standard. It was not possible to obtain values for 10 wt% 
calcium acetate as after setting the cements appeared to possess very low cohesive properties 
and broke apart on handling.  
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Table 3.2.1 After both 1 and 30-days setting there was no significant (p<0.05) difference in the compressive strength values between the standard and cement containing 5 wt% 
sodium chloride, In comparison, the compressive strengths of cements containing the other three additives were all significantly (p<0.05) lower but still higher than cancellous bone. 
There was also little difference between the relative porosities of the standard and cements containing 5 wt% chloride. In contrast, the other additives, with the exception of calcium 
acetate after 30-days setting all possessed higher porosities. The specific densities of chloride and acetate cements were lower than the standard, whereas, aluminate and 
hexaphosphate cements after 1-day were approximately equal to the standard and after 30-days the 10 wt% additions were lower (compressive strength n=30).     
 
Additive Wt% 
additive 
Compressive 
strength/MPa 
(1-day) 
Compressive 
strength/MPa 
(30-day) 
Relative 
porosities % 
(1-day) 
Relative 
porosities % 
(30-day) 
Specific densities g cm
-3
  
(1-day) 
Specific densities g cm
-3
 
(30-day) 
PC standard  53 ± 3 79 ± 7 21 ± 1 13 ± 1 2.61 ± 0.05 2.50 ± 0.05 
Sodium chloride 5 
10 
51 ± 4 
28 ± 4 
80 ± 5 
56 ± 5 
21 ± 1 
26 ± 1 
12 ± 1 
16 ± 1 
2.51 ± 0.05 
2.49 ± 0.05 
2.35 ± 0.05 
2.28 ± 0.05 
Sodium aluminate 5 
10 
33 ± 4
3
 
23 ± 4
4
 
42 ± 3 
29 ± 5 
23 ± 1 
28 ± 1 
15 ± 1 
16 ± 1 
2.65 ± 0.05 
2.72 ± 0.05 
2.53 ± 0.05 
2.41 ± 0.05 
Sodium 
hexaphosphate 
5 
10 
42 ± 4 
25 ± 4 
52 ± 3 
42 ± 4 
22 ± 1 
31 ± 1 
16 ± 1 
20 ± 1 
2.61 ± 0.05 
2.69 ± 0.05 
2.53 ± 0.05 
2.53 ± 0.05 
Calcium acetate 5 29 ± 4 
 
59 ± 3 
 
25 ± 1 
 
11 ± 1 
 
2.54 ± 0.05 
 
2.20 ± 0.05 
 
                                                 
3
 Numbers in italic indicate 5 wt% additions 
4
 Numbers in bold indicate 10 wt% additions.  
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3.2.4 Sulphate analysis using FTIR 
There was a sharp increase in the calcium sulphate dihydrate (gypsum) peak at 1100 cm
-1
 
during the first 60 minutes of setting for cements containing 5 wt% sodium hexaphosphate 
and sodium aluminate (see figure 3.2.4a and 3.2.4b).  The absorbance band of sulphate (SO4
2-
) has previously been indicated to be in this region and based on the profiles of standard 
calcium sulphates, the observed peak most closely relates to calcium sulphate di-hydrate 
(gypsum) (180-182). In contrast, the gypsum peak for the PC standard and cements 
containing 5 wt% sodium chloride and calcium acetate did not noticeably increase during the 
first 2 h of the setting reaction. When 5 wt% calcium sulphate dihydrate (gypsum) was added 
directly to the cement the peak corresponding with the additive understandably increased 
(figure 3.2.4c). However, when 5 wt% gypsum was added with 5 wt% sodium 
hexaphosphate, the peak was higher than when gypsum was added alone (see figures 3.2.4c 
and 3.2.4d). In addition, to the increase in peak heights for cements containing gypsum and 
hexaphosphate the cement setting time was increased from 9 minutes to 15 minutes.    
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Figure 3.2.4 FTIR spectra illustrating the absorbance of the sulphate band of PC during the first 60 minutes of 
setting. (A) After initially mixing the cements there was an increase in peak heights in cements containing 5 wt% 
sodium hexaphosphate and sodium aluminate. (B) Peak height continued to increase during the first 60 minutes of 
setting. (C) When 5 wt% calcium sulphate dihydrate (gypsum) was added to the cement there was an increase in 
peak height. However, there was an even greater increase in peak height when 5 wt% sodium hexaphosphate was 
added in addition to the calcium sulphate. (D) Peak height of the calcium sulphate/hexaphosphate combined cement 
continued to increase over 60 minutes setting (sample number n=3).  
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3.2.5  Phase analysis using X-ray diffraction (XRD) 
After 1-days setting crystalline peaks representing calcium hydroxide (18° theta), ettringite 
(9° and 16° thetas) and C-S-H (29° theta) were present in the PC standard and cements 
containing sodium chloride and calcium acetate (figure 3.2.5). In contrast, PC containing 
sodium hexaphosphate and sodium aluminate demonstrated none of these peaks. After 30-
days setting all the cements had developed crystalline peaks indicating the presence of 
calcium hydroxide and C-S-H.  
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Figure 3.2.5 X-ray diffraction patterns of PC after (A) 24h and (B) 30-days. From front to back PC, 5 wt% sodium 
chloride, sodium aluminate, sodium hexaphosphate and calcium acetate. Both the standard and cements containing 
chloride and acetate developed ettringite (9 and 16° thetas) and C-S-H peaks (29° theta) after 24h. All the cements 
developed C-S-H peaks after 30-days.     
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3.2.6 Cement elemental analysis using energy dispersive X-ray spectroscopy 
Elemental analysis of the surface crystals of cements modified with sodium hexaphosphate 
most closely resembled unhydrated tetracalcium aluminoferrite with only a 17% difference 
between the theoretical optimum and observed ratios for the Ca/O ratios. The O/Al ratio of 
the cements modified with calcium aluminate indicated that there was a 6% difference 
between the ideal structure for calcium monosulphate and the Ca/O ratio only a 13% different 
(for full calculations refer to appendices).   
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3.2.7 Cement surface morphology using scanning electron microscopy (SEM) 
Standard PC (figure 3.2.6a) and PC containing 5 wt% sodium chloride (figure 3.2.6b) both 
possessed ordered surface crystals of approximately 10 - 20 µm in length (figure 3.2.6c). In 
contrast, PC containing 5 wt% sodium hexaphosphate was composed solely of ordered cubic 
crystals approximately 5-10 µm in width. The surface of PC containing 5 wt% calcium 
acetate possessed cuboid crystals (< 10 µm) (figure 3.2.6d), whilst 5 wt% sodium aluminate 
additions generated flat hexagonal crystals approximately 10 µm in diameter and needle 
shaped crystals over 20 µm in diameter (figure 3.2.6e).  
 
 
   
Figure 3.2.6 SEM micrographs demonstrating the surface morphology of (A) PC standard and cements containing 5 
wt% (B) sodium chloride (C) sodium hexaphosphate (D) calcium acetate (E) sodium aluminate. Cements containing 
sodium hexaphosphate possessed a cubic shape, whereas sodium aluminate cements possessed hexagonal crystals and 
rod shaped crystals approximately 20 um long. The calcium acetate cements contained many small crystals less than 
5 µm in diameter.  
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3.3 CHAPTER:  Establishing injectability and decreasing setting times using the 
additives calcium chloride and calcium nitrate   
3.3.1 Injectability studies 
Both calcium chloride and calcium nitrate acted as liquefying agents for PC. A 5 wt% 
addition of either salt or an equal 2.5 wt% combination of the two significantly (p<0.05) 
increased cement extrusion compared with the PC standard (figure 3.3.1). There was a further 
significant (p<0.05) increase in extrusion when the total additive wt% was increased to 
10 wt%. Mixing the additives also increased the injectability of the cement increasing 
extrusion by 10 wt%. The apparent limit on injectability was 98 wt% extrusion with 2 wt% of 
the cement remaining in the tip of the syringe.  
 
 
Figure 3.3.1  Graph demonstrating the significant (p<0.05) increase in cement extrusion (injectability) when calcium 
chloride, calcium nitrate or a combination of the two was added to PC (standard injectability indicated by dotted 
line.  There was a significant (p<0.05) increase in extrusion with a 5 wt% addition of either additive to PC, there was 
a further significant (p<0.05) increase in injectability when the additions were increased to 10 wt% (sample number 
n=4).     
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3.3.2 Extension graphs 
Cements containing calcium chloride and/or calcium nitrate liquefiers either individually or 
in combination required only a relatively low initial force of between 3 and 30 N to extrude 
the majority of the cement from the 2 mm syringe aperture, an increase in force was required 
only when the syringe was nearly empty (figure 3.3.2). In contrast, PC without a liquefier 
demonstrated no characteristic force plateau but exhibited a sharp increase in force necessary 
for displacement as the cement failed to be extruded from the syringe.  
 
 
Figure 3.3.2 A typical force/displacement graph recorded during the injectability experiments. Adding 5 wt% of 
calcium chloride or calcium nitrate reduced the force required to displace the syringe plunger during cement 
injection. Increasing the additive content to 10 wt% further reduced the force to a point where less than 5 N was 
required to extrude over 90 wt% of the cement. 
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3.3.3 Initial cement setting time, compressive strength and density measurements 
The two additives both acted as setting accelerants when added individually or in 
combination (figure 3.3.3). The addition of calcium chloride or calcium nitrate significantly 
(p<0.05) decreased setting times from over 2 h to below 60 minutes with 5 wt% additions and 
there was a further significant (p<0.05) decrease to below 22 minutes for the 10 wt% 
additions.  
 
 
Figure 3.3.3 Graph showing the influence of different additives on the setting time compared with control cement 
(Dotted line indicates standard setting time). The addition of 5 wt% calcium chloride, calcium nitrate or a 
combination of the two significantly (p<0.05) decreased cement setting times compared with the PC standard. There 
was also a significant (P<0.05) decrease in setting times when increasing additives to 10 wt% (sample number n=3). 
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After 24 h setting cements containing 5 wt% additions of calcium chloride, calcium nitrate or 
2.5 wt% combination of the two produced compressive strengths which were comparable or 
higher than the PC standard (Table 3.3.1). In contrast, cements containing 10 wt% additions 
had significantly (p<0.05) lower compressive strengths. After 30 days cements 5 wt% 
additions all possessed significantly (p<0.05) higher compressive strengths than the standard 
cements. The compressive strengths of the 10 wt% additions of calcium chloride and nitrate 
were still significantly (p<0.05) lower than the standard cements but the 5 wt% combination 
of the two were not significantly different (p<0.05) with the standard.    
After both 1 and 30-days the relative porosities of the cements containing 5 wt% calcium 
chloride or nitrate or a 2.5 wt% combination of the two all possessed lower relative porosities 
than the PC standard. In contrast, after 24 h cements containing a total of 10 wt% additive all 
had lower porosities, but after 30-days the porosities were comparable with the standard 
cement. The specific density of the cement in the presence of chloride and nitrate was 
consistently lower than the standard regardless of the wt% used. As the specific density of 
cement decreases with adsorption of water this indicated that in the presence of chloride and 
nitrates the cements hydrated more quickly, i.e. the setting reaction was accelerated.
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Table 3.3.1 Compressive strength, relative porosities and specific densities for cements containing additions of either calcium chloride, calcium nitrate or a combination of the two. 
After both 1 and 30-days setting, cements containing 5 wt% calcium nitrate or 2.5 wt% combinations of calcium chloride and calcium nitrate possessed significantly (p<0.05) higher 
compressive strengths than the PC standard. In contrast, cements containing a total additive addition of 10 wt% possessed significantly (p<0.05) lower compressive strengths than the 
PC standard. The relative porosities of the cements containing 5 wt% additions were lower than the PC standard, whereas the cements containing 10 wt% additions were consistently 
higher. Adding 5 or 10 wt% of any additive reduced the specific densities of the set cements. Standard deviation (compressive strength) and minimum error of method (specific 
density, porosity) are given as error (compressive strength n=30). 
 
Additive Wt% of 
admixture  
Compressive 
strength/MPa 
(1-day) 
Compressive 
strength/MPa 
(30-day) 
Relative 
porosities\ % 
(1-day) 
Relative 
porosities\ % 
(30-day) 
Specific 
densities\ g/cm
3
 
(1-day) 
Specific 
densities\ g/cm
3
 
(30-day) 
PC standard  56 ± 4 73 ± 7 23 ± 1 20 ± 1 2.55 ± 0.05 2.44 ± 0.05 
Calcium 
chloride 
5 
10 
57 ± 7 
43 ± 6 
88 ± 8 
63 ± 7 
19 ± 1 
25 ± 1 
15 ± 1 
19 ± 1 
2.45 ± 0.05 
2.43 ± 0.05 
2.38 ± 0.05 
2.32 ± 0.05 
Calcium nitrate 5 
10 
66 ± 7 
45 ± 6 
89 ± 8 
62 ± 6 
18 ± 1 
26 ± 1 
13 ± 1 
22 ± 6 
2.47 ± 0.05 
2.43 ± 0.05 
2.37 ± 0.05 
2.33 ± 0.05 
Calcium 
chloride/nitrate 
combination 
2.5 
5 
67 ± 7 
44 ± 7 
99 ± 6 
73 ± 7 
17 ± 1 
27 ± 1 
13 ± 1 
19 ± 1 
2.47 ± 0.05 
2.43 ± 0.05 
2.36 ± 0.05 
2.32 ± 0.05 
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3.3.4 Surface charge investigations using zeta-potential measurements 
The surface charge of the standard cement particles was approximately -12 mV. Calcium 
nitrate and calcium chloride addition significantly (p<0.05) reduced the negative charge of 
the cement resulting in charge neutralisation of the cements (figure 3.3.4).  
 
 
Figure 3.3.4 Zeta potential measurements of hydrating PC in the presence of calcium chloride and calcium nitrate. 
Inclusion of the additives to Portland cement caused an inflection in the surface charge of the hydrating cement 
(sample number n=3). 
  
RESULTS  
87 
 
3.3.5 Cement enthalpy change investigations by differential scanning calorimetry (DSC) 
An addition of 5 wt% calcium chloride to PC produced an overall exotherm which was not 
significantly (p<0.05) different from the standard cement, mean of 25 and 29 J g 
-1
 cement 
respectively (figure 3.3.5). The profile of the chloride cements heat signature indicated that 
the exotherm was predominantly generated within the first 10 minutes of setting, which 
coincided with the setting time of the cement as determined via the Gilmore needles test. On 
closer inspection the peak appeared to be composed of three distinct shoulders. The PC 
standard and cements containing 5 wt% calcium nitrate both possessed similar heat signatures 
where the exotherm was released in a single asymmetric peak over 2 h. Addition of calcium 
nitrate did not produce a significantly higher exotherm compared with the PC standard but 
the exothermic peak at approximately 40 minutes appeared consistently earlier than the PC 
standard. 
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Figure 3.3.5 (a) Graphs illustrating the isothermal calorimetry traces of PC standard and cements containing either 5 
wt% calcium nitrate or 5 wt% calcium chloride during the first 120 minutes of cement setting. The addition of 
calcium chloride produced a similar overall energy release with the standard cement except that the majority of 
energy with the chlorides was released early during the setting reaction. In contrast, cements containing nitrate had a 
similar trace profile with the standard cements. (b) When the chloride exotherm was investigated more closely the 
trace appeared to comprise 3 distinct exotherms which all occurred within the first 10 minutes of the start of the 
setting reaction (sample number n=3).     
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3.3.6 FTIR analysis 
The absorbance peak at 3640 cm
-1
 appeared to correspond with calcium hydroxide the major 
by-product of the hydration phase C-S-H (figure 3.3.6). Therefore, this peak may have 
indicated the early presence of this setting phase in the cements containing calcium nitrate. 
 
 
Figure 3.3.6 (A) FTIR spectra of PC standard and cements containing either 5 wt% calcium chloride or calcium 
nitrate 2 minutes after cement mixing. 6 (B) After 120 minutes the calcium nitrate cements had developed a peak at 
3640 cm-1 indicating the presence of calcium hydroxide (sample number n=3).  
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3.3.7  Phase analysis using X-ray diffraction  
After 2 h setting cements containing 5 wt% calcium chloride demonstrated peaks at 9° and 
16° theta corresponding with the set cement phase ettringite (figure 3.3.7). Whereas cements 
containing 5 wt% calcium nitrate had a small peak at 18° theta corresponding with calcium 
hydroxide. The only noticeable PC standard peak was at 25° theta corresponding with 
anhydrous calcium sulphate. After 24 h all of the cements contained ettringite and calcium 
hydroxide peak in addition to a small peak at 29° theta corresponding with C-S-H formation. 
After 30-days of setting the calcium hydroxide peak in all the cements appeared significantly 
higher than the 1-day set cements. 
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Figure 3.3.7 X-ray diffraction patterns of set cements after 2 h (7A), 24 h (7B) and 30-days (7C). After 2 h calcium 
chloride enhanced peaks at 9° and 16° thetas corresponding with the set cement phase ettringite. Cements containing 
calcium nitrate possessed a calcium hydroxide peak at 18° theta. In contrast, after 2 h the only discernible peak for 
the PC standard was calcium sulphate di-hydrate at 25° theta. After 24 h all of the cements had developed ettringite 
peaks in addition to those corresponding with C-S-H formation at 29° theta. After 30-days setting the peaks 
corresponding with calcium hydroxide were significantly higher.   
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3.4 CHAPTER: Modification of Portland cement with the citrate anion  
3.4.1 Injectability studies 
Cement injectability was highest for an addition of either 2 wt% sodium or potassium citrate 
with both additions enabling 90 wt% cement extrusion (figure 3.4.1). However, when 
increasing the additive content to 5 wt% the injectability significantly (p<0.05) decreased to a 
value lower than the PC standard. For cement containing calcium citrate the injectability was 
significantly (p<0.05) higher than the PC standard whereas cements containing citric acid 
showed significantly (p<0.05) lower injectabilities. The standard cement was also injected at 
a PLR of 4.75 g ml
-1 
(equivalent to the PLR of PC minus a 5 wt% citrate addition) indicating 
that by simply increasing the water content of the cement it was not possible to increase 
cement injectability to the level that could be achieved with an additive addition. 
 
 
Figure 3.4.1 Graph showing cement extrusion in the presence of various citrate additives. Injectability significantly 
(p<0.05) increased with the additions of sodium and potassium citrate up to a limit of 2 wt%. Further increasing the 
additions of either of these citrates to 5 wt% significantly reduced cement injectability. Calcium citrate significantly 
(p<0.05) increased cement injectability compared with the PC standard, whereas citric acid significantly (p<0.05) 
reduced injectability (sample number n=4).  
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3.4.2 Extension graphs 
For cements containing a 2 wt% addition of sodium or potassium citrate only a relatively low 
initial force of between 3 to 5 N was required to extrude the majority of the cement. An 
increase in force was required only when the syringe was nearly empty (figure 3.4.2). In 
contrast, with 5 wt% sodium or potassium citrate no characteristic force plateau was evident 
but a sharp increase in force with little displacement became apparent as the cement failed to 
extrude from the syringe.  
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Figure 3.4.2 A typical force/displacement graph recorded during the injectability experiments. With a 2 wt% 
addition of sodium or potassium citrate a force of less than 10 N was required to extrude the cement. Altering the 
wt% produced reduced injectabilities.    
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3.4.3 Setting time measurements  
Increasing the addition of sodium or potassium citrate from 0.5-5 wt% significantly (p<0.05) 
reduced PC setting times (from 123 minutes for the PC standard to 3 minutes with a 5 wt% 
addition of citrate) (figure 3.4.3). The setting time for cements containing either calcium 
citrate or citric acid could not be measured as the paste was too dry to assess the imprint of 
the Gilmore needle.  
 
 
Figure 3.4.3 Graph showing the initial setting times of cements in the presence of 2-5 wt% sodium and potassium 
citrate indicating that both additives acted as accelerants (sample number n=3). 
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3.4.4 Compressive strengths 
The highest compressive strengths were obtained by 2 wt% additions of either sodium or 
potassium citrate to the cement (98 and 125 MPa respectively after 30 days setting) 
(table 3.4.1). Observation indicated that calcium citrate and citric acid did not set within the 
moulds after 6 h so it was not possible to obtain compressive strength values for either of 
these additives.  
The lowest porosities and strut densities were also observed with the 2 wt% additions of 
potassium and sodium citrate. For each individual additive addition the 30 day relative 
porosity and specific density values were lower than measured at 1 day.   
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Table 3.4.1 Compressive strength, relative porosities and specific densities for cements containing additions of 0.5- 5 wt% sodium and potassium citrate. Maximum compressive 
strengths were achieved by the additions of either 2 wt% sodium or potassium citrate. The 2 wt% cements also possessed lower porosities and strut densities than the 0.5 and 5 wt% 
additions and were also lower than the PC standard (compressive strength n=30).      
Admixture Wt % Compressive 
strength/MPa 
(1-day) 
Compressive 
strength/MPa 
(30-day) 
Relative 
porosities % 
(1-day) 
Relative 
porosities % 
(30-day) 
Specific 
densities g/cm
3
 
(1-day) 
Specific densities 
g/cm
3
 (30-day) 
PC standard  66 ± 8 83 ± 7 19 ± 1 13 ± 1 2.62 ± 0.01 2.51 ± 0.01 
Sodium citrate 0.5 57 ± 9 71 ± 7 18 ± 1 15 ± 1 2.57 ± 0.01 2.44 ± 0.01 
 2 75 ± 8 98 ± 11 14 ± 1 10 ± 1 2.55 ± 0.01 2.40 ± 0.01 
 5 44 ± 6 75 ± 8 19 ± 1 14 ± 1 2.54 ± 0.01 2.43 ± 0.01 
Potassium citrate 2 72 ± 7 125 ± 14 13 ± 1 8 ± 1 2.54 ± 0.01 2.35 ± 0.01 
 5  44 ± 7 79 ± 6 21 ± 1 13 ± 1  2.60 ± 0.01 2.39 ± 0.01 
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3.4.5 Investigating surface charge with zeta-potential measurements. 
The addition of sodium or potassium citrate to PC significantly (p<0.05) increased the magnitude 
of the negative surface charge compared with the PC standard (figure 3.4.4). In contrast, the 
addition of both citric acid and calcium citrate did not significantly (p<0.05) effect the magnitude 
of the overall negative surface charge.  
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Figure 3.4.4 Graph depicting zeta potential measurements of PC in the presence of various citrates. Cements containing 
sodium or potassium citrate (-18 and -19 mV respectively) were both significantly (p<0.05) more negative than the PC 
standard (-11 mV). Citric acid (-14 mV) and calcium citrate (-6 mV) were not significantly (p<0.05) from the pc standard 
(sample number n=3).   
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3.4.6 Cement enthalpy changes measured using differential scanning calorimetry (DSC) 
The mean enthalpy changes during the hydration of PC in the presence of either 2wt% sodium or 
potassium citrate were 83 and 96 J g
-1
 respectively (figure 3.4.5a). Both of these values were 
significantly (p<0.05) greater than those obtained from the PC standard with a value of 30 J g
-1
. 
The heat trace profiles of potassium and sodium citrate additions to PC were also similar with an 
initial exotherm after approximately 20 minutes followed by a lower peak after approximately 
40 minutes. For both sodium and potassium citrate additions the first peak corresponded with the 
initial setting of the cement which occurred at 24 and 20 minutes respectively. The addition of 
calcium citrate produced one exotherm with a single peak after 84 minutes with a mean enthalpy 
change of 40 J g
-1
. PC with addition of 2 wt% citric acid did not to yield any heat from the 
setting reaction.  
An addition of 2 wt% calcium citrate to PC appeared to generate a similar but extended trace 
profile as seen for the sodium and potassium citrate additives (figure 3.4.5a). When the kinetics 
of the setting reaction of the 2 wt% calcium citrate were accelerated by testing the enthalpy 
change at 37 °C a similar double peak profile was obtained (figure 3.4.5b). On addition of 5 wt% 
sodium citrate there was a significant acceleration of the hydration reaction which prevented 
measurement of the initial exotherm after sample preparation with this additive. However, based 
on the height and width of the initial peak the overall hydration enthalpy appeared greater than 
when only 2 wt% of the additive was used. The trace contained a second exotherm shoulder at 18 
minutes which was also seen in the 2 wt% additions. The initial setting times of the 5 wt% 
sodium citrate cements also corresponded with the position of the first major exotherm occurring 
within the first 3 minutes of setting.  
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Figure 3.4.5 (a) 3 Graph showing the enthalpy change of PC with 2wt% of various citrate compounds during the first 2 h 
of cement hydration. The greatest enthalpy changes were observed with potassium and sodium citrate which also 
possessed similar profiles. (5b) Enthalpy change with PC containing 5 wt% sodium citrate (25°C) and calcium citrate set 
at 37°C. For the 5 wt% sodium citrate cement the kinetics of reaction were so fast that it was not possible to measure the 
initial exotherm (sample number n=3).    
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3.4.7 Cement phase analysis using X-ray diffraction (XRD). 
There was no ettringite present in the PC standard or cements containing 2 wt% citric acid after 
2h setting as indicated by the lack of peaks at 9 and 16° thetas (figure 3.4.6a). In contrast, 
cements containing 2 wt% sodium, potassium and calcium citrate possessed peaks corresponding 
with ettringite. After 24 h of setting the PC standard had developed an ettringite peak in addition 
to a calcium hydroxide peak at 18° theta (figure 3.4.6b). None of the citrate containing cements 
developed a calcium hydroxide peak before 24 h. Between 1 and 30-days both the cements 
containing 2 wt% sodium and potassium citrate developed peaks at 18° theta (figure 3.4.6c).       
 
 
0
50
100
150
200
250
300
6
8
10
12
14
16
18
R
e
la
ti
ve
 i
n
te
n
s
it
y
Degrees 2 theta
 
 
2wt% calcium citrate 
2wt% sodium citrate 
 2 wt% potassium citrate 
2wt% citric acid 
PC standard 
A 
RESULTS  
101 
 
0
50
100
150
200
250
300
6
8
10
12
14
16
18
20
R
e
la
ti
ve
 i
n
te
n
s
it
y
Degrees 2 theta
 
0
50
100
150
200
250
300
350
400
6
8
10
12
14
16
18
R
e
la
ti
ve
 i
n
te
n
s
it
y
Degrees 2 theta
  
Figure 3.4.6 Spectra showing the X-ray diffraction patterns for PC containing 2 wt% of various citrate compounds. (A) 
after 2 h of setting only sodium and potassium citrates possessed ettringite peaks at 2 ° and 16 ° theta. (B) In contrast, 
after 24 h PC standard had also developed this peak in addition to another peak at 18 theta corresponding with Ca(OH)2. 
(C) After 30-days both standard and citrate cements possessed ettringite and Ca(OH)2 .  
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3.4.8 FTIR analysis 
There was a sharp increase in the calcium sulphate dihydrate (gypsum) peak at 1100 cm
-1
 during 
the first 60 minutes of setting for cements containing 2 wt% sodium and potassium citrate (figure 
3.4.7a). The ʋ3 absorption band of sulphate (SO4
2-
) is in this region and based on the profiles of 
standard calcium sulphates the peak related most closely to gypsum (180-182). In contrast, the 
gypsum peak for the PC standard and cements containing 2 wt% sodium citrate and citric acid 
did not increase during the first 2 h of reaction. When 5 wt% sodium citrate was added to the 
cement the gypsum peak was noticeably higher than with a 2 wt% addition (figure 3.4.7b). When 
5 wt% gypsum was added in addition to the 5 wt% sodium citrate the gypsum peak was higher 
compared with when the citrate was used independently.  
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 Figure 3.4.7 (a) FTIR spectra for PC and PC containing 2 wt% citrates after the first hour of setting. The absorbance of 
the sulphate band (1100 cm-1) in the cements containing sodium and potassium citrate was noticeably higher than the PC 
standard. In contrast, the wide water peak at (3500 cm-1) of PC had decreased noticeably compared with the citrate 
containing cements. (B) When 5 wt% gypsum was added to the cement the sulphate band increased compared with the 
PC standard. The highest peak heights were achieved by adding gypsum in conjunction with citrate (sample number 
n=3). 
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3.4.9 Investigating surface morphology using scanning electron microscopy (SEM)  
Crystals approximately 2-4 µm in diameter matching the morphology of ettringite were present 
after 24 h setting on the cement surface containing both 2 wt% sodium and potassium citrate 
(figures 3.4.8b and 3.4.8c respectively). PC standard and cement containing 2 wt% calcium 
citrate did not possess any crystals of similar morphology (figures 3.4.8a and 3.4.8d 
respectively). After 24 h the crystals on the surface of both the PC standard (figure 3.4.8e) and 
the cement containing 2 wt% sodium citrate (figure 3.4.8f) had extended to approximately 10µm, 
see figures 8e and f respectively.  
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Figure 3.4.8 Scanning electron micrographs showing the surface morphology of (A) PC standard after 2h of cement 
setting (B) PC containing 5 wt% sodium citrate and (C) 2 wt% potassium citrate. The addition of both of these additives 
produced small needle shaped crystals 3 m in length. (D) The addition of calcium citrate after 2 h did not produce any of 
these crystals. After 24 h of cement setting larger, 10 m, needle shaped crystals were present in both the (E) PC standard 
and (F) 2 wt% sodium citrate. 
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3.4.10 Elemental analysis using energy dispersive X-ray spectroscopy (EDX).  
When the elemental composition of the 10 µm crystals were analysed using energy dispersive X-
ray  spectroscopy (EDX) there was only a 3 % and 12 % difference to the theoretical values for 
ettringite in the O/Al and O/S ratios respectively (for full calculations refer to appendices).  
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3.5 Chapter: Effect of additives on the flexural strength of Portland cements. 
Additions of 2 wt% sodium citrate to PC or 2.5 wt% combinations of calcium chloride and 
calcium nitrate were shown to increase cement injectability, reduce setting times and maintain 
compressive strength values (see chapters 3.3 and 3.4). A survival probability plot of the biaxial 
flexural strengths of the PC based materials indicated an asymmetrical distribution of the sample 
groups (figure 3.5.1).    
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Figure 3.5.1 Probability of survival curves for different cements illustrating the flexural strengths at which samples of a 
group of cements (n=30) failed (Portland cement (PC) standard, PC with 2 wt% sodium citrate and PC with 2.5 wt% of 
both calcium chloride and calcium nitrate).  There was an asymmetrical distribution of flexural strengths in cements 
containing both calcium chloride and nitrate (sample number n=30). 
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A 10 wt% addition of the radiopacifier bismuth oxide did not significantly (p<0.05) decrease the 
flexural strength of the material with mean strengths for all specimen groups above 20 MPa 
(figure 3.5.2).  
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Figure.3.5.2 Graph demonstrating the flexural strengths of groups (n=30) of Portland cement 
(PC) containing 10 wt% bismuth oxide and PC containing bismuth oxide in addition to other 
setting accelerants (sample number n=30).  
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The confidence intervals of the Weibull modulus for all the PC variations overlapped indicating 
the additives did not significantly (p<0.05) affect the defect distribution within the brittle 
material. However, the linerisation of the Weibull data produced an R
2
 value below 0.9 (figure 
3.5.3). 
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Figure 3.5.3 The Weibull modulus of all the Portland cement variations were plotted on a 
single graph including 95% confidence intervals. The confidence intervals for all the 
variations overlapped indicating the distribution of defects were similar in all samples.  
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Table 3.5.1 Confidence in the linearisation of Weibull data was reflected by R2 values.  Only 2 wt% sodium citrate 
produced a value below 0.90. 
  
Additives R
2
 
PC standard 0.98 
PC + 10 wt% bismuth oxide 0.99 
PC + 2 wt% sodium citrate 0.89 
PC + 2 wt% sodium citrate + 10 wt% bismuth oxide 0.97 
PC + 2.5 wt% calcium chloride and calcium nitrate 0.94 
PC + 2.5 wt% calcium chloride and calcium nitrate + 10 wt% bismuth oxide 0.95 
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3.6 CHAPTER: Investigating the rheology and injectability of Portland cement 
3.6.1 Investigating the dynamic viscosity of Portland cement with sodium citrate additives 
using a parallel plate rheometer  
The PC standard had an initial viscosity of approximately 1400 Pa.s which increased by 
1000 Pa.s during the 30 minute experiment (figure 3.6.1b). In contrast, cements containing 
2 wt% sodium citrate possessed a significantly (p<0.05) lower initial dynamic viscosity of 
30 Pa.s which increased significantly (p<0.05) after 10 minutes as the cement was observed to 
set (figure 3.6.1a).  
  
RESULTS  
112 
 
Time (minutes)
0 10 20 30
D
y
n
a
m
ic
 v
is
c
o
s
it
y
 (
P
a
.s
)
0
20000
40000
60000
PC standard
PC with 2 wt% citrate 
 
Time (minutes)
0 10 20 30
D
y
n
a
m
ic
 v
is
c
o
s
it
y
 (
P
a
.s
)
-1000
0
1000
2000
3000
4000
PC standard
PC with 2 wt% citrate 
 
 
Figure 3.6.1 (a) Graphs depicting dynamic viscosity of Portland cement (PC) standard and PC containing a 2 wt% 
sodium citrate addition at 10 minute intervals for 30 minutes. The dynamic viscosity of the standard cement remained 
relatively constant during the setting period. In contrast, the viscosity of the cements containing 2 wt% sodium citrate 
significantly increased after 10 minutes. (b) The PC standard possessed an initial viscosity of approximately 1400 Pa.s. In 
contrast, the initial dynamic viscosity of cements containing 2 wt% sodium citrate was 40 Pa.s and increased to 
approximately 300 Pa s after 10 minutes (sample number n=3). 
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For the first 60 s of the viscosity testing the PC standard remained between ~1000-1400 Pa.s 
(figure 3.6.2). However, from 1-4 minutes the viscosity increased to 8000 Pa s and the cement 
was observed to begin to set on the wide aspect plate rheometer.  
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Figure 3.6.2 Graph of dynamic viscosity of PC standard during setting demonstrating the gradual increase in viscosity 
over 250 seconds.  
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Cements containing 5 wt% sodium citrate demonstrated a fluctuating viscosity during the first 10 
minutes of setting (figure 3.6.3). The Gilmore needles test has previously indicated that the 
cement sets in under 3 minutes. The fluctuations may have occurred as a result of the cycle of 
cement bond formation proceeded by bond breakage as a consequence of the shear forces applied 
by the rheometer.  
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Figure 3.6.3 Graph showing the viscosity of PC containing 5 wt% sodium citrate over 10 minutes on the plate rheometer 
at a shear rate of 0.3 s-1. The fluctuations in the dynamic viscosity indicated that the cement bonds were created and then 
instantly broken.  
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3.6.2 Injectability of Portland cement through a 5cm needle 
Adding needles to the syringes containing PC standard significantly (p<0.05) reduced cement 
extrusion (figure 3.6.4). In contrast, needle addition had little effect on the extrusion of cements 
containing liquefying additives.  
 
 
Figure 3.6.4 Graph demonstrating the effect of needle. There was a 50% decrease in cement injectability when injecting 
the PC standard through a needle. In contrast, the needle had only a minor impact on the injectability with PC containing 
an additive (sample number n=4).  
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There was a decrease in the displacement of the syringe plunger when needles were added to the 
end of the standard PC syringes (figure 3.6.5). This was reflected in the decrease in injectability 
of the standard cements. 
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Figure 3.6.5 Force/displacement graph recorded during the injectability experiment of PC standard with and without 
cannula. The 50 % reduction in injectability of the PC standard can be visualised as the syringe plunger failed to extend 
with a cannula attached.  
 
There was no noticeable effect of cannula addition on plunger displacement when either 2 wt% 
sodium citrate or 10 wt% calcium chloride was added to the cement powder (figure 3.6.6).  
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Figure 3.6.6 Force/displacement graphs recorded during the injectability experiment for cements containing (a) 2 wt% 
sodium citrate and (b) 10 wt% calcium chloride.  There was no noticeable effect on plunger extension when a cannula was 
added to the syringes. 
A 
B 
RESULTS  
118 
 
3.6.3 Monitoring the pressure drop of Portland cement with 2 wt% sodium citrate compared 
with PMMA  
A modified universal testing machine was used to assess the pressure drop (N) of an injectable 
PC containing 2 wt% sodium citrate (figure 3.6.7). The cement required a mean of 20 N of force 
to be injected  into porous Sawbone™ (200 µm pore diameter).   
 
 
Figure 3.6.7 Injectability equipment measuring the pressure drop (N) when cements were injected into a Sawbone™ 
matrix with 200 µm pore size. Portland cement (PC) with a 2 wt% sodium citrate addition required less than 20 N to 
inject 100 ml of cement into the matrix (sample number n=3). 
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3.6.4 Investigate the use of Micro-CT (µ-CT) to assess cement phase separation during 
Portland cement injection  
During the first part of the investigation a number of PC standard discs (6mm by 3mm) with 
ranging powder-to-liquid ratios (PLRs) were produced to assess if the µCT-grey value counts
5
 
varied between standards (figure 3.6.8). After producing the samples it was observed from static 
µ-CT images that a number of macro pores and macro cracks (>200 µm) became noticeably 
greater as the PLR of the cement was reduced from 5 to 2.5 g/ml. At a PLR of 2.5 macro cracks 
constituted approximately 10 % of the surface of the cement.  
 
 
                                                 
5
 Each pixel was assigned a grey scale value (from a total of 250). These values were then summed and the total 
percentage of each of the 250 grey values present within the image calculated.  
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Figure 3.6.8 µ-CT images depicting the cross-section of a Portland cement standard disk with a 6 mm diameter ranging 
from a powder-to-liquid ratio of 2.5-5 g/ml.  
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The change is grey value counts were investigated using two different methods. Firstly, an 8-bit 
histogram was created around the circumference of the circular cement sample (figure 3.6.9a). In 
the second method a mask of the sample was created and the grey scale values threshold to 
remove the macro-pores and cracks (figure 3.6.9b).   
 
 
 
Figure 3.6.9 µ-CT images depicting the cross section of a Portland cement standard disk with a 6 mm diameter. Two 
different methods were used to calculate the change in grey values of the standard Portland cement. (a) In the first 
example the entire sample was selected and a grey-scale histogram created for the entire cement surface including macro 
pores and cracks. (b) In the second example a mask of the sample was created which excluded the macro pores and cracks 
from the grey-scale calculation. 
 
When the grey value counts from figures 3.6.9a/b were plotted there was no noticeable 
difference in the counts (figure 3.6.10) indicating that even though the cracks were observable on 
the images this could not be quantified with an 8-bit image.  
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Figure 3.6.10 Grey value count of the Portland cement using (a) the entire sample including macro-pores and cracks from 
figure 3.6.9a (b) excluding the defects from figure 3.6.9b. There was no noticeable trend in grey values between varying 
PLRs (sample number n=3). 
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3.6.5 Micro-CT to assess localised cement diffusion within bone 
The injection chamber in figure 3.6.11 contained Sawbone™ with a porosity of 200 µm 
replicating the porosity of cancellous bone. When PC was injected into the pores the cement 
spread out in a cloud formation. When the cement was injected into the porcine bone the cement 
did not appear to penetrate the pore system with an approximate diameter of 50 µm. 
 
  
  
  
Figure 3.6.11 (a) sawbone polymer with a homogeneous pore diameter of approximately 200 µm. (b) Sawbone after 
injection with PC containing 2 wt% sodium citrate (see figure 3.57). The cement diffused in a spherical cloud shape (c) 
Porcine vertebrae bone with an artificial fracture created following loading using a universal testing machine. (d) µ-CT 
image of the porcine bone with PC bone cement injected.  
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3.7 Investigating the cytocompatibility of Portland cement 
3.7.1 Growth curves for 3T3 fibroblasts incubated with Portland cement discs (6 mm by 3 
mm)  
3.7.1.1 Portland cement discs set for 24 h in split moulds removed and positioned in the centre of 
a 35 mm petri dish prior to seeding with 3T3 fibroblasts  
After initially seeding 5000 cells the lag growth phase in all petri dishes continued for 
approximately the first 2 days of the experiment (figure 3.7.1). During the exponential growth 
phase at days 6 and 8 the number of cells in the control petri dishes, with no cement, were 
significantly (p<0.05) higher than the dishes containing PC discs. In contrast, at these same 
timepoints there was no significant (p<0.05) difference in cell numbers in petri dishes containing 
discs of standard PC and those containing PC discs with either calcium chloride or calcium 
nitrate. At the beginning of the stationary phase the control wells contained approximatly 35x10
4
 
cells while cells incubated with the PC discs all contained under 31x10
4
 cells. 
  
RESULTS  
125 
 
 
Figure 3.7.1Growth curves for 3T3 fibroblasts incubated with PC discs containing either 5 wt% of the setting accelerants 
calcium chloride or calcium nitrate (the cements were set for 24 h prior to incubation with the cells). At days 6 and 8 the 
cell count in the control dishes containing no cement were significantly (p<0.05) higher than dishes containing cement 
discs (sample number n=3).   
 
3.7.1.2 Portland cement discs set for 6 h in split moulds removed and stored in distilled water for 
18 h before being positioned in the centre of a 35 mm petri dish and seeded with 3T3 fibroblasts  
The initial lag phase occurred for the first 3 days after seeding. At the end of this period there 
was no significant (p<0.05) difference in cell numbers between the control dishes and those 
containing any type of cement disc (figure 3.7.2). During the exponential growth phase between 
days 5 to 9 the cell numbers in the control petri dishes and those containing cement remained 
similar. At each time point at least one set of cement discs either PC standard or PC containing 
either calcium chloride or calcium nitrate demonstrated no significant (p<0.05) difference with 
the control. However, when all the time points over the 11-day experiment were grouped for 
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each set of discs the petri dishes which contained cement had overall significantly (p<0.05) 
lower cell numbers than the control.  
 
Figure 3.7.2 Growth curves for 3T3 fibroblasts incubated with PC or PC containing either 5 wt% of the setting 
accelerants calcium chloride or calcium nitrate (the cements were set for 6 h in split moulds and then for 18h in ddH2O 
prior to incubation with the cells). Overall, during the 11 day experiment the cell counts in the control dishes containing 
no cement were significantly (p<0.05) higher than the dishes containing PC discs (sample number n=3).   
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3.7.1.3 Distribution of 3T3 fibroblast cells incubated with PC discs set for 24 h in a split mould 
At 0, 3 and 7 days the cells incubated with the PC standard discs set for 24 h were imaged using 
phase contrast light microscopy (figure 3.7.3). The 3T3 fibroblasts appeared to initially cluster 
around the exterior of the cement discs when seeded (figure 3.7.3a). Cell density appeared 
evenly distributed around the material after 3-days of incubation with no distinct zone of growth 
inhibition (figure 3.7.3b). After 7-days cell density had increased with cells growing within 
approximately 50 µm of the surface of the cement (figure 3.7.3c).   
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Figure 3.7.3 Phase contrast microscopy images of 3T3 fibroblasts incubated with 24 h set Portland cement for A) 0 B) 3 
and C) 7 days. There was no distinct zone of inhibition and cells appeared to colonise  up to the edge of the cement.   
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3.7.2 Growth curves of bone marrow stromal cells in the presence of PC 
3.7.2.1 Portland cement discs set for 0.3 or 1 hour in split moulds removed and positioned in the 
centre of a 35 mm petri dish prior to seeding with bone marrow cells 
Cements set for only 20 minutes prior to incubation with the bone marrow cells produced an 
acute cytotoxic effect leading to cell death (figure 3.7.4a).  After 1 hour setting the PC standard 
discs remained cytotoxic to cells. However, the cells incubated with PC discs containing 2 wt% 
sodium citrate demonstrated moderate growth rates from 5 to 13 days but cell numbers remained 
significantly (p<0.05) lower than the control wells containing no cement (figure 3.7.4b).  
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Figure 3.7.4 Growth curves of bone marrow cells incubated with Portland cement discs (6mm x 3mm) which had been set 
for either A) 20 minutes or B) 1 hour. Cements set for only 20 minutes prior to exposure to cells were cytotoxic causing 
cell death. After 1 h of cement setting there was moderate growth after 5 days in petri-dishes containing PC discs 
containing 2 wt% sodium citrate (sample number n=3). 
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3.7.2.2 Portland cement discs set for 3 or 12 hour in split moulds removed and positioned in the 
centre of a 35 mm petri dish prior to seeding with bone marrow cells 
Cements set for 3 h containing the citrate additive had significantly (p<0.05) higher cell counts 
than the equivalent cement set for only 1 hour (figure 3.7.5a).  At 3 h setting the cells incubated 
with the standard cement also demonstrated growth with 30,000 cells present after 13-days of 
incubation. When cells were incubated with cements that had been allowed to set for 12 hours 
(figure 3.7.5b) cell counts between the standard and cements with accelerant additives were not 
significantly (p<0.05) different yet both remained significantly (P<0.05) lower than the control 
wells.  
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Figure 3.7.5 Growth curves of bone marrow cells incubated with Portland cement discs (6mm x 3mm) which had been set 
for A) 3 hours or B) 12 hours. The cement discs set for 3 h demonstrated significantly (p<0.05) higher cell counts after 13 
days of incubation than when the cement was set for only 1 hour. At 12 hours of cement setting the cell counts in the 
dishes containing either standard discs or ones with the citrate additive were not significantly (p<0.05) different. 
However, the cell counts in the control dishes remained significantly (p<0.05) higher (sample number n=3).    
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3.7.2.3 Distribution and morphology of bone marrow cells incubated with PC discs  
After exposing cells to cement discs set  for 1 hour that contained 2 wt% sodium citrate there 
was initially a high cell death count  in an approximate 1300 µm radius around the circumference 
of the material (figure 3.7.6a). Cellular morphology differentiated within this radius with cells 
within 1100 µm appearing ruptured and lysed (zone A). In zone B a transition occurred between 
cells with ruptured membranes  to those of typical bone marrow morphology. Similar transition 
zones were observed when cells were incubated with cement discs containing 2 wt% sodium 
citrate set for 3 hours but the zones a, b and c were only a few 100 µm wide (figure 3.7.6b). Cells 
were able to colonise up to the edge of the cement discs containing sodium citrate which had set 
for 12 h.  
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Figure 3.7.6 Distribution and morphology of mesenchymal bone marrow stem cells incubated with cement containing 
2 wt% sodium citrate (A) citrate cements set for 1 h demonstrated a zone of cell growth inhibition of approximately 1300 
µm surrounding the cement (B) after the same incubation period the cements set for 3h had a decreased zone of 
approximately 250 µm wide (C) cements set for 12 h produced no zone of cell growth inhibition. 
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3.7.3 Effect of cement induced pH changes on culture medium 
Within 1-2 minutes of exposing freshly prepared cement (set for 20 minutes containing 2 wt% 
sodium citrate) to 3 ml of culture medium in a 35 mm Petri dish the phenol red indicator dye 
demonstrated a highly alkaline pH (figure 3.7.7). Measurements of pH revealed the media was in 
the region of pH 11.  
 
 
Figure 3.7.7 Photograph of 6-well plate containing PC samples (upper row) set for 20 minutes in culture medium. The 
phenol red dye is vivid pink indicating the high alkalinity of the media after exposure to the cement material.  
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3.7.4 Alizarin red staining to test for calcium mineralisation  
After the PC discs containing 2 wt% sodium citrate set for 1 hour were removed from the petri 
dishes after 13 days incubation with bone marrow cells and stained with alizarin red dye a red 
halo emerged around the discs circumference (figure 3.7.8a). As alizarin red binds to calcium 
based material it would appear that a portion of the cements calcium species were eluted during 
the cellular incubation period. The high calcium content of the material made it difficult to assess 
calcification deposits that may have been produced by the bone marrow stromal cells (figure 
3.7.8b).  
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Figure 3.7.8 (A) A dark red halo was visible after alizarin red staining in the area where the  cements set for 1 hour were 
originally aligned in the 35 mm petri dishes indicating calcium deposition surrounding the material. (B) Microscopy 
image of bone marrow cells after alizarin red staining. It was difficult to assess if calcification was caused by the  bone 
marrow stromal cells or the mineral content of the material.  
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3.7.5 Reverse transcription polymerase chain reaction (RT-PCR) 
The bone marrow stromal cells incubated with PC discs set for either 1 or 12 h demonstrated 
increased levels of gene transcription for several osteoblast phenotype genes compared with 
control wells containing no cement (figure 3.7.9). These included alkaline phosphatase 
(ALPase), bone sialoprotein (BSP), osteonectin (ON) and osteopontin (OPN). There was no 
observed difference in expression levels of osteoadherin and bone morphogenic protein 
compared with the control. Osteocalcin expression was absent in both the control and cements 
exposed to PC. There was no observable increase in the cell proliferation marker Ki-67 between 
the control wells and those containing PC.     
 
Figure 3.7.9 Cells were exposed to cement containing 2 wt% sodium citrate set for both 1 and 12 h and the gene 
expression of several osteoblast phenotype genes recorded by RT-PCR (visualised on agarose gel). In the presence of 
cement there was increased expression of alkaline phosphatase, Bone morphogenic protein, osteonectin and osteopontin.     
RESULTS  
139 
 
3.7.6 Using buffers to reduce the alkalinity of the Portland cement setting reaction 
An addition of 2 or 10 wt% sodium dihydrogen orthophosphate and 10 wt% additions of either 
potassium phosphate dibasic or Tris EDTA significantly (p<0.05) reduced the pH of the 
20 minute set cement (figure 3.7.10). Cement containing 2 wt% sodium citrate was set for 12 h 
and pH measured as 8.92 ± 0.11 which was significantly (p<0.05) lower than the cement set for 
only 20 minutes. However, the reduction of pH remained above the physiological optimum for 
cell growth of pH 7.4 (183).   
 
 
Figure 3.7.10 pH of 3.5 ml of cell culture medium incubated with a PC disc (6mm x 3mm) for 20 minutes. The standard 
contained 2 wt% sodium citrate the other discs contained 2 wt% sodium citrate in addition to 2 or 10 wt% of a chosen 
buffer.  An addition of 2 or 10 wt% sodium dihydrogen orthophosphate and 10 wt% additions of either potassium 
phosphate dibasic or Tris EDTA significantly (p<0.05) reduced the pH of the setting cement (sample number n=3). 
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Additions of potassium phosphate dibasic, 10 wt% sodium dihydrogen orthophosphate and 10 
wt% Tris EDTA prevented the cement from setting. Additions of both 2 wt% sodium dihydrogen 
orthophosphate and 2 wt% Tris EDTA significantly (p<0.05) increased the setting times 
compared with PC containing only 2 wt% sodium citrate (figure 3.7.11).  
 
 
Figure 3.7.11 The effect on setting time of buffer additions to PC was tested with the Gilmore needles test. Additions of 
potassium phosphate dibasic, 10 wt% sodium dihydrogen orthophosphate and 10 wt% Tris EDTA prevented the cement 
from setting. Two wt% additions of sodium dihydrogen orthophosphate and 2 wt% Tris EDTA extended the material 
setting times (sample number n=3).  
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CHAPTER 4: DISCUSSION 
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4 DISCUSSION 
4.1 CHAPTER: Investigating the parameters for an injectability model  
4.1.1 The effect of powder-to-liquid ratio on cement injectability and setting times 
The first stage of the injectability experiments assessed whether over 90 wt% cement extrusion, a 
prerequisite requirement of the industrial collaborator, would be feasible by simply increasing 
the water content of the standard cement. From figure 3.1.1, it became evident that even at a PLR 
of 2.2 g ml
-1
 which was considered low (184), it was not possible to achieve this goal without a 
liquefying additive. The rheology of the materials was not measured but it was observed that the 
dense cement particles were sedimenting at the bottom of the syringe. Phase separation of the 
cements powder and liquid phase is a known problem with ceramic materials and has been 
shown to be the leading cause of poor injectability in calcium phosphate cements (166, 185). 
Excess water in cements also leads to high cement porosity as the water is not consumed within 
the cement setting reaction which can result in poor compressive strengths (125). Setting times 
of PC without an additive were also in excess of the 15-20 minute window for the vertebroplasty 
operation (refer to figure 3.1.3) (186).   
4.1.2 The effect of cross-head speed on injectability  
Approximately 30 mm plunger depression was required to extrude fully the 5 g of cement from 
the syringe (figure 3.1.4). As the cross-head speeds under investigation ranged from 3-
30 mm min
-1
 this equated to extrusion times between 1-10 minutes. A series of cross-head speeds 
from 10 mm min
-1
 (187) to over 120 mm min
-1
 (185) have previously been used in studies 
extruding calcium phosphate cements from similar size syringes (5 ml).  It was observed, during 
the experiment, that when extruding the cement at 3 mm min
-1
 a set cement bolus formed at the 
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tip of the syringes when a setting accelerant was present and was momentarily preventing more 
cement from being extruded. Cement setting in the cement tip may have reduced the injectability 
of the slower extruded cements. Clinically acrylic bone cements are required to remain usable 
between 6.5-15 minutes (15). For instance, Osteopal ® (Heraeus, Germany) a PMMA based 
bone cement used extensively for PVP operations, has an injectability time of 7 minutes (188) 
whereas CMW1® (DePuy, UK) is just over 13 minutes (189). Personal communication with a 
radiographer routinely performing the operation also indicated that a working time of 
approximately 10 minutes was sufficient and preferable (167). When the formulations were 
further studied in chapter 3.6, time dependency of injectability was investigated in greater detail.  
 
4.1.3 The effect of dispersing additives in the powder vs. liquid phase 
During the initial stages of the project it was observed that many of the additives, including 
calcium acetate and sodium hexaphosphate, possessed dual functionality acting as both 
liquefying agents and setting accelerants. Both of the additives investigated were highly soluble 
and dissolved fully in the liquid phase (153, 190). The homogeneously mixed solutions may have 
provided the accelerating additives with greater access to the surface of the hydrating cement 
particles accounting for both the decreased setting times (figure 3.1.5) and conversely the 
reduced injectabilities when the additives were dissolved in the liquid phase. (166).  
4.1.4 Batch variation and effect of cement aging and storage on the various phases of 
Portland cement 
For a future commercial product, it is important that both the elemental and phase composition of 
the unhydrated cement powder remains consistent between batches. The EDX analysis indicated 
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that both batches of cement possessed similar levels of tricalcium silicate and that there were no 
major changes in the elemental composition of the material (table 3.1.1). However, the decreased 
XRD peak intensities of the 2005 compared with the 2011 batch of PC may indicate cement 
aggregate formation in the powder phase of the older batch of the material (figure 3.1.7). The 
XRD peak intensities for crystal structures associated with the unreacted/clinker phases had 
decreased in the older batch but equally there were no corresponding increases in peaks 
associated with hydrated cement phases. The older batch of cement may have become partially 
hydrated forming crystal unit structures distinct from the known fully hydrated phases of PC, but 
with no characteristic XRD absorption peaks (179).    
 
4.1.5 Effect of cement powder filtering on the physical properties and phase composition of 
Portland cement 
The increased XRD peak intensities (figure 3.1.8) as the filter aperture size was reduced from 
500-63 µm may indicate the removal of non X-ray absorbing agglomerates at the lower diameter 
aperture size (179). The significantly (p<0.05) decreased setting times of the cement sieved 
through the 75 µm filter as opposed to the 63 µm filter, indicated that possibly an important 
cement phase was being removed within this range of filter apertures (figure 3.1.9). PC typically 
has 5 wt% calcium sulphate dihydrate (gypsum) added during production in order to coat the 
calcium aluminate phase, thus preventing early hydration (flash setting) which leads to a weak 
cement structure (113). However, the XRD determined phase composition did not alter after the 
sieving through a 63 µm aperture which may have provided an explanation for the reduced 
setting times. To examine whether there was any elemental differences between the cements 
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passed through different pore diameters, the cement would need to be examined via a technique 
such as EDX or X-ray fluorescence (XRF).   
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4.2 CHAPTER: Development of Portland cement for orthopaedic applications, 
establishing injectability and decreasing setting times using researched additives 
4.2.1 Injectability studies in the presence of sodium chloride, sodium aluminate, sodium 
hexaphosphate and calcium acetate. 
Sodium hexaphosphate  has previously demonstrated to be a calcium phosphate cement liquefier 
(153).  A 1-2 wt% addition modified cements from being un-injectable to enable extrusion of 
over 97 wt% from a syringe with a 2 mm aperture. A decrease in the surface charge of the 
calcium phosphate cements after mixing indicated the electrostatic adsorption of the charged 
hexaphosphate anion onto the cements positive surface. It has been suggested that binding of 
liquefiers, such as sodium hexaphosphate, results in repulsion between cement particles both 
electrostatically and sterically due to the large size of the anion (153).  It has been inferred that 
these forces led to a dispersal of cement aggregates while also preventing further flocculation 
leading to the liquefying effect (23, 191, 192). Increasing the quantity of the liquefying additives 
in the present study from 5 to 10 wt% may have caused an increase in the electrostatic repulsion 
effect between the cement particles, leading to the improved liquefying abilities (figure 3.2.1). 
Future studies will examine the surface charge of the material using a zetasizer.   
Similar to sodium hexaphosphate, sodium chloride and calcium acetate both fully ionise in water 
to form anionic species. The deprotonated carboxyl groups formed by these carboxylic acid salts 
form the basis of the binding groups for the commercially available PC liquefiers 
“polycarboxylate derivatives” (151). This group of liquefiers cause cement grain dispersion as a 
result of both electrostatic and steric repulsions generated by the extended anionic side chains 
(193). However, as acetate and chloride do not possess extended side chains the binding of ions 
onto the positive surface may simply neutralise positive charges such as Portlandite [CaOH]
+
 and 
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forming Friedel salts [Ca2AlOH6]
+ 
forming on the cements surface (194). Zeta-potential 
measurements may be employed to investigate if charge neutralisation as opposed to electrostatic 
repulsion was occurring with the acetate and chloride additives. However, as the balancing 
cation calcium also interacts with the forming cement surface it may not be possible to 
accurately assess how the surface charge changes in the cement (195, 196).  
Sodium aluminate may also act as a liquefier due to the large difference in electronegativity 
between aluminium (1.61) and oxygen (3.44) which provides oxygen with a disproportionate 
share of the π (pi) electrons in the aluminium oxygen bond (197). The transient negative dipole 
may attract the additive to the cements positive surface.  
Gbureck et al (187) studied the injectability of calcium phosphate cements (CPC) and obtained 
similar extrusion graphs (figure 3.2.2) for cements containing liquefying additives with CPC 
cement. The low initial force required to extrude the majority of the cement paste containing a 
10 wt% liquefier suggests a homogeneous cement paste with few agglomerates. There was a 
gradual increase in the force plateau level when the additive content was decreased to 5 wt%, 
perhaps indicating an increase in agglomerate levels. For the PC standard the continuous increase 
in force required to extrude the cement may be linked to the formation of high numbers of 
agglomerates. 
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4.2.2  Density and porosity studies 
The specific density of the PC standard (≈ 2.5 g cm-3) (table 3.2.1) was lower than the strut 
density of PC powder (≈3.1 g cm-3) (198) as a result of the hydration reaction of water 
(≈1.0 g cm-3) with the powder phase. The lower specific densities of PC containing 10 wt% 
sodium chloride (2.28 g cm
-3
) and calcium acetate (2.20 g cm
-3
) cements indicated a greater 
degree of conversion of reactants than the standard cement as water reacted with the cement 
powder. In contrast, the higher specific densities of the 10 wt% additions of the sodium 
aluminate and sodium hexaphosphate cements indicated a lower degree of hydration. Porosity 
within cement systems can stem from two sources. Firstly, from water added to form the cement 
paste, which was not consumed from the setting reaction, and secondly from entrapped air 
resulting from dry powder agglomerates (198). Thus, the relatively lower porosities of the 
sodium chloride and calcium acetate cements may reflect less unconsumed water within the 
cement system, whereas the higher porosities of the sodium aluminate and sodium 
hexaphosphate cements demonstrated the opposite.  
 
4.2.3 Investigating cement phase composition with X-ray diffraction (XRD.) 
The presence of the major hydration products of PC setting, calcium silicate hydrate (C-S-H) and 
ettringite, within the standard cements and cements containing sodium chloride and acetate 
indicated these cements formed the major hydration products of PC (figure 3.2.5) (113). The 
presence of crystalline calcium hydroxide, the major by-product of calcium silicate hydration 
provided further evidence that C-S-H formation was occurring within 24 h of these cements 
setting. In contrast, the absence of any of these phases in cements containing sodium aluminate 
or sodium hexaphosphate implied that typical cement setting was inhibited for at least the first 
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24 h. However, the presence of a C-S-H peak after 30-days indicated normal cement setting had 
resumed after the first 24 h. The production of C-S-H in the acetate cements appeared to have led 
to excessive calcium hydroxide by-product formation (figure 3.2.5). Excessive calcium 
hydroxide in cements has previously been linked to poor mechanical properties (199) which may 
partly explain the low compressive strengths of the acetate cements even though the major 
hydration products were present in the phase analysis. In previous investigations calcium acetate 
has been added up to 2.5 wt% and has demonstrated strength increasing effects on PC (165).  
 
4.2.4 Investigating surface phase morphology using scanning electron microscopy (SEM) 
and elemental analysis using energy dispersive X-ray spectroscopy 
The flat, hexagonal and needle shaped crystals present in the aluminate cement (figure 3.2.6e) 
were characteristic of calcium monosulphate which was confirmed by the elemental analysis. 
Typically, in PC when all the gypsum has been consumed by the formation of ettringite 
(equation 1.8.4) the remaining aluminate will begin to react with the formed ettringite to create 
calcium monosulphate which possesses a lower sulphate content (equation 1.8.5) (117).  
3CaO.Al2O3 + 3CaSO4.2H2O + 26H2O           6CaO.Al2O3.3SO3.32H2O 
(Tricalcium aluminate  + gypsum + water          ettringite) 
(Equation 1.8.4) 
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2(3CaO.Al2O3) + 6CaO.Al2O3.3SO3.32H2O + 4 H2O           3(4CaO.Al2O3.SO3.12H2O) 
(calcium aluminate + ettringite + water          calcium monosulphate) 
(Equation 1.8.5) 
The monosulphate phase does not typically appear for at least 3-days after setting indicating its 
formation had been accelerated. Monosulphate  possesses a weaker constitution than ettringite 
which may explain the comparatively low compressive strengths of the aluminate cements (200).  
The PC standard (figure 3.2.6a) and cements containing chloride(figure 3.2.6b) both possessed a 
surface morphology which appeared to be composed of  C-S-H which was also implicated by the 
elemental analysis (201). The surface structure of the calcium acetate cements appeared to be 
largely constituted of calcium hydroxide crystals which added more evidence that high calcium 
hydroxide levels were creating weak cements with the additive. The morphology of cements 
containing sodium hexaphosphate appeared to be radically different from known PC crystal 
structures and may have represented a novel complex formed between sodium hexaphosphate 
and PC.  
 
4.2.5 Investigating sulphate species using FTIR. 
Cements typically contain approximately 5 wt% calcium sulphate dihydrate (gypsum) to coat the 
calcium aluminate phase thus preventing early hydration and the formation of calcium aluminate 
hydrate, which forms a weak cement structure (equation 1.8.3)  (113).  
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3CaO.Al2O3 + Ca(OH)2 + 12H2O          4CaO.Al2O3.13H2O 
(Tricalcium aluminate + calcium hydroxide + water         calcium aluminate hydrate) 
(Equation 1.8.3) 
 
The increased unbound gypsum absorbance which occurred during the first 60 minutes of 
setting, when sodium hexaphosphate and sodium aluminate (figure 3.2.4b) were present may 
have indicated these additives were removing gypsum bound to the surface of the aluminate 
phase resulting in flash setting. This hypothesis was tested by the addition of gypsum powder to 
the cements containing 5 wt% sodium hexaphosphate. The increased height of the absorbance 
peak when gypsum and sodium hexaphosphate (figure 3.2.4d) were combined in equal wt% 
indicated that at 5 wt% the hexaphosphate anions had the capacity to remove more gypsum from 
the aluminate phase than was contained in the cement.  PC flash setting may have explained the 
early setting of cements containing sodium hexaphosphate but which ultimately lacked cement 
strength. The extended setting times of the combined gypsum/ sodium hexaphosphate cements 
indicated that even though sodium hexaphosphate was removing gypsum from the aluminate 
there was enough gypsum to prevent flash setting from occurring.  
In summary, sodium aluminate has been used as an accelerant in several commercial 
formulations for the building industry (155, 202). With a 7 wt% addition of aluminate the setting 
time of PC had been accelerated to as low as 10 minutes (155). The accelerating effect of 
aluminate has been attributed to the early formation of both major strength producing phases of 
PC, C-S-H, as well as the secondary major hydration phase ettringite (157, 158). The present 
study indicated two setting reactions may have occurred simultaneously in the presence of 
sodium aluminate. Increasing the aluminate content within the cement led to a decrease in the 
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gypsum: aluminate ratio which may have caused premature aluminate hydration (flash setting). 
Possibly, the limited quantity of ettringite which was produced was immediately converted into 
calcium monosulphate due to the limited sulphate availability and excess concentrations of 
aluminate. This would result in calcium monosulphate crystals present in the SEM analysis but 
only a limited trace of crystalline ettringite and monosulphate because the quantities being 
converted were so small. Sodium hexaphosphate produced a novel cement structure which was 
highly porous and may have been a novel type of flash setting. Calcium acetate had both C-S-H 
and ettringite phases present within the crystal structure of the cement (figure 3.2.5) with low 
porosities and strut densities indicating hydrated cement. The additive may have produced 
cements with low compressive strengths due to high calcium hydroxide production which 
weakened the cement structure (110). The PC standard and cements modified with 5 wt% 
sodium chloride both possessed similar relative porosities, specific densities and developed C-S-
H after the first 24 h of setting which indicated that the additive did not adversely affect the 
cement setting reaction.  Setting of cements in the presence of sodium hexaphosphate appeared 
to be caused by flash setting, but the EDX did not confirm the presence of calcium aluminate 
hydrate, the product which forms during this type of setting. The complex formed between 
hexaphosphate and the hydrating cement powder appeared to be novel.  
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4.2.6 Conclusions 
Seven Portland cement accelerants and one calcium phosphate liquefier were chosen from table 
1.10.1 and 1.10.2 and tested for the ability to improve PC injectability. Sodium chloride, sodium 
aluminate, sodium hexaphosphate and calcium acetate all significantly (p<0.05) increased the 
injectability of the cement. In contrast, methyl cellulose, calcium sulphate dihydrate, calcium 
carbonate and oxalic acid significantly (p<0.05) decreased it. All of the additives which 
increased injectability also significantly (p<0.05) reduced the setting time of the cement. Sodium 
chloride and calcium acetate appeared to accelerate C-S-H production but an excess of the by-
product of the setting reaction calcium hydroxide may have prevented acetate cements from 
achieving high compressive strengths. Sodium hexaphosphate appeared to form a novel complex 
which resembled flash setting. Based on the current set of additives modifying PC to become 
injectable and set in a time applicable for vertebroplasty operations is possible with cement 
strength in excess of a vertebra (1.4-9 MPa)(31-33). 
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4.3 CHAPTER: Establishing injectability and decreasing setting times using the 
additives calcium chloride and calcium nitrate  
4.3.1 Injectability studies in the presence of calcium chloride and nitrate 
Each hydrated phase of PC carries a different surface charge with Portlandite and Friedel salts 
being positive whereas ettringite and calcium monosulphate possess negative surface charges 
(194). The final cement surface charge is a combination of all of the various hydrating phases. 
However, the overall slight negative surface charge of PC can be explained by ionisation of the 
silanol groups of C-S-H, the major hydration product of PC (equation 4.3.1) (194-196, 203).  
 
>SiOH →SiO- + H+  
(Equation 4.3.1) 
The -12 mV value observed for the PC standard was close to the theoretical surface charge range 
for C-S-H (-9.2 to -12.7 mV) in a low calcium environment (196, 203). This may have been an 
indication that the surface charge of the hydrating PC was also determined by the calcium 
silicate phase (figure 3.3.4). Cement agglomerates which reduce cement flowability and possibly 
injectability of cement pastes are caused by attraction of oppositely charged surface particles 
(204). Typically, commercial liquefiers are large negatively charged polyvalent compounds 
which work by binding to the surface of PC creating an electrostatic repulsion force between the 
cement particles which disperses the aggregates, leading to the liquefying effect (191, 205, 206). 
In contrast, chloride in the presence of Ca
2+
, appeared to neutralise the cement surface through a 
series of reactions. Firstly, neutralisation occurs through the adsorption of Ca
2+ 
onto dissociated 
silanol groups (equation 4.3.2 and 4.3.3).  
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>SiOH + Ca
2+ → SiOCa+ + H+  
(Equation 4.3.2)  
>SiOH + Ca
2+ 
+ Cl
- → SiOCaCl + H+  
(Equation 4.3.3) 
 
Secondly, chloride has also been shown to neutralise positively charged Portlandite (equation 
4.3.4) (194).  
 
[CaOH]
+
 + Cl
-
 → CaOHCl  
(Equation 4.3.4) 
 
Lastly, both chloride and nitrate neutralise the forming Friedel salts of the hydrating aluminate 
phase (equation 4.3.5 and 4.3.6) (194, 207).  
 
[Ca2Al(OH)6]
+
 + CaCl2 + 2H2O → [Ca2Al(OH)6]Cl.2H2O + Ca
2+
  
(Equation 4.3.5) 
2[Ca2Al(OH)6]
+
 + 2Ca(NO3)2 + 6H2O → [Ca2Al(OH)6] (NO3)2.6H2O + Ca
2+  
(equation 4.3.6) 
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This leads to a neutralisation of the cement particles that may reduce agglomeration as there are 
less oppositely charged particles (194). Therefore, the liquefying effect of chloride and nitrate is 
likely to be based on charge neutralisation as opposed to other liquefiers which function through 
electrostatic or steric repulsion of cement particles (148).  
4.3.2 Characterising the setting reaction in the presence of calcium chloride and nitrate. 
Previous calorimetry studies have indicated that the accelerating effect of calcium chloride on 
PC setting may have been due to an increased early rate of heat evolution in the presence of the 
additive (208). The heat signature obtained during the present study indicated that the 
accelerating effect of chloride may be due to early energy generation that was not evident in the 
PC standard (figure 3.3.5). This initial exotherm appeared to be composed of three distinct 
sections which may have corresponded with three unique reactions, or, a single reaction with 
multiple exotherm stages.  The early presence of the set cement phase ettringite within the first 
2 h of cement setting indicated that at least a portion of this initial exotherm in cements with the 
chloride additive was due to early ettringite formation. It has  been inferred from previous infra-
red spectroscopy studies that calcium chloride modified PCs also demonstrated increased silicate 
polymerisation to produce a more structured C-S-H bond formation compared with standard PCs 
leading to the increased cement strength in the presence of the additive (160). The presence of a 
peak corresponding with C-S-H in the XRD phase analysis studies indicated that C-S-H was 
present within the first 24 h of setting (figure 3.3.7). However, as the peak was not present after 
the first 2 h of setting the primary mode of acceleration by calcium chloride appeared to be 
ettringite formation which is a known cause for early cement strength (113). The rate of the 
setting reaction for cements containing calcium nitrate has previously been linked to the belite 
(C2S) content in the clinker phase (162). Belite dissolves slowly to form short C-S-H fibres 
DISCUSSION 
157 
 
which provide long term strength for the cement and the short C-S-H bonds possibly contributed 
to the high cement strengths for the 5 wt% nitrate modified cements (161). The early presence of 
calcium hydroxide was observed in both the XRD and FTIR studies (figure 3.3.6) as a by-
product of C-S-H formation, possibly indicating calcium silicate dissolution that led to early C-
S-H development (110, 209). Even though the heat signatures of the PC standard and cements 
containing 5 wt% calcium nitrate were similar (figure 3.35b), the exotherms for nitrate 
containing cements were significantly higher (p<0.05). This may have indicated an increased rate 
of reaction of PC in the presence of 5 wt% calcium nitrate. After 24 h, both the PC standard and 
calcium nitrate possessed crystalline peaks corresponding with C-S-H (figure 3.3.7).  
Decreased cement strength with increasing addition of supplements correlated with increased 
cement porosities (table 3.3.1). Increased porosity may have been an indication of a higher 
proportion of nitrate and chloride being washed out from the pores of the forming cements as 
additive addition increased (198). As water became adsorbed into the structure of cement the 
specific density of the material decreased (210). Therefore, the decreased strut densities of PC in 
the presence of chloride and nitrate compared with standard PC indicated the additives may have 
been accelerating the cement hydration reaction. 
When combining additives a synergistic effect could be achieved with cements being more 
injectable and possessing higher compressive strengths (figure 3.3.1 and table 3.3.1 
respectively). Increased injectability may be due to a degree of complementary surface binding 
of the two additives leading to a greater degree of surface charge neutralisation. The increased 
compressive strength may have been as a result of chloride stimulating ettringite formation, 
whereas nitrate enhances C-S-H production.    
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Polymethylmethacrylate (PMMA) is the bone cement used in the majority of vertebroplasty 
operations (72).However, the material possesses several major disadvantages, it cures at 
temperatures up to 90°C (15), the methylacrylate monomer is toxic and has been shown to 
damage osteocytes (76) and leakage of the monomer has also been linked to pulmonary 
embolism (19). Viable alternatives are actively being researched and several have been approved 
for clinical use e.g. “Cortoss™” by “Orhovita™” and “ChronOS Inject™” by “Synthes™” (48). 
For PC ceramic materials this is first study to fully address all the issues associated with using 
the material for vertebroplasty i.e. poor injectability and long setting time while characterising 
the material with zeta-potential measurements, XRD, FTIR and calorimetry. With addition of 
simple organic chemicals the material is now injectable, has setting times and compressive 
strengths equivalent with PMMA. The material also possesses good clinical equivalence as it is 
the major constituent of MTA a material used for dental applications (3). After clinical trials it 
may therefore be a viable alternative cement for use in the vertebroplasty procedure.     
4.3.3 Conclusions. 
Calcium chloride and calcium nitrate both acted as liquefying agents and setting accelerants 
producing cements which had compressive strengths equal to or greater than the PC standard. 
Calcium chloride appeared to accelerate the setting reaction through an early exotherm which 
was responsible for early ettringite formation. In contrast, calcium nitrate stimulated early C-S-H 
formation. Combining the additives had a synergistic effect increasing injectabilities whilst also 
improving compressive strengths.  
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4.4 CHAPTER: Modification of Portland cement with the citrate anion: underlying 
mechanisms 
4.4.1 Injectability studies in the presence of sodium and potassium citrate. 
The overall negative surface charge of PC has previously been attributed to the ionisation of the 
silanol groups of C-S-H (the major phase of PC) (equation 4.3.1) as a consequence of PC and C-
S-H sharing similar zeta potentials  (C-S-H ranges from -12.7 to -9.4 mV and hydrated PC  has a 
value of approximately -10 mV) (194-196, 203).  
 
>SiOH → >SiO- + H+  
(Equation 4.3.1)
 
The -11 mV surface charge of the hydrating PC obtained during the present study was also 
similar to the known range of C-S-H surface charge indicating that the hydrating surface of PC 
may also be dictated by the calcium silicate phase. The increase in the magnitude of surface 
charge of PC in the presence of sodium and potassium citrate and citric acid (-19, -18 and -
14 mV respectively) indicated the adsorption of the citrate anion onto the surface of hydrating 
PC (figure 3.4.4). Once bound, the resulting electrostatic repulsion force between similarly 
negatively charged cement particles caused cement aggregate dispersion thus leading to 
improved injectability (191, 205, 206). The reduced charge magnitude of cements containing 
calcium citrate may have been due to binding of the calcium ion to PC which is known to 
decrease the overall surface charge of hydrated PC (equation 4.3.2).  
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>SiOH + Ca
2+
 → >SiOCa+ + H+ 
 
(Equation 4.3.2) 
4.4.2 Early acceleration of the Portland cement setting reaction in the presence of sodium 
citrate. 
At low concentrations sodium citrate has previously been described to be a cement retardant but 
acted as an accelerant when used at high concentrations, however, the underlying mechanism has 
never been satisfactorily explained (211). The cement surface morphology (SEM) (figure 3.4.8), 
surface structure composition (EDX) and phase analysis (XRD) (figure 3.4.6) studies of PC, all 
independently indicated that the early accelerating effect of citrate may be caused by the 
formation of ettringite, [Ca3Al(OH)6]2(SO4)3·26H2O. Ettringite has previously been shown to be 
essential for generating the early strength of PC and was identified in the citrate modified 
cements after 2 h but not in standard cements, with both cements containing this phase after 24 h 
(figure 3.4.6) (110). The ettringite crystals in the presence of citrate did not develop the typical 
‘spherulite’ structures produced by artificially seeding low densities of pure ettringite crystals 
(figure 3.4.8)(212). However, it has previously been demonstrated that the size and density of the 
needle shaped crystals of pure ettringite can be influenced by additives (212, 213). In particular, 
one previous study investigating the effect of sodium citrate on pure ettringite demonstrated that 
citrate produced “small, short needle”, shaped ettringite crystals due to increased crystal 
nucleation (213). The central ‘spherulite’ core may simply have been masked by crystal density 
(refer to figure 3.3.8f). The initial lack of any exotherm generated during the first 15 minutes 
with any 2 wt% citrate additive indicated that citrate binding and consequent aggregate 
dispersion prevented early bond formation leading to a retardation effect (figure 3.4.5a).  
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In addition to ettringite formation the very short setting time of cement with a 5 wt% addition of 
citrate also indicated that the additive may have been causing the cement to flash set (figure 
3.4.3). Cements typically contain approximately 5 wt% calcium sulphate dihydrate (gypsum) to 
coat the calcium aluminate phase thus preventing early hydration (flash setting) which leads to a 
weak cement structure (113). The increase in absorbance of the FTIR unbound gypsum peak at 
approximately 1100 cm
-1
 occurring during the first 60 minutes of cement setting when 5 wt% 
sodium citrate was added to PC indicated that citrate at this concentration was removing gypsum 
from the surface of the cement particles altering the quantity of bound/unbound gypsum (figure 
3.4.7b) (209). Removing gypsum from the calcium aluminate phase then resulted in the 
formation of calcium aluminate hydrate (4 CaO.Al2O3.13H2O), the cause of flash setting. This 
hypothesis was tested by the addition of gypsum to the cements containing 5 wt% sodium citrate 
where the rapid onset of cement setting was prevented by providing an additional source of 
gypsum to coat the aluminate phase. The increased height of the absorbance peak after 60 
minutes when gypsum and sodium citrate were combined in equal wt% indicated that at 5 wt% 
the citrate anion had the capacity to remove more gypsum from the aluminate phase than was 
contained within the cement (figure 3.4.7b). The decreased height of the gypsum peak after 
60 minutes of setting when only 2 instead of 5 wt% addition of sodium citrate was used indicated 
a decrease in the removal of gypsum from the aluminate phase (figure 3.4.7a). In small quantities 
citrate appeared to accelerate the reaction of tricalcium aluminate with gypsum to form ettringite 
but in excess all the gypsum was removed from the aluminate causing flash setting.  
 
Sodium citrate additions at both 2 and 5wt% generated an initial exothermic peak which 
corresponded with the initial setting times of the respective cements (figures 3.4.5a and 3.4.3). It 
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has been reported that flash setting is an exothermic reaction and in both instances it is indicated 
that flash setting may have been responsible at least in part for early cement setting when sodium 
citrate was present (113). However, the formation of ettringite is also a known exothermic 
reaction and it is likely that ettringite formation may be responsible for the second characteristic 
exotherm in the DSC measurements at approximately 40 minutes (figure 3.4.5a) (110, 214).  
The lack of a calcium hydroxide peak, the by-product of calcium silicate hydration, in the phase 
analysis of any cement containing citrate (figure 3.4.6) indicated that for at least the first 24 h of 
setting citrate was additionally blocking C-S-H production, thus preventing the consumption of 
water in this reaction which was subsequently available for increased ettringite generation.  
 
4.4.3 Investigating long-term cement strength. 
The lower porosities of the cements modified with 2 wt% citrate when compared with the PC 
standard indicated that water was consumed more rapidly in the hydration reaction when citrate 
was present thus causing lower porosity (as less excess water was present in the structure to 
cause porosity) (refer to table 3.4.1) (198). The low specific densities of the citrate modified 
cements indicated a higher degree of hydration when compared with the PC as the denser 
powder phase was hydrated into less dense material by chemically binding low density water.  
  
DISCUSSION 
163 
 
A relationship between compressive strength and relative porosity has previously been 
established (equation 4.4.2) (215-217).  
    √
     
    
             
(Equation 4.4.2) 
Where CS is the compressive strength; Eo is the modulus of zero porosity material; R is the 
fracture surface energy; c is the critical flaw size; and RP is the relative porosity.  
If the materials constants (under the square root) remain unchanged, Equation 4.4.3 simplifies to 
a linear relationship between the natural logarithm of compressive strength and relative porosity  
 
   (  )               
(Equation 4.4.3) 
The natural logarithms of the compressive strength values from table 1 were plotted as a function 
of relative porosity after 30-days setting. The strong linear relationship (R
2
 =0.97) between ln 
(citrate CS) and porosity (figure 4.4.1) indicated that the material constants were not altered 
when the cements were modified with sodium or potassium citrate.  
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Figure 4.4.1Graph showing natural log of compressive strength vs. relative porosity after 30-days for 0.5- 2 
wt% sodium and potassium citrate. The linear relationship between the samples indicated that the additives 
did not alter the cements material constants. 
 
In summary the evidence suggested that a 2 wt% addition of sodium citrate blocked calcium 
silicate hydration. In turn, this left a limited amount of water in the high PLR cement, (cements 
are usually mixed at 3 g ml
-1
 whereas 5 g ml
-1
 was used in this study), to partake in an alternative 
reaction such as the hydration of the calcium aluminate phase. As sodium citrate has the ability 
to remove gypsum from the aluminate phase, a portion of the aluminate was simply hydrated 
causing flash setting. However, it appeared that the major proportion of the water was utilised to 
produce ettringite within the first two hours of cement setting. During the course of the 
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proceeding 30 days the phase analysis of the cements indicated that cements containing 2 wt% 
sodium or potassium citrate did develop a C-S-H phase later. A combination of accelerated early 
ettringite formation preceding C-S-H production provides a possible explanation for the low 
porosities of the citrate modified cements resulting in high compressive strengths (up to 50 % 
compared with standard Portland cement). 
 
4.4.4 Accelerating the setting reaction of PC with other salts of citrate and citric acid. 
The concentration of citrate anions contained within the liquid phase of the setting cement may 
determine the cements setting characteristics.  Sodium citrate possesses a Kd value of 0.2 M and 
potassium citrate has a marginally higher value of 0.37 M (218). Both of these citrate salts had 
similar influences on setting characteristics including injectability, setting times and compressive 
strengths (refer to figures 3.4.1, 3.4.3 and table 3.4.1 respectively). In contrast, calcium citrate 
had a lower dissociation constant of 1 mM. The cement possessed extended setting times and 
reduced injectabilities compared with the sodium and potassium salts. The reduced exotherm of 
calcium citrate may be another indicator of a reduced citrate concentration (figure 3.4.5a). When 
the kinetics of the setting reaction were accelerated by increasing the setting temperature to 
37 °C the exothermic trace had a similar profile to the ones of the sodium and potassium salts 
(refer to figure 3.4.5b). The phase analysis of the 2 wt% calcium citrate cements suggested that 
ettringite was present within the first 2 h of mixing but at a reduced quantity compared with 
sodium or potassium citrate (figure 3.4.6). Introducing hydrogen cations from citric acid into the 
liquid phase may have disrupted the alkaline setting conditions of PC (113). The cements were 
observed to set as a very dry powder which produced no exotherm and also possessed strut 
densities similar to unhydrated PC powder.  
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4.4.5 Conclusions 
Sodium citrate additions established PC injectability and improved compressive strengths while 
reducing cement setting times compared with the standard cement, making PC a possible 
candidate for use as a bone cement. The present study suggests that the citrate anion reduced 
cement viscosity by binding to cement grain particles creating an electrostatic repulsion force 
within the cement paste. Citrate accelerated cement setting through a combination of early 
ettringite formation and calcium aluminate hydrate formation. This present study has 
demonstrated both the mechanism of citrates action with PC as well as the possibility to generate 
a durable high strength injectable PC based cement.  
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4.5 CHAPTER: Flexural strengths 
4.5.1 Comparing compressive strength and biaxial flexural strength testing  
Compressive strength testing constitutes an important role in acrylic bone cement testing and is 
present in implants for surgery ISO 5833:2002 (15). During axial compressive strength testing 
the compressive forces (σc) applied to the flat contact points at each end of the specimen (figure 
4.5.1) resolve into both shear forces and tensile stresses (σt) (219). It is an unknown combination 
of the two forces which eventually leads to specimen failure.  
 
 
 
  
  
 
 
  
 
 
 
σc 
Figure 4.5.1. Diagram illustrating the forces created during compressive strength testing. Shear 
forces are experienced at the contact points forming shear cones which result in tensile stresses 
within the central portion of the cylinder. 
σc 
σt σt 
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In contrast, specimen failure for brittle samples with biaxial flexural strength testing occurs 
solely due to tensile forces on the lower face of the specimen (fig 4.5.2).  
 
Figure 4.5.2 Diagram illustrating the forces being created during flexural strength testing. Specimen failure is a result of 
tensile forces on the underside of the sample.  
 
As the maximum tensile stresses occur within the central loading area spurious edge failures are 
eliminated which is an advantage over the more commonly used three point flexure testing (220). 
Samples are also insensitive to specimen geometry and independent of flaw direction.  
According to ISO 5833: 2002 the minimum acceptable flexural strength for acrylic bone cements 
is 50 MPa which is approximately double the mean values for the PC based cements on test (15). 
Calcium phosphate ceramic cements possess bending strengths in the region of 4 MPa and 
σt 
σc 
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Hydroxyapatite materials failed before the test began (221). The bending strengths of ceramic 
materials may be viewed as a disadvantage compared with acrylic cements such as PMMA. 
However, as bone is also a ceramic material the bending strengths of PC may more closely 
match the native environment.  
4.5.2 Weibull Modulus 
The evaluation of mean strength data and associated standard deviations can be misleading, as 
the use of mean strength is based on the assumption that the materials possess a “normal” flaw 
size distribution. However, the defect population within all brittle materials, such as PC 
frequently lacks this level of homogeneity resulting in failure at lower strengths especially where 
a high defect distribution is present (222). The asymmetrical distribution of flexural strengths 
with cements containing 2.5 wt% calcium chloride and calcium nitrate (figure 3.5.1) may have 
indicated heterogeneity in the flaw size distribution of the “tail” samples which would not be 
evident from studying the mean strength values.  
Statistical analysis, using alternative distribution functions such as the Weibull distribution can 
provide a more meaningful interpretation of the strength data, determining the reliability of the 
data and allowing prediction of the probability of failure of a brittle material (172, 222). Weibull 
modulus is the shape parameter of the defect distribution. A high Weibull modulus is indicative 
of narrow distributions of defects and increased reliability of the strength data of that particular 
material. The 95 % confidence intervals for the specimen groups under investigation all 
overlapped indicating that the additive additions did not significantly alter the flaw size 
distribution of the material.  
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The presence of a single defect population is indicated by an R
2
 value of close to 1, which 
characterises a perfect distribution and a value less than 0.9 represents a multimodal distribution 
which distorts the strength data away from the straight line (223). The value of 0.89 for cements 
containing 2 wt% sodium citrate indicates that this specimen population may possess a 
multimodal defect distribution.  
4.5.3 Conclusions 
The Weibull moduli of specimen groups containing PC and a variety of additives indicated that 
the defect distribution was not altered by the addition of additives.  
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4.6 CHAPTER: Investigating the rheology and injectability of Portland cement 
4.6.1 Injectability of Portland cement through needles with a 11 gauge diameter 
Acrylic based bone cement materials such as PMMA are both rheopectic (i.e. the viscosity of the 
material alters during setting) and pseudoplastic (i.e. the viscosity varies with shear rate) (224) 
(225). During the present rheological study only the rheopectic property of the cements was 
investigated (figure 3.6.1). Portland cement (PC) sets via a chemical setting reaction and the high 
shear rate created by a plate rheometer could potentially disrupt bond formation decreasing 
cement viscosity potentially resulting in an inaccurate reflection of in vivo setting (113). The 
effect of a comparatively low shear force (0.3 s
-1
) was observed in figure 3.6.3 as the 5 wt% 
sodium citrate cement failed to set on the rheometer. During the setting period the dynamic 
viscosity of the cement fluctuated possibly as a result of chemical bonds forming only to be 
broken by the shear forces created by the rheometer plates. Both calorimetry and FTIR studies 
(chapter 3.4) indicated that the initial cement setting of PC with 5 wt% sodium citrate arose from 
the early hydration of the tricalcium aluminate phase (flash setting) which created a weakly 
bonded cement structure that appeared to enhance early bond breakage under shear and other 
external forces.  
Testing the rheopectic properties of the cement was also problematic due to the wide aspect ratio 
(15:1) of the plate rheometer (refer to figure 3.6.2). The large sample surface may have 
contributed to the observed acceleration of cement setting compared with the Gilmore needles 
test (2:1 aspect ratio) (figure 3.4.3). The marked increase in viscosity of the standard PC 
(figure 3.6.2), which previously was found to have an initial setting time of over 2 hours, was 
observed to begin setting within 4 minutes. Hence, the cements were only tested for 60 seconds 
periods on the rheometer before being discarded. 
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The initial viscosities of both acrylic and calcium phosphate cements have previously been 
investigated. After initial mixing the acrylic cements Vertebroplastic  (DePuy Inc, England), DP-
Pour (DenPlus Inc., Canada) and Simplex (Howmedical International Limited, England) had 
initial viscosities of 50, 70 and 300 Pa.s respectively (96). In contrast, the calcium phosphate 
based cements, Biopex (Taisho Pharmaceutical, Japan) and ChronOS (Palacos, US) both had 
lower initial viscosities of approximately 45 Pa.s. The initial viscosity of PC with a 2 wt% 
addition of sodium citrate was similar to commercial calcium phosphate cements (40 Pa.s) 
(figure 3.6.1a). However, without additives the initial viscosity of PC standard was considerably 
higher (25 times) at 1000 Pa.s. Decreased cement viscosity between the citrate modified and 
standard cements correlated with increased cement injectability from figure 3.4.1. Further 
rheological testing of other liquefying additives with PC would be required to verify the link 
between cement viscosity and injectability.   
Identifying the ideal viscosity for cement injectability is difficult as the process is divided into; 
“cement delivery” which involves the flow of cement from the syringe into the needle and 
secondly the “infiltration” of the cement once it has entered the vertebrae (226-228). Clinical 
studies of vertebroplasty have demonstrated that the requirements for both external cement 
delivery and internal infiltration generate conflicting physical requirements and for successful 
injection a rheological compromise is required (96). The viscosity must be low enough so that 
when a surgeon applies pressure to the syringe the desired volume of cement is extruded through 
the needle without needle blockages. Needle blockages may render the syringe unusable 
requiring more cement to be mixed which is unfeasible in a time dependent operation such as 
vertebroplasty (229).  However,  in patients with low bone density the bone cement may 
penetrate into the macropore system of the cancellous bone forming “glove like” extensions (96, 
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225). If a surgeon identifies this type of cement distribution using fluoroscopy the operation will 
be stopped as these extensions are known to be weak and have been documented to cause post-
operative complications such as cement leakage (226). During a successful vertebroplasty 
operation after an initial volume of approximately 2 ml the cement forms a “cloud” expansion 
pattern monitored using fluoroscopy as it uniformly expands within the vertebrae (226).  
Baroud et al (96) investigated what clinicians constituted a successful injection by recording the 
pressure drop between the syringe and the needle. In a “successful injection” the pressure exerted 
to activate the syringe was between 0.5 -1.7 MPa, above 2 MPa the surgeons were unable to 
inject sufficient cement and below 0.5 MPa the “glove like” extensions of cement began to occur 
within the vertebrae. When determining the parameters for the injectability during the current 
project it was decided that the injection force which could be reasonably applied to a syringe 
plunger was approximately 100 N. Other studies have used forces in excess of 250 N with 
syringes using similar plunger mechanisms (187, 230). However, such high forces are only 
applicable for screw type plungers. The width of needle used also varies between studies Kreb et 
al (231) used an 8 gauge (3.6 mm) wide needle which was significantly wider than the 12 gauge 
(2.7 mm) commonly used within the vertebroplasty operation (167). The pressure drop across the 
syringe during the present investigation was a maximum of 0.65 MPa (figure 3.6.7) which was at 
the lower end of the scale and accordingly may result in “glove like” extensions of the bone 
cement within the vertebrae pore structure if the procedure was performed in vivo (45). However, 
the micro-CT scan of the sawbone model with a representative pore diameter of osteoporotic 
bone (200 µm) did not indicate that any “glove-like” extensions occurring (figure 3.6.11b) (232). 
Niewenhuijse et al (233) reported cement leakage of low and high viscosity cements and found 
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that there was no significant difference between the two types indicating that the link between 
low viscosity cements and leakage may not been conclusively determined.   
Force balance equations have previously been applied to cement injectability in order to 
calculate which is greater the pressure required for “cement delivery” or “infiltration”. The two 
equations which were balanced were the Hagen-Poiseuille, which describes the delivery of a 
fluid through a cylindrical tube (i.e. needle) and Darcy’s law which describes the infiltration of a 
fluid through a porous media (230). The outcome of the calculation concluded that the 
infiltration pressure accounted for only 6 % of the total injection pressure and therefore the 
needle geometry was the limiting factor for cement delivery in vertebroplasty (96).  
The ideal viscosity for injecting acrylic cement through an 8 gauge needle to obtain a “successful 
delivery” was determined to be in the region of 100 to 200 Pa.s (96). This viscosity range was 
higher than the ones recorded for four of the five commercial cements discussed earlier and is 
also higher than the 40 Pa.s for PC with a 2 wt% sodium citrate modification (refer to figure 
3.6.1). All of the commercial cements have passed the extensive clinical trials set by the 
Medicines and Healthcare products Regulatory Agency (MHRA). Baroud et al (96) ideal 
viscosity for “successful delivery” outcomes were based on a statistically insignificant number of 
clinical cases and may require revising.   
Modified Portland cement with a 2 wt% addition of sodium citrate maintained a viscosity of 
below 300 Pa s for the first 10 minutes of viscosity testing (refer to figure 3.6.1), which was 
approximately equal to the viscosity of the simplex bone cement. This may indicate that the bone 
cement remains injectable for this period of time, however, this would require testing using the 
“injectability testing” method as outlined in chapter one of the materials and methods.  
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4.6.2 Investigating phase separation with micro-CT. 
The major limitation of ceramic cements such as calcium phosphate and PC is that under 
injection pressure the powder and liquid phases may separate. This effect known as “filter 
pressing” and decreases the powder-to-liquid ratio (PLR) of the extruded cement while 
conversely increasing the powder content of the cement remaining in the syringe (234). 
Understanding the process is of great interest as it is believed to be the primary cause of needle 
blockages (103). Filter pressing has been studied ex-vivo by recording the mass of cement 
extruded from the syringe compared with the mass of the cement remaining in the syringe using 
a defined plunger force. As the density of the cement is higher than the density of water  
3.8 g ml
-1
 and 1 g ml
-1
 respectively, it is possible to calculate the extent of the phase separation 
of the material (125).   
The current investigation extruded cements through 11 gauge needles and there was a maximum 
of 3 wt% decrease in injectability with any of the PC containing an additive when the needle was 
attached (refer to figure 3.6.4). The internal diameter of the syringe aperture of 2 mm may have 
been the limiting factor for cement injectability rather than the 50 mm needle with an internal 
diameter of 2.15 mm. Once an injectable PC has passed the syringe outlet the cement appeared 
unimpeded by the needle. The force/ displacement graphs illustrated the similarity in injectability 
profiles of cements with and without a needle when sodium citrate or calcium chloride was 
present (refer to figure 3.6.6).   
During a vertebroplasty operation recording the mass of the syringe pre and post procedure 
would indirectly indicate if phase separation had occurred through the syringe outlet/needle 
during injection. However, during the “infiltration” process when the cement is percolating 
within the vertebrae filter pressing may also be occurring within the pores of the cement. It is 
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important to monitor this process as stated earlier the “glove like” extrusions which may occur 
are weak and may lead to cement extravasation.  
Microtomography (µ-CT) is a commonly used procedure in a clinical environment and may be 
able to monitor phase separation in vivo as there should be a difference in density between 
cements with different PLR’s which may be detectable using µ-CT. The technique has 
previously been used on pathological vertebrae to assess the interface properties of bone and 
PMMA (235). Zhao et al (236) proposed the use of in vivo CT scans to model subject specific 
vertebral models to aid in assessment of orthopaedic interventions such as vertebroplasty. Lin et 
al (237) employed a similar technique for assessing bone formation prior to surgery in order to 
obtain a better clinical outcome.  
The grey value count of the µ-CT images was measured for a range of different PLR cements 
measuring 6 mm width by 3 mm height (figure 3.6.8). There was no significant (p<0.05) 
difference in the grey scale value between samples when using a comparatively high µ-CT 
resolution of 13 µm even when the macropores, which appeared in dark black (figure 3.6.9b, 
PLR 2.5 g/ml), were excluded from the study. Therefore, it is unlikely that clinical µ-CT with far 
lower resolutions (500 µm) would be able to discern a grey scale count difference and hence a 
density and phase separation difference.  
 
4.6.3 Injection of Portland cement into a porous vertebral model. 
The µ-CT of the sawbone used in the vertebroplasty model (figure 3.6.11) indicated that even 
with a very small force (20 N) in a porous bone replica with an average pore size diameter of 
200 µm the spread of the cement was observed to infiltrate in a “cloud” formation not “finger 
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like” extensions. The force to create the “cloud” formation was significantly less than the values 
for successful infiltration as characterised by Baroud et al (96, 225).  
The present model did contain a number of assumptions which decreased its overall accuracy. 
There was no porosity gradient in the sawbone model which would have permitted the 
investigation of percolation of the cement in varying bone densities (238). The model was also 
made of a polymer which may inaccurately represent the binding of the bone cement in vivo. In 
addition, there was also lack of bone marrow substitute which if present may have decreased 
cement percolation. 
 
4.6.4 Conclusions 
The initial viscosity of PC with a 2 wt% addition of sodium citrate was consistent with the 
viscosity of injectable calcium phosphate bone cements used for vertebroplasty. The citrate 
modified cements remained injectable for approximately 10 minutes before beginning to set 
which was reflected by an increase in viscosity after 20 minutes. Needle addition had no 
significant effect on the injectability of PC containing liquefying additives. However, a needle 
reduced the injectability of PC standard by 50 wt%. Micro-CT was investigated as a possible 
method for detecting liquid from powder phase separation which may be occurring in the 
vertebrae and also as a method for cement extravasation. However, the technique was not 
sensitive enough to discern cement separation.  
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4.7 Investigating the cytocompatibility of Portland cement (PC) 
Since the food and drug administration (FDA) approved the use of Portland cement (PC) based 
mineral trioxide aggregate for dental applications in the late 1990’s there has been considerable 
interest in the cytocompatibility of PC (3, 139, 239-245). Many in vitro studies assessing the 
biological compatibility of the material have found it to be non-cytotoxic inferring PC possesses 
both osteoinductive and odontoinductive properties (138, 239, 246-249). However, unlike the 
material properties testing of bone cements there is no agreed standardised method when testing 
for cytocompatibility. Material volume to cell culture volumes vary with nearly every study, as 
does the length of material setting and whether the PC has been set in water prior to exposure to 
cells. Lack of a general testing consensus may have resulted in an inaccurate reflection of PCs 
cytocompatibility. For instance, Zhu et al (138) indicated “good adhesion and spreading (of 
osteoblasts) on the surface of MTA” based on SEM morphological studies. However, the media 
in which the material was set was “changed every day for 2 weeks”. According to the author this 
allowed not only material setting but also “some cytotoxic material” to be eluted before exposure 
to primary osteoblasts. Min et al (247)  used the MTT  assay to determine the viability of cells in 
contact with PC and showed there was no statistical difference in viability between  human pulp 
cells which were in contact with the material and those which were not. Again, the cement was 
not freshly prepared as it would be used in vivo and left to set for 24 h before exposure to the 
pulp cells. Balto et al (249) also used cement set for 24 h before exposure to PC and observed 
attachment of the material with SEM studies to the surface of PC. However, when the same 
experiment was repeated with freshly mixed material, cells were “round, less in density, 
exhibited surface defects and lacked attachment to MTA”. During the vertebroplasty operation 
the cement will be injected directly into the vertebrae and immediately exposed to extracellular 
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fluid. Therefore, any in vitro study should include immediate exposure of mammalian cells to 
freshly prepared PC as shown in figure 3.7.4a. Exposure of cells to a highly alkaline environment 
produced by freshly mixed PC has previously been shown to induce cell lysis in mouse fibroblast 
and macrophage cell lines (250). The high alkalinity of PC (above pH 11 refer to figure 3.7.10) 
may account for the initial cytotoxic effect after the bone marrow cells were exposed to freshly 
mixed cement. However, the cytotoxicity of the newly formed material may also be caused by 
the dissolution of a calcium containing species from the material as demonstrated by the Alizarin 
red stain (refer to figure 3.7.8). Alizarin red binds to calcium containing species and 
demonstrated a positive reaction around the circumference of the cement. Interestingly, the cause 
of the high alkalinity, calcium hydroxide, is one of the reasons given for the favourable cell 
growth rates in the presence of the material due to increased calcium levels (136, 251, 252) .  
 
The 3T3 fibroblast cultures were incubated with cement discs which had been set for either 24 h 
or for 6 h in a mould and then for 18 h in water (refer to figure 3.7.1). Even without setting 
accelerants the Gilmore needles test has previously indicated (chapters 3.3 and 3.4) that initial 
setting of all the cements including the PC standard (2 hours) should have occurred prior to 
exposure to the cell culture medium. As the cements were all set prior to incubation this may 
explain why cell growth was not significantly (p<0.05) different between cells incubated with 
standard or accelerated cement (refer to figures 3.7.1 and 3.7.2). The control wells consistently 
demonstrated higher cell numbers compared with the wells containing cement discs which may 
have indicated that even when set a constituent of the cement was hindering cell growth. The 
decrease in the cytotoxic effect of the material with bone marrow cells as material setting times 
were increased from 20 minutes to 12 h was directly linked to a decrease in the initial pH of the 
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culture medium when exposed to PC (refer to figures 3.7.4 and 3.7.5). However, the size and 
quantity of calcium deposited around the circumference of the material was not investigated and 
may also have demonstrated a correlation with material cytotoxicity. Calcium hydroxide is 
produced as both a by-product of calcium silicate hydration, the major phase of PC and as the 
mineral calcium oxide present within PC is hydrated (110, 113). Setting the cement in water 
should dissolve calcium hydroxide crystals that form so reducing concentrations within the 
material prior to cell exposure. This may explain the reduced cytotoxic effect of the material that 
was identified with the 3T3 cell line where the cements were essentially washed (refer to figures 
3.7.1 and 3.7.2). As calcium hydroxide is produced as the cement sets, quantities should increase 
over time leading to higher levels in cements set for longer periods. Therefore, cement set for 
12 hours as opposed to 20 minutes would have had greater concentrations of calcium hydroxide 
produced from the calcium silicate hydration. It may appear counter-intuitive then that the longer 
set cements were more cytotoxic if alkalinity was the major cause of cell death. However, there 
may be an explanation based on cement setting chemistry. Early PC setting is divided into two 
characteristically distinct phases, the first is the formation of a “gel like matrix” forming before 
the initial set of the material, whilst at completion of setting the material then possess a distinct 
pore structure (110, 253). A possible explanation for the decreased pH of the cement set for 
12 hours as opposed to 20 minutes is that at the latter time point the material is in the “gel phase” 
and as a consequence all of the mineral calcium oxide has access and can dissolve into the 
culture medium. However, once set at 12 h only calcium oxide with direct contact with the pore 
solution can dissolve entrapping the remainder of the calcium oxide in the core of the cement 
thereby reducing the pH of the culture medium after exposure to the cement. Alternatively, the 
“calcium halo” eluted from the material could be reduced after setting allowing the cells to grow 
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in closer proximity to the material. However, the “calcium halo” was not measured during the 
present experiment but this could be accomplished in future experiments using light microscopy. 
 
4.7.1 Investigating the use of buffers to reduce the pH of the material 
During the vertebroplasty procedure the cement will be injected directly into the vertebrae being 
exposed to a hydraulic environment. The high alkalinity may pose a chronic risk to surrounding 
tissues as may any eluted materials. The material may also pose wider acute  risk to the patient if 
the material or created alkalinity is dispersed by the posterior-intercostal blood supply (254).  
From the range of non-toxic
6
 buffers chosen to reduce the alkalinity of the material none reduced 
the pH to a physiological range (pH 7.4) for cell survival while maintain the setting times of the 
cement (255). One alternative maybe to inject an FDA/MHRA approved fast waterproof 
resorbable dental sealant into the vertebral cavity first to protect the cement. This material would 
not be required to structurally support the vertebrae long-term.      
 
4.8 The elution of calcium containing species from PC 
The Alizarin red stain binds to calcium ions creating a chromophore species which can be 
viewed using calorimetry. During biomineralisation calcium ions accumulate at matrix nodules 
as a precursor material for hydroxyapatite (Ca10 (PO4)6(OH2)2) formation (256) (257). The stain 
was used to assess if the bone marrow cells had initiated osteogenesis as indicated by the 
upregulation of many of the key osteoblast phenotype genes (refer to figure 3.7.9). However, it 
was unclear if the positive calcium stain was a result of biomineralisation or elution of a calcium 
                                                 
6
 Based on the Chemical Hazard and Risk Assessment (HAZDAT) 
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based material from the calcium silicate based PC, which was clearly evident in (alizarin red 
figure 3.7.8).    
4.8.1 Investigating gene expression with RT-PCR 
The genes osteoadherin (OSAD), alkaline phosphatase (ALPase), bone morphogenic protein 
(BMP), bone sialoprotein (BSP), osteonectin (ON), osteopontin (OPN) and osteocalcin (OCN) 
were all chosen for investigation due to their key role in the biomineralisation process. OSAD is 
a protein involved with hydroxyapatite formation, ALPase hydrolyses inorganic pyrophophates 
(P2O7
4-
) which increases local orthophosphate ion (PO4
3-
) concentration for hydroxyapatite 
formation, BMP is a growth factor associated with osteogenesis, ON is a protein which binds 
calcium, BSP is a component of bone extracellular matrix, OPN is important in anchoring 
osteoclast cells and osteocalcin is involved in the metabolic regulation of osteoblast cells (122-
124,138). The increased expression levels of ALPase, BSP, ON and OPN in the presence of PC 
may be an indication of the cells undergoing early osteogenic differentiation in the presence of 
the material (refer to figure 3.7.9). Increased transcription levels of the early osteogenic marker, 
alkaline phosphatase have been observed with RT-PCR in human pulp cells (122) (132), 
periodontal and gingival fibroblasts (131) and the MG-63 osteosarcoma cell line (240). In 
addition to an increase in gene expression levels of ALPase an increase in enzymatic activity has 
also been monitored directly using the Lowry et al (258) protocol utilising p-nitro phenyl 
phosphate assay. Human dental pulp (122) and rat osteosarcoma cells (259) have also 
demonstrated increases in ALPase activity when incubated with PC.  Concentrations of the 
extracellular matrix protein, BSP, have been observed to increase in  human orofacial bone 
mesenchymal stem cells (123), human dental pulp stem cells (139) (132) and MG63 
Osteosarcoma cells lines (240) when in  contact with calcium silicate based materials.  The 
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extracellular matrix glycoprotein, osteonectin and the bone remodelling protein osteopontin have 
previously demonstrated increased expression in periodontal fibroblasts exposed to calcium 
silicate materials (131) whilst the OCN gene was not expressed in any cultures exposed to a 
cement or the control.   However, the osteocalcin protein has demonstrated to be present in 
human dental pulp stem cells and MG63 in the presence of PC (122, 139, 240). The absence of 
OCN during the present investigation may be accounted for by either deterioration of the primers 
or inaccuracies in primer preparation.  
 
This is the first study to investigate expression of the cellular proliferation marker, Ki-67  The 
protein is only present during the active phases of the cell cycle G1, S, G2 and mitosis but is 
absent in resting cells so its expression is used as an indicator that mitotic division is occurring 
(260). The lack of observable difference in gene expression of Ki-67 levels between the control 
cultures and those in the presence of cement indicate that cellular proliferation rates were similar 
at the 5-day time-point between all the cultures. The effects of PC on transcription markers for 
mitotic division have been investigated with the MAPKinase family of genes (ERK 1 and 2). 
Western blot studies measuring the concentration of the extracellular regulated kinases (ERKs)-1 
and -2 demonstrated increased protein concentrations in the presence of PC in human 
osteosarcoma cells (U2OS) (261) The MAPKinases family are one of the central components of 
the phosphorylation signalling pathway which increases cellular proliferation through the 
mitogenic signalling pathway. The investigation suggested that a component of MTA maybe an 
external mitogen activator but further studies were required (261). In 2012 Zhao et al (139) used 
western blotting to study MAPK levels dental pulp cells when exposed to the PC derived 
material mineral trioxide aggregate (MTA). In addition to finding increased expression of 
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MAPK the study also found increased expression of a range of odontoblastic proteins including 
ALPase, dental sialoprotein, collagen 1, OCN and BSP. The study then prevented the translation 
of the MAPK protein by the addition of the inhibitor SP600125. Removing the MAPK protein 
lowered gene expression of many of the odontoblastic genes mentioned above. Based on this 
correlation the group suggested a link between MAPK and ododontogensis. As many of the 
genes between the odontogenesis and osteogenesis are shared a similar experiment investigating 
MAPK expression knockout in mesenchymal bone cells in the presence of PC may be a worthy 
future investigation.      
 
Immuno-assay studies of the interleukin cytokine family have also yielded some interesting 
results. Osteosarcoma cells exposed to MTA have shown to increase quantities of interleukin-6 a 
potent bone resorbing factor produced by osteoblasts (262) and Interlukin 8 an important factor 
for angiogenesis. In contrast, the levels of the  inflammatory cytokines Interlukin-1 did not 
increase in quantity, indicating that a PC vertebroplasty implant may not inflame surrounding 
tissue (263).  
 
4.8.2 Conclusion 
Freshly mixed Portland cement demonstrated a cytotoxic effect on bone marrow cells. This 
effect may be due to the alkalinity of the material or from degradation of the cement material 
leaking into cell cultures. The high alkalinity of the material may be caused by premature 
hydration of the calcium oxide mineral content of the cement. The cells which survive up-
regulate several key genes for the biomineralisation process including alkaline phosphatase, bone 
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sialoprotein, osteonectin and osteopontin. Extending cement setting times appears to reduce the 
cytotoxicity of the material this may be as a result of hydroxide crystals in the core of the 
material not having access to the exterior cell culture media.  
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5 FUTURE WORK 
During the current investigation the expression of 9 genes associated with the osteogenic 
phenotype were studied in bone marrow cells incubated with PC set for either 1 or 12 hours. 
Future studies should widen the selection of genes to include other osteogenic differentiation 
markers such as the transcription factor (Cbfa1), which activates osteocalcin production (264). 
Studying a marker such as Cbfa1 which is transcribed prior to another major osteogenic marker 
would permit the earliest possible identification of cells undergoing the differentiation process. 
In addition, studying transcription levels of bone marrow cells exposed to cement set in the 
interval between 1-12 hours may generate insights into gene transcription during the setting 
transition period. In the present study only one cellular proliferation marker was investigated, Ki-
67, the MAPKinase family of genes (ERK 1 and 2) have also been studied as transcription 
markers for ceramic cements and may provide complementary insights into the state of cellular 
proliferation in the presence of PC (261). Performing a DNA micro-array on lysed bone marrow 
cells, which had been exposed to setting PC, would permit simultaneous identification of a large 
array of osteogenic genes expressed in the presence of the material. 
The major issue observed from the biological studies was the occurrence of cellular necrosis in 
the presence of newly mixed cement.  Buffer additions to the cements were investigated and 
appeared to interfere with the physical characteristics of the cement and only a select few 
significantly reduced the pH of the setting material. Another possible solution to address the 
initial high alkalinity of PC would be to inject a non-load bearing resorbable resin into the 
fracture cavity prior to the injection of the ceramic cement. The resin would resorb over time, 
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however, this generates new issues such as the integration of PC after resorption and the 
breakdown of the resin in the body.  
Stability of PC was investigated using XRD characterisation to compare a new batch of PC with 
one was aged for 5 years and which demonstrated deterioration with time.  A more 
comprehensive study comprising a number of aged batches is required to assess the deterioration 
of the material. A range of temperatures and humidity’s could be employed to expedite the aging 
process. Only one type of grey Portland cement (Mastercrete, Lafarge, UK) was used during the 
current investigation as it had demonstrated high compressive strengths when used in previous 
model systems (184). However, the additives may need to be tested with other cements if the 
industrial sponsor requires a different source for the material.   
During the project a range of techniques such as SEM, EDX, XRD and zeta potential have been 
employed to characterise the effect of additives on the hydration reactions of PC. However, as 
PC sets via several  setting reactions often occurring simultaneously it is often difficult to 
determine the effect of an additive on a single hydration phase such as ettringite 
([Ca3Al(OH)6]2(SO4)3.26H2O) (213) or calcium silicates (CaOx. SiO2.H2Oy) (265). Carlson and 
Berman (266) developed a method to produce ettringite crystals from a saturated solution of 
calcium hydroxide ( 1.85 g l
-1
) with aluminium sulphate solution (Al2(SO4)3.18H2O). The 
accelerants and liquefiers investigated in the present study could be added independently during 
the nucleation reaction of ettringite in order to assess the effects of an additive on a single 
cement phase.  
The vertebroplasty model used a synthetic sawbone to inject the cement into instead of bone or 
hydroxyapatite. At the University of Bath presently a porous, synthetic calcium phosphate 
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structure modelled on cancellous vertebrae is being developed. Once the prototype is complete it 
would be possible to investigate the injectability and binding of the cement in with a composition 
the same as bone.  
For a brittle ceramic material such as PC fatigue testing will be important in order to assess the 
cements durability. It will also be necessary to calculate the bending modulus using three point 
bending tests as they are a key component of bone cement ISO 5833 and compare the results 
with the biaxial flexural strength results (15). Biaxial flexural strength testing was used during 
the present study to limit spurious edge failures which may arise with 3-point bend tests (220).
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6 CLINICAL RELEVANCE AND CONCLUSIONS 
There are presently a number of commercially available PMMA based bone cements specifically 
designed for vertebroplasty; Osteopal® manufactured by Heraeus, Germany, CMW1® by 
Depuy, UK and KyphX HVR® by Medtronic Spinal, USA. All of the PMMA based cements 
present similar clinical complications including an exothermic setting reaction, toxic monomer 
and lack of osseointegration. Cortoss® by Orthovita, USA has emerged as the only real 
commercially viable alternative to PMMA and possesses lower curing temperatures, appropriate 
setting times for the vertebroplasty procedure and sufficient injectability through an orthopaedic 
needle. In the future calcium phosphate based cements with excellent osseointegration may 
become a commercial success as vertebroplasty cements, however, they are currently only 
applicable for non-load bearing operations such as cranioplasty due to the lack of mechanical 
strength. 
In its native form PC is not a viable material for use in vertebroplasty as it is non-injectable and 
sets in hours not the 15-20 minutes required for the stabilising procedure (167). The material 
does however possess several advantages including compressive strengths equivalent to PMMA 
and high durability. Encapsulation of drugs or biologically active compounds is also possible 
with porous cement systems such as PC and calcium phosphates. 
The current research has demonstrated that with simple inorganic chemicals, of known structure 
and with no known previously documented harmful biological effects, it is possible to inject over 
97 wt% PC paste from a syringe with a 2 mm aperture. The attachment of an 11 g needle 
(chapter 3.6) to the syringe reduced extrusion by only 1-3 %. The limited rheology testing also 
demonstrated that cement with added liquefier (i.e. 2 wt% sodium citrate) possessed significantly 
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(p<0.05) lower viscosities than the standard cement. Adding the liquefier in the liquid as opposed 
to the powder phase of the cement reduced injectability and cement setting times. Many of the 
additives demonstrated dual functionality possessing both liquefying and setting accelerant 
capabilities. Dissolving additives in the liquid phase may have accelerated the setting process 
which reduced injectability. During the initial stages of the project sieving cements was 
demonstrated to significantly (p<0.05) reduce the setting time of the standard cement and XRD 
analysis indicated that filtering removed reacted cement aggregate. Hygroscopic PC appeared to 
absorb water from the air as the cement aged creating aggregate. This may have indicated that 
the cement requires airtight sealing at the end of the manufacturing process. 
A wide range of cement characterisation techniques were employed during the present study 
which provided an insight into the effect of liquefiers and accelerants on PCs complex setting 
reaction. On several occasions the data from multiple techniques indicated that a particular 
accelerant e.g. calcium chloride or sodium citrate was accelerating the formation of a particular 
cement phase e.g. ettringite.  
PC when freshly mixed was acutely cytotoxic to bone marrow cells incubated with the material. 
The cytotoxicity may have been as a result of the alkalinity of the material (pH 11) or the elution 
of cement material into the growth media. For the vertebroplasty procedure the material would 
be injected directly into a fractured vertebra in contact with bodily fluids with the potential of 
entering the blood supply of the patient potentially causing acute cytotoxic effects. Buffer 
addition to reduce the setting pH interfered with the physical characteristics of the setting cement 
and may not be a feasible solution for reducing cement alkalinity. One possible solution for 
reducing the alkalinity of the material is the injection of a resorbable resin into the fracture cavity 
prior to the injection of the cement. However, this generates a new set of issues including 
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integration of PC after material resorption and the breakdown of the resin inside the body. Once 
PC has set the material up-regulates several genes associated with the osteogenic phenotype 
including osteoadherin, alkaline phosphatase, bone sialoprotein, osteonectin and osteopontin.     
There are presently a host of biomaterials being studied which are also addressing the 
disadvantages with PMMA (89, 267). Some of the most interesting involve hybrid materials 
which incorporate resins for structural integrity with calcium phosphate for osseointegration  
(104).  
Portland cement is one of a number of materials being researched to address the issues presented 
by PMMA. With the addition of liquefiers and setting accelerants the cement is injectable, sets in 
a time appropriate for the vertebroplasty procedure and possesses compressive strengths similar 
with PMMA. However, the acute cytotoxicity of the newly mixed material will have to be 
resolved before the cements use in vertebroplasty can be realised. 
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7 APPENDICES 
7.1 EDX analysis 
Major elements present within Portland cement 
Atomic element Atomic mass 
Calcium 40 
Silicon 28 
Sulphur 32 
Aluminium 27 
Oxygen 16 
Hydrogen 1 
Iron 56 
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Cement clinker phase Chemical formula atom Molecular mass % of total mass 
Tricalcium silicate 3CaO.SiO2 Ca 120 53 
  O 80 35 
  Si 28 12 
  Total = 228 100 
Dicalcium silicate 2CaO.SiO2 Ca 2 80 
  O 4 64 
  Si 1 28 
  Total = 172 100 
Tricalcium aluminate 3CaO.Al2O3 Ca 120 44 
  O 96 36 
  Al 54 20 
  Total = 270 100 
Tetracalcium 
aluminoferrite 
4CaO.Al2O3.Fe2O3 Ca 160 33 
  O 160 33 
  Al 54 11 
  Fe 112 23 
  Total = 486 100 
Calcium sulphate 
dihydrate 
CaSO4.2H2O Ca 40 23 
  S 32 19 
  O 96 56 
  H 4 2 
  Total = 172 100 
Calcium sulphate 
hemihydrate 
CaSO4.H2O Ca 40 26 
  S 32 21 
  O 80 52 
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  H 2 1 
   154 100 
  Total = 154 100 
Calcium sulphate 
anhydrous 
CaSO4 Ca 40 30 
  S 28 21 
  O 64 48 
  Total = 132 100 
     
Hydration Phases Chemical formula atom Molecular mass % of total mass 
Ettringite (Aft phase) 
 
6 CaO.Al2O3.3SO3.32H2O Ca 240 19 
  O 800 64 
  Al 54 4 
  S 96 8 
  H 64 5 
  Total = 1254 100 
Calcium monosulphate 
(afm phase) 
4CaO.Al2O3.SO3.12H2O Ca 160 26 
  O 352 57 
  Al 54 9 
  S 32 5 
  H 24 4 
  Total = 622 100 
Calcium silicate hydrate 
(C-S-H) 
3 CaO.2SiO2.8H2O Ca 120 30 
  O 240 59 
  Si 28 7 
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  H 16 4 
  Total = 376 100 
Calcium aluminate 
hydrate 
4CaO.Al2O3.13H2O 
 
Ca 160 29 
  O 320 57 
  Al 54 10 
  H 26 5 
  Total = 560 100 
APPENDICES 
199 
 
7.1.1 Theoretical optimum ratios for Portland cement clinker and hydration products 
 
Compounds prior to hydration  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
tricalcium silicates 1.50 4.29 2.86         
dicalcium silicates 1.25 2.86 2.29         
tricalcium aluminates 1.25   2.22 1.78       
tetracalcium aluminoferrite 1.00   2.96 2.96 1.43 1.43 0.48    
calcium sulphate di-hydrate 0.42        1.25 3.00  
calcium sulphate hemihydrate 1.25        1.25 2.50  
calcium sulphate anhydrous 0.63        1.43 2.29  
Compounds after hydration            
Ettringite 0.30   4.44 14.81 4.44   2.50 8.33 1.78 
calcium monosulphate 0.45   2.96 6.52    5.00 11.00 0.59 
calcium silicate hydrate (C-S-H) 0.50 4.29 8.57         
tricalcium aluminate hydrate 0.5   2.962963 5.925926       
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EDX (Aged batch of Portland cement) (section 3.1.5) 
 
 
Element Weight% Atomic%  
         
O  52.35 71.40  
Na  0.50 0.47  
Mg  0.73 0.65  
Al  2.10 1.70  
Si  6.83 5.31  
S  2.07 1.41  
K 1.15 0.64  
Ca  32.66 17.78  
Fe  1.61 0.63  
    
Totals 100.00   
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  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
 Observed ratios 0.62 4.78 7.66 15.55 24.93 20.29 32.52 1.30 15.78 25.29 0.99 
            
  
 Percentage difference in observed vs. 
theoretical ratios 
  
                  
Compounds prior to 
hydration  Ca/O* Ca/Si* O/Si* Ca/Al* O/Al* Ca/Fe* O/Fe* Al/Fe* Ca/S* O/S*   
tricalcium silicates 58.41 -11.46 -168.00                 
dicalcium silicates 50.09 -67.20 -234.70                 
tricalcium aluminates 50.09     -600.56 -1300.48             
tetracalcium aluminoferrite 37.61     -425.42 -742.18 -1318.58 -2173.81 -171.74       
calcium sulphate di-hydrate -48.54               -1162.22 -743.00   
calcium sulphate 
hemihydrate -24.78               -1162.22 -911.59   
calcium sulphate anhydrous 0.97               -1003.34 -532.25   
                        
                        
Compounds after hydration                       
Ettringite -107.96     -250.28 -68.32       -531.11 -51.71 50.71 
calcium monosulphate -38.64     -425.42 -282.34       -215.56 -129.91 -79.22 
calcium silicate hydrate (C-S-
H) -7.57 -123.45 -106.60                 
calcium aluminoferrite 
hydrate (C-AF-H) 0.97     -250.28 -250.61 -847.93 -847.97 -171.74       
 
    (
              
                 
 )      
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EDX New batch of Portland cement (results section 3.1.5) 
 
Element Weight% Atomic%  
         
O  53.16 72.20  
Na  0.47 0.44  
Mg  0.69 0.62  
Al  1.76 1.41  
Si  6.31 4.88  
S  2.05 1.39  
K  0.87 0.49  
Ca  33.14 17.97  
Fe  1.55 0.60  
    
Totals 100.00   
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  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
 Observed ratios 0.62 5.25 8.42 18.83 30.20 21.38 34.30 1.14 16.17 25.93 1.16 
                        
 
 Percentage difference in observed vs. theoretical ratios 
 
Compounds prior to hydration  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S   
tricalcium silicates 58.44 -22.42 
-
194.57                 
dicalcium silicates 50.13 -83.64 
-
267.89                 
tricalcium aluminates 50.13     -748.18 
-
1596.88             
tetracalcium aluminoferrite 37.66     -536.13 -920.42 
-
1395.15 
-
2298.38 
-
136.56       
calcium sulphate di-hydrate -48.43               
-
1193.27 -764.39   
calcium sulphate hemihydrate -24.68               
-
1193.27 -937.27   
calcium sulphate anhydrous 1.05               
-
1030.48 -548.29   
                        
                        
Compounds after hydration                       
Ettringite -107.80     -324.09 -103.95       -546.63 -55.56 41.76 
calcium monosulphate -38.53     -536.13 -363.26       -223.32 -135.74 
-
111.78 
calcium silicate hydrate (C-S-H) -7.48 
-
145.42 
-
127.08                 
calcium aluminoferrite hydrate (C-AF-H) 1.05     -324.09 -324.82 -899.10 -899.91 
-
136.56       
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PC Cement with sodium hexaphosphate  
 
Element Weight% Atomic%  
         
O  54.42 74.92  
Si  0.13 0.11  
Ca  45.45 24.98  
    
Totals 100.00   
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  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
 Observed ratios 1 349 419                 
  
Percentage difference in observed vs. theoretical ratios 
  
Compounds prior to hydration  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S 
 tricalcium silicates 44 -8044 -14537               
 
dicalcium silicates 33 
-
12116 -18180               
 tricalcium aluminates 33                   
 tetracalcium aluminoferrite 17                   
 calcium sulphate di-hydrate -99                   
 calcium sulphate hemihydrate -67                   
 calcium sulphate anhydrous -32                   
 
            
            Compounds after hydration                       
Ettringite -178                   100 
calcium monosulphate -85                   100 
calcium silicate hydrate (C-S-H) -44 
-
16226 -11183                 
calcium aluminoferrite hydrate (C-AF-H) -32                     
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Element Weight% Atomic%  
         
O  57.62 74.94  
Na  0.58 0.52  
Al  8.31 6.41  
Si  2.13 1.58  
P  0.45 0.30  
S  1.53 0.99  
Ca  29.38 15.25  
    
Totals 100.00   
 
  
PC Cement with sodium aluminate 
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  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
 Observed ratios 1 14 27 4 7       19 38 0 
                        
Percentage difference in observed vs. theoretical ratios 
 
Compounds prior to hydration  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S 
 tricalcium silicates 66 -222 -846               
 
dicalcium silicates 59 -382 
-
1081               
 tricalcium aluminates 59     -59 -290           
 tetracalcium aluminoferrite 49     -19 -134           
 calcium sulphate di-hydrate -21               -1436 -1155 
 calcium sulphate hemihydrate -2               -1436 -1406 
 calcium sulphate anhydrous 19               -1243 -842 
 
            
            Compounds after hydration                       
Ettringite -70     20 53       -668 -126 91 
calcium monosulphate -13     -19 -6       -284 -242 67 
calcium silicate hydrate (C-S-H) 12 -545 -629                 
calcium aluminoferrite hydrate (C-AF-
H) 19     20 2             
 
  
APPENDICES 
208 
 
Element Weight% Atomic%  
         
O  33.17 52.84  
Na  0.41 0.46  
Mg  0.33 0.34  
Al  2.32 2.19  
Si  13.60 12.34  
S  2.26 1.79  
K  1.20 0.78  
Ca  44.23 28.12  
Fe  2.48 1.13  
    
Totals 100.00   
 
  
EDX Sodium citrate addition 
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Ratios                       
  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S S/Al 
  1 3 2 19 14 18 13 1 20 15 1 
                        
Compounds prior to hydration  Ca/O Ca/Si O/Si Ca/Al O/Al Ca/Fe O/Fe Al/Fe Ca/S O/S 
 tricalcium silicates 11 24 15               
 dicalcium silicates -7 -14 -7               
 tricalcium aluminates -7     -759 -703           
 tetracalcium aluminoferrite -33     -544 -383 -1147 -835 -95     
 
calcium sulphate di-hydrate -217               
-
1466 -389 
 
calcium sulphate hemihydrate -167               
-
1466 -487 
 
calcium sulphate anhydrous -112               
-
1269 -267 
 
            
            Compounds after hydration                       
Ettringite -344     -329 3       -683 12 51 
calcium monosulphate -196     -544 -119       -291 -33 -77 
calcium silicate hydrate (C-S-H) -130 -52 34                 
calcium aluminoferrite hydrate (C-AF-
H) -112     -329 -101 -733 -290 -95       
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